Theoretical and experimental investigation of anaesthetic effects in the brain by Noroozbabaee, Leyla
 
 
 
http://researchcommons.waikato.ac.nz/ 
 
 
Research Commons at the University of Waikato 
 
Copyright Statement: 
The digital copy of this thesis is protected by the Copyright Act 1994 (New Zealand). 
The thesis may be consulted by you, provided you comply with the provisions of the 
Act and the following conditions of use:  
 Any use you make of these documents or images must be for research or private 
study purposes only, and you may not make them available to any other person.  
 Authors control the copyright of their thesis. You will recognise the author’s right 
to be identified as the author of the thesis, and due acknowledgement will be 
made to the author where appropriate.  
 You will obtain the author’s permission before publishing any material from the 
thesis.  
 
Theoretical and experimental
investigation of
anaesthetic effects
in the brain
A thesis submitted
for the degree of
Doctor of Philosophy
in Physics
by
Leyla Noroozbabaee
October 2016
The University of Waikato

Abstract
The main motivation of this study is to develop a better understanding of anaesthetic
drug effects on brain dynamics including the paradoxical enhancement of seizure activity
by some anaesthetic drugs. This thesis investigates two mean-field descriptions for the
effect of general anaesthetic agents on brain activity: the extended Waikato cortical model
(WM) and the Hindriks and van Putten (HvP) thalamocortical model. In the standard
Waikato model, the population-average neuron voltage is determined by incoming activity
at both electrical (gap-junction) and chemical synapses, the latter mediated by AMPA
(excitatory) and GABAA (inhibitory) receptors. Here we extend the standard WM by
including NMDA (excitatory) and GABAB (inhibitory) synapses. GABAergic anaesthet-
ics, such as propofol, boost cortical inhibition by prolonging the tail of the unitary IPSP
(inhibitory postsynaptic potential) at GABAA receptors, while increasing the synaptic
gain at the slower-acting GABAB receptors. Dissociative anaesthetics act on NMDA re-
ceptors to give a voltage-dependent alteration of excitatory synaptic gain. We find that
increasing GABAB or NMDA effect can alter the spatiotemporal dynamics of the stan-
dard WM, tending to suppress spatial (Turing) patterns in favour of temporal (Hopf)
oscillations. The extended WM predicts increased susceptibility to seizure when GABAB
effect is increased, particularly if the GABAergic agent reduces gap-junction diffusion.
We tested these WM predictions with two biological experiments. We found that
potentiation of GABAB receptors in slices of mouse cortical tissue tended to enhance
seizure-like activity. However, our in vivo investigation of the effect of closure of gap
junctions did not reveal any seizure patterns in mouse EEG signals.
In the second part of this thesis, we present a detailed analysis of the HvP thalam-
ocortical mean-field model for propofol anaesthesia. While we were able to confirm the
Hindriks and van Putten predictions of increases in delta and alpha power at low levels
of anaesthetic sedation, we find that for deeper anaesthetic effect, the model jumps from
the low-firing state to an extremely high-firing stable state (∼250 spikes/s), and remains
stuck there even at GABAA prolongations as high as 300% which would be expected to
induce full comatose suppression of all firing activity. To overcome this pathological be-
haviour, we tested two possible modifications: first, eliminating the population-dependent
anaesthetic sensitivity (efficacy) of the HvP model; second, incorporating reversal poten-
tials and tuning the excitatory sigmoid parameters defining the mapping from voltage
ii
to firing rate. The first modification removes the pathological state, but predicts de-
creasing alpha and delta power as drug concentration increases. The second modification
predicts induction-emergence hysteresis (drug concentration is higher at induction than
at emergence), but the alpha rhythm is lost, being replaced by a dominant delta-band
oscillation.
Original contributions
To the best of my knowledge, this thesis contains no copy or paraphrase of work pub-
lished by another person, except where duly acknowledged in the text. In Chapter 3, the
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My major contribution in this thesis is the detailed study of the dynamical behaviour
of the Hindriks and van Putten (HvP) thalamo-cortical system equations across the full
physiological range of anaesthetic concentration, highlighting a deficiency of the HvP
model under deepening anaesthesia. Then, I investigate some modifications to overcome
the unphysiological behaviour observed in the HvP model.
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Chapter 1
Introduction
The main motivation of this study is to improve our understanding of patients’ responses
to anaesthetics and to reduce the risk of seizures. This is accomplished by studying drug
effects on brain dynamics, focusing on anaesthetic drugs, as some anaesthetics induce
seizures.
The brain is a complex system characterized by its structures and its dynamics. Al-
though its structural architecture has been studied for more than a hundred years, its
dynamics has been investigated for just the last few decades. In this thesis, we study
the dynamical behaviour of an anaesthetised brain through two different modelling ap-
proaches: cortical and thalamo-cortical.
Having a basic knowledge of brain structure is a necessary prerequisite for investigation
of brain dynamics. We start this chapter with an overview of fundamental neurophysio-
logical concepts and definitions relevant to single neurons as the primary elements of the
nervous system.
Then follows a brief summary of brain architecture, focusing on cerebral cortex and
thalamus, brain rhythms and functional states. We are particularly interested in the
altered rhythms of the anaesthetized brain, attempting to identify the underlying mech-
anisms for anaesthesia induction and recovery.
In the second part of this chapter, I review several computational mean-field ap-
proaches for an anaesthetised brain and their related formulations. I conclude with a
comparison between the different models and their outcomes.
1.1 Elements of neurophysiology
Capturing the essential neurological features of spiking neurons is necessary since these
comprise the basic building blocks of the nervous system. Similarly, understanding single-
neuron dynamics is the first step towards the large-scale modelling of neural populations.
1.1.1 Neuron
Nerve cells known as neurons are functional units of nervous system that contain specific
structures: cell body, dendrites, axon and axon terminals. The cell body is the metabolic
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Figure 1.1. Schematic of a biological neuron. Neurotransmitters released at the axon terminal
of a presynaptic neuron induce small excitatory or inhibitory voltage pulses in the dendritic
branches of the receiving neuron [a]. These incoming voltage events propagate to the cell body
(soma) where they are integrated. If a threshold voltage is exceeded, a large voltage spike or
action potential is generated [b], which propagates down the axon towards the axon terminal,
where neurotransmitters are released to stimulate the next neuron [c].
centre of the neuron responsible for cell protein synthesis. Dendrites are short cytoplasmic
processes that extend from the cell body and serve as the main apparatus for receiving
stimuli from other neurons. The cell body also gives rise to the axon, a long cytoplasmic
process that transmits electrical impulses from the cell body to other neurons via the
axon terminals. As shown in Fig. 1.1, when a nerve cell is stimulated, the electrical
current from local neural populations is sampled by the postsynaptic dendrites. These
currents propagate toward the cell body where they are integrated, producing changes
in the internal voltage of the cell. If the voltage change is small, then the voltage can
propagate along the axon for a short distance. But if the perturbed voltage exceeds the
voltage threshold, then a large voltage spike (action potential) is triggered, and travels
along the axon away from the soma body towards the terminal branches, causing release
of neurotransmitters into the synaptic cleft.
1.1.2 Synapses
Neurons communicate with each other through synapses. Synapses can be either chemical
or electrical:
• In chemical synaptic signalling, the sending cell is called the presynaptic neuron
while the cell receiving the signal is the postsynaptic neuron. The presynaptic axon
terminal is separated from the postsynaptic cell by a small space called the synaptic
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Figure 1.2. Schematic diagram of synapses. (a) Chemical synapse. In response to the arrival
of an action potential, voltage-gated calcium channels are activated, causing the release of neu-
rotransmitters from vesicles in the axon terminal of presynapses into the synaptic cleft where
neurotransmitters bind to the appropriate receptors on the postsynaptic neuron. (b) Electrical
synapse. Electrical transmission is mediated by clusters of intercellular channels called gap junc-
tions that connect the cytoplasm of the two neighbouring cells, and thereby enable bidirectional
passage of electrical currents carried by ions.
cleft, Fig. 1.2(a). Most presynaptic axons terminate near the dendrites of the post-
synaptic cell. Signals from presynaptic neurons cause release of neurotransmitters
that diffuse across the synaptic cleft to bind with receptors on the postsynaptic den-
drite resulting in changes in the membrane potential [37]. Receptors are classified
as either ionotropic receptors (ligand-gated) or metabotropic receptors:
1. For ionotropic (direct) receptors, the postsynaptic receptor contains both the
transmitter binding site and the ion channel which can be opened by the trans-
mitter as part of the same receptor. These receptors can be activated by neu-
rotransmitters (ligands) like α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) or deactivated by neurotransmitters like gamma-aminobutyric
acid (GABAA) and glycine.
2. For metabotropic (indirect) receptors, the transmitter binds to receptors like
G protein-coupled receptors that are neither excitatory nor inhibitory. They
are not able to open ion channels themselves, but modulate the actions of exci-
tatory and inhibitory neurotransmitters. GABAB is a metabotropic receptor.
Direct receptors are often referred to as fast receptors, since their activation time is
much shorter than the response time of indirect receptors [5].
• In electrical synapses, Fig. 1.2(b), there is a direct connection from one neuron
to another through gap junctions. These gaps allow physiological components like
molecules and ions, and electrical impulses to pass directly from one cell to another
[65].
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Ion Inside (mM) Outside (mM) Nernst potential (mV)
K+ 140 5 89
Na+ 5 to 15 145 90 to 61
Cl− 4 110 −89
Ca2+ 10−4 2.5 to 5 136 to 145
Table 1.1. Typical ion concentrations and Nernst potentials for a resting neuron. Nernst volt-
age which represents the equilibrium potential is calculated using Eq. (1.8) in the standard con-
dition for a neuron at body temperature (37◦C) with RT/F = 26.7 mV (R = 8.314 J K−1 mol−1
is the ideal gas constant; F = 9.648 × 104 C mol−1 is the Faraday constant; T is the absolute
temperature in K) [78].
In Chapter 3, we present the extended version of the Waikato model with four different
receptor populations: AMPA, GABAA, GABAB and N-methyl-D-aspartate (NMDA). For
modelling their response functions, we need to be able to estimate their relative rise and
decay times.
1.1.3 Membrane potential
All living cells maintain a potential difference across the cell membrane. The membrane
potential of a postsynaptic cell may either increase or decrease relative to its resting poten-
tial, depending on the nature of the released neurotransmitter and the type of receptor it
binds to. The membrane potential arises from two physical concepts: ionic concentration
gradients and electric forces.
• Na+, Cl− and K+ are the three main ionic species found inside a living cell. The
concentration of K+ ions inside the cell is about 10 times higher than that outside,
while the concentrations of Na+ and Cl− are much higher outside than in; see Table
1.1. Due to these concentration differences, sodium and chloride ions tend to move
into the cell, while potassium ions diffuse outwards.
• Electrical forces arise due to the separation of charges.
The membrane potential at which the diffusion and electrical forces are exactly balanced
is known as the equilibrium potential. We discuss this concept in more detail in the
following section.
1.1.4 Rest potential
When a neuron is at rest state, there is a potential difference across its membrane due to
an imbalance of electrical charges between the interior and exterior of the cell. The resting
potential of excitable cells lies in the range −60 to −95 mV. Two different equations can
be used to calculate rest potential; the choice of equation depends on the number of ion
species free to move across the membrane.
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Nernst equation
If only one type of ion channel is present, then the Nernst potential sets the equilibrium
or resting membrane potential. It can be calculated from the charge on the ion and its
concentration gradient across the membrane using Fick’s law of diffusion [22].
If the concentration of ions at point x is C(x) [ions/cm3], then the diffusive flux
through the membrane, Jdiff [ions/cm
2.s], is given by Fick’s law of diffusion which in one
dimension reads
Jdiff = −DdC
dx
, (1.1)
where x is the spatial dimension and D is the diffusion constant [cm2/s]. The other
physical force which is responsible for the movement of ions is the electrical drift described
by the microscopic version of Ohm’s law:
Jdrift = −µz C dV
dx
, (1.2)
where V (x) [volts] is the potential at point x, z is the valence of the ion, and µ is mobility
[cm2/volt s]. The total flux, Jt, across the membrane is given by the sum of these two:
Jt = −DdC
dx
− µz C dV
dx
. (1.3)
Einstein’s relation, also known as the electrical mobility equation for diffusion of charged
particles, connects the mobility with the diffusion coefficient:
D =
kT
q
µ, (1.4)
where k is Boltzmann’s constant [J K−1], T is the absolute temperature [K], and q is the
charge of the particle in coulombs. Substituting Eq. (1.4) in (1.3), we rewrite the total
flux as:
Jt = −µ
(
kT
q
)
dC
dx
− µz C dV
dx
. (1.5)
The Nernst equation is obtained by setting the total flux to zero, for a given ion species.
Replacing kT/q with RT/F , where R = 8.314 J K−1 mol−1 is the ideal gas constant and
F = 9.648 × 104 C mol−1 is the Faraday constant, we are able to convert this equation
expressed in terms of the number of individual molecules into its molar equivalent:
FC z
dV
dx
= −RT dC
dx
(1.6)
which can be integrated [22] through the following equation:∫ Vin
Vout
dV = −RT
zF
∫ Cin
Cout
dC
C
, (1.7)
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where Cout and Cin are ion concentrations outside and inside the cell, respectively, and
Vout and Vin represent the membrane potential. Equation (1.7) can be solved to give
Vm = Vin − Vout = −RT
zF
ln
Cin
Cout
, (1.8)
where Vm is the equilibrium potential across the membrane.
Goldman-Hodgkin-Katz equation
For cases where two or more ions are present, to calculate the resting cell potential the
Goldman-Hodgkin-Katz (GHK) equation should be used rather than the Nernst equation.
In the GHK equation, the relative contribution of each ion to the membrane potential is
considered not only through its concentration gradient and valence, but also by its relative
permeability [22]. The GHK voltage for cell membrane is given by:
Vm =
RT
F
ln
(
PNa[Na
+]out + PK[K
+]out + PCl[Cl
−]in
PNa[Na
+]in + PK[K
+]in + PCl[Cl
−]out
)
(1.9)
where Vm is the membrane potential, Pion is the permeability [cm/s] for a given ion and
[ion]out and [ion]in are the extracellular and intracellular ion concentration, respectively,
in [ions/cm3].
The reversal potential for a given ion is the membrane voltage at which there is no net
ion flux through the individual channel, and is identical to the Nernst potential only for
the case of a single ion channel being active. Reversal potential and membrane equilibrium
are not identical in human neuron membrane, as there are multiple ion channel types. In
other words, a membrane potential for which the summation of the ionic currents is zero,
does not necessarily correspond to a true reversal potential for each ion channel, as not
all ions will be in equilibrium.
To maintain resting potential and to propagate action potentials, neurons are con-
stantly exchanging ions with the extracellular environment. However, the electric poten-
tial generated by an individual neuron is too small to be detected by electroencephalog-
raphy (EEG) scalp electrodes. In fact, a common modelling assumption is that the EEG
is the temporally and spatially-averaged local fluctuation of populations of excitatory
neurons around their resting potential [13, 90]. However, some researchers (e.g., Hutt et
al. [44]) model the soma voltage which results from a membrane integration of all postsy-
naptic potentials: the excitatory postsynaptic voltages minus the inhibitory postsynaptic
voltages.
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1.2 Brain activity and the effect of anaesthetic drugs
Because of the complexities of brain structure, modellers limit their focus to those brain
areas which are presumed to be most relevant to their research goals. To investigate the
brain function affected by anaesthetic agents, two areas are considered to be of primary
importance: cerebral cortex and thalamus.
The cortex is grey matter, divided into two almost symmetrical halves called cerebral
hemispheres, composed of about 1010 excitatory and inhibitory interacting neurons. The
cerebral cortex is connected to various subcortical structures such as the thalamus and
the basal ganglia, transmitting information to them via efferent connections and receiving
information from them through afferent connections. The cerebral cortex directs all forms
of conscious experience, including perception, emotion, thought, planning, and memoriza-
tion. Thalamus is located in the centre of the brain, with nerve fibres branching out to
the cerebral cortex in all directions, acting as a relay between subcortical areas and the
cerebral cortex. Thalamus plays a major role in regulating arousal, consciousness, and
activity [27,56,81]. Damage to the thalamus can lead to permanent coma.
To study brain activity, EEG is one of the common methods. EEG scalp electrodes
detect the summed electrical activity of excitatory postsynaptic potentials in apical den-
drites of pyramidal neurons in the exterior layers of the cortex. The spatiotemporally
oscillating EEG forms brain rhythms which reveal brain states that can be distinguished
through frequency and amplitude as illustrated in Fig. 1.3.
1.2.1 Normal brain rhythms
EEG electrodes can determine the relative strengths and locations of electrical activity
in different brain regions [96]. Brain activity changes in a consistent and recognizable
way according to the functional status of the brain, such as alertness, relaxation, sleep,
anaesthesia, lack of oxygen and certain neural diseases, such as epilepsy [15]. EEG activity
in particular frequency bands can be extracted using spectral analysis of EEG recordings,
and are categorized as below [6, 16,83] illustrated in Fig. 1.3.
Delta is the name given to EEG activity in the frequency range 0.5 to 3 Hz. Delta
activity is characterised by high amplitude slow waves, and is observed in central and
frontal areas of the cerebral cortex. Delta activity is probably the major EEG pattern of
the deeply asleep and anaesthetized human brain.
Theta covers the frequency range 3.5 to 8 Hz and is classified as “slow” activity.
Commonly seen in drowsiness, theta activity is associated with relaxed, meditative, and
creative states. Theta response is the most stable component in frontal regions of the
cortex.
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Figure 1.3. EEG brain rhythms. (a) Delta waves 0.5− 3 Hz, deep sleep and anaesthesia; (b)
Theta waves 3−8 Hz, extreme relaxation and drowsiness; (c) Alpha waves 8−14 Hz, just before
falling asleep and hypnosis; (d) Beta waves 12 − 30 Hz, awake and normal alert consciousness;
(e) Gamma waves 30−100 Hz, high level information processing (modified from different figures
in [16]).
Alpha activity ranges from 8 to 14 Hz. It is seen in the posterior regions of the cortex.
It emerges with closing of the eyes and with relaxation, and attenuates with eye opening
or mental exertion. It is the major rhythm seen in normal relaxed adults.
Beta has a frequency range from 15 to about 30 Hz. Beta is seen usually on both
sides in symmetrical distribution and is most evident frontally. Beta activity is closely
linked to motor behaviour and is generally attenuated during active movements.
Gamma is the name given to EEG activity above 30 Hz. Gamma rhythms are
distributed in different cortical and subcortical structures [7, 16], and are thought to
represent binding of different populations of neurons together into a network for the
purpose of carrying out a particular cognitive or motor function.
1.2.2 Pathological brain rhythms
Seizures are the clinical manifestation of the pathological synchronous electrical activity in
the brain. They emerge from a hyperexcitable focus within the brain where synchronized
electrical activity originates. Seizures are mainly classified into three different types [19]:
1. Focal seizures affect one hemisphere of the brain.
2. Generalized epilepsy is characterised by global seizures with no apparent cause.
3. Unclassified epileptic seizures which are of unknown origin and may not have
distinct clinical and electrical features that allow easy classification.
Figure 1.4(a) presents brain activity in the presence of seizures, while Fig. 1.4(b) shows
brain activity in the absence of seizures.
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Figure 1.4. Recorded EEG activity in the presence and the absence of seizures, from Fig. 1
of [12].
Approximately 10% of the population has a single convulsive episode during their
lifetime. In this situation, the use of anticonvulsants is not indicated. If there are recurrent
seizures, and the diagnosis of epilepsy is confirmed, routine treatment with antiepileptic
drugs is initiated [68]. The mechanism of action of these drugs is not fully explained, but
appears to be related to the decrease of sodium ion current (blocking voltage-dependent
sodium channels), increasing the inhibitory effects of GABA, and blocking the NMDA
and AMPA receptors.
Anaesthesiologists are frequently faced with seizures in epileptic and nonepileptic
patients in the surgical theatre. Some anaesthetic drugs used during anaesthesia pos-
sess proconvulsant properties that may trigger clinical seizures at induction or emer-
gence. Anaesthetic-induced epilepsy has been reported during anaesthesia with sevoflu-
rane, isoflurane, etomidate, and opioids as well as propofol [111]. In Chapter 4, we aim
to investigate the effects of anaesthetic drugs on brain activity and also the possible
underlying mechanism of seizure activity in an anaesthetised brain.
1.2.3 Stages of anaesthesia
Attempts at producing a state of general anaesthesia can be traced throughout recorded
history in the writings of the ancient Persian, Egyptian, Greek, Roman, and Chinese
scholars [74,94]. During the Middle Ages scientists made significant advances in medicine
in the Eastern world, while their European counterparts also made important advances.
By the middle of the seventeenth century, narcotic drugs become more popular as Nicolas
Bailly administered a narcotic potion to a patient before an operation; however, Bailly
was arrested and fined for practising witchcraft. In 1846, William Morton first intro-
duced ether anaesthesia. This was followed shortly after by nitrous oxide and chloroform.
Within a few decades, surgical anaesthesia was being used around the world. Although
anaesthetic drugs and delivery techniques have changed, the principles of anaesthesia and
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its stages have remained largely unchanged since 1937 when Guedel developed a catego-
rization of the stages of general anaesthesia [34]. These include [34,38]:
1. Induction The period between the administration of anaesthetic drugs and loss of
consciousness (LOC). At this stage the patient experiences pain relief and dizzy,
dreamy disorientation.
2. Excitement The time following LOC associated with intense activity like uncon-
trolled movement and possibly irregular heart rate and breathing. Due to risks for
some patients, the ideal anaesthetic protocol yields a quick and smooth progression
to stage 3, which also results in a more rapid recovery.
3. Surgical anaesthesia Muscles are relaxed, breathing becomes regular and surgery
can begin.
4. Recovery The effects of anaesthetic drugs are eliminated and the patient wakes
up.
1.2.4 Anaesthetic drug effects on brain activity
Anaesthesia controls pain and produces unconsciousness and loss of memory by interfering
with neuron communication. In an active brain, the dominant frequency of the EEG lies
between 12.5 and 30 Hz, while after administration of anaesthetic drugs it drops to very
low δ-band frequencies (0.5 − 4 Hz) in phase 2 of anaesthesia Fig. 1.5(B); this is very
similar to the EEG pattern for the naturally sleeping brain in non-REM stage 3 sleep; see
Fig. 1.5(C).
Although different groups of general anaesthetics act through distinct molecular tar-
gets and therefore via different mechanisms, all produce the same clinical outcome which
is unconsciousness [26]. Two common molecular targets of anaesthetic drugs are GABA
and NMDA receptors [21,90]:
• GABAergic anaesthetics (e.g., propofol, etomidate, alfaxalone, and thiopental): the
anaesthetic molecule binds to a specific site on the GABA receptor of the postsynap-
tic neuron, causing chloride ion channels to remain open longer, allowing chloride
ions to accumulate inside the postsynaptic neuron. Consequently the neuron be-
comes more hyperpolarized, and therefore less likely to fire, see Fig. 1.6. In general,
these anaesthetic agents enhance the inhibitory effect of GABA receptors by in-
creasing the time decay of the inhibitory postsynaptic potential [1, 8, 56,106].
• NMDAergic anaesthetics (e.g., ketamine and nitrous oxide): this class of agents
act on NMDA receptors of the postsynaptic neuron by reducing the amplitude
of postsynaptic potential of the excitatory receptor, so are referred to as NMDA-
antagonists. Modelling the action of this receptor is not easy as the duration of
the excitatory postsynaptic response to a presynaptic action potential depends not
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Figure 1.5. Electroencephalographic patterns during the awake state, general anaesthesia, and
sleep. Panel A shows the EEG patterns when the patient is awake, with eyes open (left) and
the alpha rhythm and with eyes closed (right). Panel B illustrates EEG patterns during the
states of general anaesthesia: paradoxical excitation, phases 1 and 2, burst suppression, and
the isoelectric tracing. Panel C shows the EEG patterns during the stages of sleep: rapid-eye-
movement (REM) sleep; and stages 1, 2, and 3 of non-REM (slow-wave) sleep (EEG tracings
during awake and general anaesthesia from Fig. 1 of [83] and EEG tracings during sleep from
Fig. 3 of [103]).
only on anaesthetic concentration but also on the voltage state of the receiving
neuron [56,81].
Two significant drug-related phenomena that have attracted researcher attention in
the last few decades are the biphasic response and hysteresis.
Biphasic response refers to the dose-dependent changes in EEG activity, with an ini-
tial increase at relatively low concentrations, and a subsequent decrease with increasing
concentrations [52,59,82]. Figure 1.7 illustrates the biphasic effect of propofol anaesthetic
on EEG signal for two different frequency ranges, 0 to 5 Hz and 11 to 15 Hz.
Hysteresis: The blood concentration of anaesthetic agent needed to put a patient to
sleep is greater than the concentration observed when the patient returns to conscious-
ness. Figure 1.8 shows EEG signal amplitude as a function of measured propofol blood
concentration. There are two distinct surges in activity at distinct drug concentrations:
the patient loses consciousness at a considerably higher propofol (about 2.5-fold) concen-
tration than that at which she wakes up. Researchers have identified two possible reasons
for this phenomenon. First, it takes some time for the drug to diffuse from the blood (the
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Figure 1.6. GABA receptor and GABAergic anaesthetic drugs. (a) An action potential
arriving at the terminal of an inhibitory neuron results in diffusion of GABA neurotransmitter
across the membrane where it binds to the pentameric GABAA receptor, allowing chloride
ions flow to the postsynaptic neuron, leading to hyperpolarization. (b) General anaesthetics
prolong chloride channel opening and increase postsynaptic inhibition. (c) A pentameric GABAA
receptor complex in the lipid bilayer membrane consists of five protein subunits (from Fig. 3
of [81]).
measurement site) into the brain (the “effect” site), leading to the so-called effect-site
displacement error which can be partially compensated for using pharmacokinetic mod-
elling [24, 59, 99]. Second, it has been observed that the central nervous system tends to
resist transition between conscious and unconscious states; this is known as the neural
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Figure 1.7. Biphasic effect of propofol anaesthetic on 0 to 5 Hz and 11 to 15 Hz EEG sig-
nal. During the 10 min of propofol infusion, anaesthetic concentration increases steadily. At
low concentrations, the EEG signal shows initial activation, followed by power decrease as con-
centration is further increased and the patient becomes deeply unconscious. A second EEG
activation peak is observed as the anaesthetic concentration reduces and the patient starts to
emerge from unconsciousness (graph modified from Steyn-Ross et al [91]; data supplied courtesy
of Kuizenga, and reported as “Patient 7” in [59].).
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Figure 1.8. EEG “amplitude” data from Fig. 1.7 plotted as a function of measured propofol
blood concentration. (a) 0–5 Hz; (b) 11–15 Hz. Each trajectory commences at the lower-left
corner at zero concentration. For the 0–5 Hz band, the activation peak is stronger during the
induction phase (right-hand peak); for the 11–15 Hz band, the activation peak is considerably
stronger at emergence (left-hand peak) (reference as for Fig. 1.7).
inertia effect. It has been found that the forward path from conscious to unconscious and
the reverse path from unconscious to conscious are not identical [28].
1.3 Mathematical models for anaesthesia
There are two complementary yet contrasting theoretical approaches to modelling neural
activity in the human brain: neural networks and population models.
Spiking neural networks The first experimentally-based mathematical model of
a spiking neuron was introduced by Hodgkin and Huxley in 1952 [42]. This model de-
scribes the initiation and propagation of action potentials in single neuron, but is not
able to explain brain activity associated with higher functions such as memory, learning
and pattern recognition, since these functions of nervous system appear to require the
coordinated activity of large numbers of neurons. Thus, modellers have been motivated
to construct networks of spiking neurons to simulate different brain states. These models
are characterized by large numbers of neurons that communicate through synapses with
information encoded or decoded through a series of pulse trains [32,66].
One of the most ambitious attempt in this area is The Blue Brain Project, founded
in May 2005 by the Brain and Mind Institute of the Ecole Polytechnique Federale de
Lausanne (EPFL) in Switzerland. The long term aim of this project is to study the brain’s
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architectural and functional principles. The initial goal of the project was simulation of
a neocortical macrocolumn, which is about 2 mm tall, has a diameter of 0.5 mm, and
contains about 60,000 neurons. The neocortical column represents the basic functional
unit of the cerebral cortex in mammals, and these units are repeated millions of times
across the cortex. The simulation does not consist simply of an artificial neural network,
but involves biologically realistic models of individual neurons and neuron communication
[67]. However, the real world application of large scale spiking neural networks has been
limited: first, the vast number of neurons and their interconnections make numerical
computation of anything close to biological reality impossible; second, many anatomical
and physiological parameters which must be incorporated into the model are known only
as average properties.
Mean-field models In this approach, researchers investigate the spatial variation
and time evolution of the average properties of large groups of excitatory and inhibitory
neurons. Mean-field models are suited to data which reflect the behaviour of populations
of neurons, such as the electroencephalogram (EEG). These models aim to relate well-
known microscopic targets of general anaesthetic action to their macroscopic consequences
as detected by changes in EEG activity. We now present a brief overview of some mean-
field models for anaesthetic action.
1.3.1 Waikato anaesthesia mean-field model (1999)
The first attempt to use mean-field modelling to reproduce the effect of the GABAer-
gic anaesthetic agent propofol on brain activity was by the Cortical Modelling Group
at Waikato University [91]. Their work adopted the Liley mean-field model [63] which
assumes that neural parameters have been averaged over small volumes of cortex known
as macrocolumn elements. These macrocolumns contain two distinct neuron populations
(85% excitatory, 15% inhibitory), which interact through chemical synapses. These in-
teractions are either short range (inside the macrocolumn), long range (excitatory inputs
from other macrocolumns), or exogenous (input from the thalamus and brain-stem) [90].
Steyn-Ross et al. [91] incorporated the effect of the general anaesthetic agent propofol
at the cortex as a modulation of the inhibitory neurotransmitter rate-constant γi [s
−1]
which was paired with an increase in inhibitory postsynaptic strength ρi [mV s],
γi =
γ0i
λ
, ρi = λρ
0
i (1.10)
where scale-factor λ ≥ 1 represents propofol effect: the zero-anaesthetic background
values of inhibitory rate-constant γ0i and synaptic strength ρ
0
i are scaled by λ after ad-
ministration of propofol. The original 1999 formulation of the Waikato model proposed
an alpha response function to model the inhibitory postsynaptic responses, Fig. 1.9(a);
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Figure 1.9. Effect of propofol on GABAergic synapses in the Waikato model. The synaptic
response function is plotted as a function of time for three different drug concentrations. As
the drug effect increases, the decay rate decreases. Model impulse responses for the (a) alpha
function γi te
−γi t and (b) biexponential function γiγ/(γ − γi)(e−γi t − e−γ t) . The symbol λ
is a dimensionless anaesthetic-effect scale-factor giving the lengthening of the inhibitory post
synaptic potential (IPSP) duration.
however, in the present work we use a biexponential response function, see Fig. 1.9(b);
more detailed information is given in Chapter 3.
The model’s steady-state voltage distribution Ve as a function of anaesthetic effect λ
enabled Steyn-Ross et al to define three distinct regions for the brain under the effect of
the anaesthetic agent propofol, Fig. 1.10. For the high levels (region I:“coma”) and low
levels (region III: “anti-anaesthetic”) of anaesthetic effect only a single state was available;
while for intermediate values (region II), three steady-state solutions were found.
The model predicts that a first-order transition to the low-firing branch can occur at
critical values of the drug concentration λ = 1.53 from A3 in high firing state (LOC: loss
of consciousness); similarly, a transition from the quiescent to the active branch can occur
at specific drug concentration λ = 0.28 from Q1 in the low firing state (ROC: recovery
of consciousness). As can be seen in Fig. 1.10, the LOC and ROC correspond to two
different levels of anaesthetic effect, predicting a drug hysteresis effect. In other words,
the patient will awaken at a lower concentration of anaesthetic than that required to put
her to sleep.
In addition to predicting a drug-hysteresis effect, the model also exhibits biphasic
behaviour. In Fig. 1.11(a), the induction path shows a power surge at λ = 1.53, followed
by an abrupt decrease in EEG power beyond this point, signalling a transition from the
wake to the anaesthetized state. In Fig. 1.11(b) the emergence phase shows a second
surge at λ = 0.28 representing return from wake to consciousness.
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Figure 1.10. Steady-state trajectory for the 1999 Steyn-Ross et al anaesthesia model [91]. In
region I for λ > 1.53, the neural firing is strongly suppressed (“coma”); in region III for λ < 0.3,
the neural firing is maximized (“seizure”). In region II, there are three different values for soma
voltage, however only two of these are stable: the upper (active) and lower (quiescent) branches
(from Fig. 5 of [90]).
In 2007 Steyn-Ross et al [93] made a significant enhancement to the biophysical fidelity
of their cortical model with the inclusion of electrical gap-junction synapses to supplement
communication via standard chemical synapses. This change supports the emergence
of spatial and spatiotemporal oscillatory modes that are not accessible in the original
1999 equations. Although the predictions of a biphasic effect and drug hysteresis are
clear model successes, there are two deficiencies in the original 1999 Waikato model for
anaesthesia:
• The biphasic power surge arises from critical slowing associated with close approach to
the saddle-node1 annihilation points at A3 (induction) and Q1 emergence, Fig. 1.10,
such that the spectral energy becomes focussed to zero frequency. There is no
possibility of a Hopf2 (at say delta or alpha frequencies) tuning of spectral response.
• The recovery of consciousness apparently requires λ-values to be smaller than unity,
implying an “anti-anaesthetic” effect.
• The recovery of consciousness apparently requires λ-values to be smaller than unity,
implying an “anti-anaesthetic” effect.
1Saddle-node bifurcation is a local bifurcation in which two equilibria of a system collide and annihilate
each other.
2Hopf bifurcation is a critical point where a system’s stability changes and a periodic solution arises.
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Figure 1.11. Spectral power predictions for Steyn-Ross et al (1999) model. (a) At low concen-
tration of propofol the EEG signal shows an initial increase in power (activation). EEG power
falls way as concentration is increased and the patient becomes deeply unconscious. (b) gives
a view of the emergence: as the drug concentration is decreased, EEG power increases; EEG
power decreases at λ = 0.28 when patient returns to conciousness (from Fig. 5.7 of [90]). These
theoretical power spectra were calculated using linear stochastic theory (e.g., see Eq. (4.5.78) of
Gardiner (2008)
Subsequent anaesthetic modelling, including later contributions by the Waikato group and
alternative models due to Liley [13], Hutt [44], Hindriks [40], and Molaee-Ardekani [71]
have addressed one or both of these limitations. As a part of my thesis research, I have
enhanced the 2007 Waikato model by including GABAB and NMDA synapses. The revised
model predictions are reported in Chapters 3 and 4.
1.3.2 Bojak and Liley (2005) anaesthesia model
Bojak and Liley (2005) presented a mean-field description of the effect of the anaesthetic
agent isoflurane on brain activity [13]. Bojak and Liley formulated a set of equations for
the peak amplitude, time decay and time rise of the excitatory and inhibitory postsynaptic
potential (PSP) as a function of drug concentration. This was done by fitting recorded
IPSPs and EPSPs to Hill equations,
Γe(c) ' Γe(0) 0.707
2.22
0.7072.22 + c2.22
, Γi(c) ' Γi(0)0.79
2.6 + 0.56c2.6
0.792.6 + c2.6
, (1.11)
δe(c) ' δe(0), δi(c) ' δi(0) , (1.12)
ζe(c) ' ζe(0), ζi(c) ' ζi(0)0.32
2.7 + 4.7c2.7
0.322.7 + c2.7
, (1.13)
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Figure 1.12. Hill equations for isoflurane impact on IPSP amplitude and decay time. (a) Peak
amplitude of inhibitory postsynaptic responses decreases as the drug concentration increases. (b)
Time decay of inhibitory postsynaptic responses increases as the drug concentration increases.
where Γ(c) indicates that the peak amplitude is a function of drug concentration, c, for
both excitatory (e) and inhibitory (i) PSPs. Figure 1.12(a) illustrates a decrease in the
peak amplitude of inhibitory postsynaptic response as drug concentration increases. While
the time rise, δ, shows negligible dependence on concentration, Eq. (1.12), the time decay,
ζ, (time required for the PSP to fall to e−1 of the maximum amplitude) of Eq. (1.13) shows
that the IPSP decay increases with isoflurane concentration, see Fig. 1.12(b). Bojak and
Liley proposed a biexponential response function R(t) [mV] to model the postsynaptic
responses
R(t) = eβδΓ α
e−βt − eαt
α− β , (1.14)
β ≡ 
e − 1
1
δ
, (1.15)
α ≡ eβ , (1.16)
where R specifies the biexponential fit in terms of δ, the rise time to maximum, and a
control parameter , a remarkably complicated nonlinear function of PSP decay time ζ(c),
 '
A′︷ ︸︸ ︷
e2.5466−1.3394k
A′′︷ ︸︸ ︷√
k − 1︸ ︷︷ ︸
A
+
B′︷ ︸︸ ︷[
e−1.2699(k−1) − 1]
B′′︷ ︸︸ ︷[
1
k2
+W−1
(
e−
0.236
k2
1− 3.146k
)]
︸ ︷︷ ︸
B
, (1.17)
with
k =
ζ(c)
ζ(0)
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Figure 1.13. Epsilon control parameter for Bojak and Liley model. -function decomposed into
two simpler parts: A and B, see Eq. (1.17). (a) illustrates A and its component parts: A′ A′′;
(b) corresponds to B which is a multiplication of B′ and B′′. Panel (c) illustrates epsilon control
parameter, the summation of A and B. Epsilon increases with drug concentration, approaching
saturation at c = 1 mM.
To better understand this function, I have decomposed it into two simpler functions A and
B. Figure 1.13 illustrates construction of the -function in terms of its component parts.
Here W−1 is the Lambert W function (see Chap. 2.2 for more details). Figure 1.13(c)
shows that the epsilon control parameter increases monotonically with drug concentration.
However, for  = 0 (i.e., no anaesthetic drug), the response reduces to a simple alpha
function
R0(t) = eΓα te
−αt . (1.18)
The authors employed swarm searches to identify 73454 suitable cortical parameter
sets shown in Fig. 1.13 using the full nonlinear model. Since these sets all allowed a
quasi-linear approximation, the very majority of parameters sets was identified in a mas-
sive Monte Calo search using a linear approximation. The first criterion was the existence
of at least one stable equilibrium solution with firing rates between 0.1 and 20 [spike/s]
at c = 0. In the case of multiple solutions, they chose the one corresponding to the
lower membrane potential. This corresponds to the bottom branch of the Steyn-Ross
et al model of Fig. 1.10. Cortical parameter sets were then classified into two different
categories, non-biphasic and biphasic.
Non-biphasic set: Theoretical power spectra were computed. Acceptable spectra re-
quired 15–50% of the total power in δ-band (0–4 Hz), 10–25% in θ (4–8 Hz), 15–40% in
α-band (8–13 Hz), and 15–40% in β–band (13–30 Hz). In addition, the power ratios were
required to follow the relations
θ
δ
< 0.6 and
θ
α
< 0.7 .
Then they checked the 90% spectral edge frequency (SEF90), which is defined as the
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Figure 1.14. Spectral power for biphasic sets. Power spectra obtained through full grid
simulations with 27 parameters sets. A biphasic response was always observed in the alpha
frequency band (from Fig. 6 of [13]).
frequency below which 90% of the power resides. Then, they computed the quality of the
α peak, requiring
Q = ∆fα/fα > 5.5 , (1.19)
where ∆fα is the full width at half maximum.
Afterwards, they checked the extremal values of the spectra in the θ, δ, and α bands.
They required that the α maximum be not larger than five times, and not smaller than
one-third, the δ maximum. Furthermore, the θ minimum could not be larger than half of
either the α or δ maxima, and not larger than 90% of the δ minimum.
Biphasic set: In addition to all requirements defined for non-biphasic sets, biphasic sets
needed to fulfil one more requirement. If the total power at c = 0.24 mM rose to at least
1.4 times its value at c = 0 mM, that parameter set was classified as biphasic. Only 86
parameter sets exhibited a biphasic response, see Fig. 1.14.
Here, we highlight three main aspects of their work:
• The biphasic effect in EEG activity at low drug concentrations could occur without
requiring a transition between two distinct states.
• Although the non-biphasic sets vastly outnumbered the biphasic sets, the biphasic
sets provided a better agreement with experimental data [13].
• The model was not able to address the issue of hysteresis in the EEG. The PSP
responses were defined based on experimental data recorded during administration
of anaesthetic drugs. In order to investigate hysteresis, access to PSP recordings
during the recovery phase of anaesthesia is necessary.
1.3.3 Molaee-Ardakani (2007) anaesthesia model
For Molaee-Ardakani et al. (2007), the main focus was on slow EEG oscillations observed
during deeper levels of desflurane-induced general anaesthesia. While the main building
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Figure 1.15. (a) Equilibrium solutions of excitatory membrane voltage he when anaesthetic
drug concentration is varied between 0 and 1.8 mM. Stars are stable and circles are unstable
solutions of a linear stability analysis. (b) Ten seconds of simulated he signals at anaesthetic
concentration 1.5 mM (from Figs 11 and 6(d) of [71]).
elements of the Molaee-Ardakani model [71] are taken from the Steyn-Ross et al [91]
and Bojak and Liley [13] mean-field cortical models, the authors incorporated a new slow
ionic modulation of the sigmoidal voltage-to-firing rate transfer function for the excitatory
neural population. This sigmoid modulation was driven by a slow gating variable that
depolarized excitatory neurons when they were in the low firing state, and hyperpolarized
them when they were in high firing state.
At higher drug concentrations the slow mechanism induced neural cells to alternate
between two levels of activity referred to as Up and Down states, see Fig. 1.15(b), corre-
sponding to enhanced delta activity. The Molaee-Ardakani model results indicated that
at low drug concentration the simulated EEG showed low power across a broad range of
frequencies, while at the high range of drug concentration, the EEG showed a significant
increases in the energy of delta activity, Fig. 1.16. The model was not able to reproduce
other typical EEG rhythms such as spindles and alpha.
1.3.4 Hutt and Longtin (2010) anaesthesia model
The Hutt and Longtin mean-field model [44] describes the effective membrane potential
and involves excitatory pyramidal cells and inhibitory interneurons, excitatory and in-
hibitory synapses, non-local spatial interactions and an axonal conduction speed with the
inclusion of time-delay. Excitatory and inhibitory synapses can occur on both dendritic
branches of excitatory and inhibitory cells. The activity of synapses and neurons are
represented as averages over the population in small areas of some millimetres square
and short time windows. Hutt and Longtin investigated the effect of the anaesthetic
agent propofol which increases the decay time of inhibitory synapses. They predicted
the occurrence of a saddle-node bifurcation at a critical propofol concentration. This
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bifurcation models the transition between consciousness and unconsciousness during the
administration of general anaesthetics.
In their study, two different biexponential functions he(t) and hi(t) represent the re-
sponse of the mean postsynaptic potential for excitatory and inhibitory populations, re-
spectively,
hi(t) = aif (p)
β1β2
β2 − β1
(
e−β1t − e−β2t) , (1.20)
he(t) = ae
α1α2
α2 − α1
(
e−α1t − e−α2t) . (1.21)
These response functions are based on experimental recordings of the responses of single
synapses [57]. Here, ai,e are the synaptic gains for inhibitory and excitatory populations;
the rise times of the response functions for excitatory and inhibitory synapses are 1/α2 and
1/β2, and 1/α1 and 1/β1 are the corresponding decay times. The function f(p) indicates
the action of different concentrations of propofol on the inhibitory synapses as specified
by the anaesthetic weighting factor p ≥ 1
f(p) = r
−r
r−1 (rp)
rp
rp−1 with r =
β2
β1
, (1.22)
which guarantees a near constant height of the impulse response function hi(t) and yields
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Figure 1.16. Power spectra of simulated he signals at different drug concentrations. (a) For
very low drug concentration c = 0.2 mM, the power spectrum extends to high frequencies. The
eigenspectrum (dashed line) corresponding to this drug concentration is a descending function
that is reminiscent of the background spectrum of a real EEG signal in the waking period. (b)
Appearance of slow waves at c = 0.75 mM increases the power of the slow delta-band (from
Fig. 7 of [71]).
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Figure 1.17. (a) The action of anaesthetic drug concentration on inhibitory synapses f(p) is
plotted as a function of the weighting factor p ≥ 1. (b) Effect of propofol on inhibitory synapses
in the Hutt (2010) model. The synaptic response function is plotted as a function of time for
three different drug concentrations. As drug effect increases, the decay rate decreases.
an increasing charge transfer of the synapse with increasing p. Unlike previous models
[13, 40, 71, 91] which treat the conversion of EPSP and IPSP at the soma separately,
this model presumes the somatic conversion of the difference of excitatory and inhibitory
postsynaptic potentials.
They reported two different sets of steady-states: a single stationary solution and
three-root solutions. However, these results were possible only for a certain range of firing
threshold voltages. The single stationary solution V− = Ve − Vi occurred for all values
of p provided that the firing threshold of excitatory neurons is equal to or lower than
the threshold of inhibitory neurons, ΘE ≤ ΘI . In contrast, three stationary solutions
occurred for some values of p if ΘE > ΘI . However, these solutions occur only for V− < 0
and for stronger inhibition than excitation.
Figure 1.18(a) represents EEG power for a single solution case, showing increasing
power in the θ and α-band and a sequential increase then decrease of power in the δ-band.
In the case of multi-valued steady-state, they focused on the top branch, Fig. 1.18(b). The
increase and decrease of the EEG-power represents biphasic behaviour, but there were
some significant differences with EEG power from clinical general anaesthesia. Their re-
sults predict that δ-power should increase and decrease before the θ- and α-power biphasic
surges, while the power spectra in general anaesthesia reveals the power enhancement and
attenuation at high frequencies precedes that at low frequencies.
Interestingly, their results support both the findings of Bojak and Liley that biphasic
power spectra may emerge in the presence of a single resting state, and also the results
of Steyn-Ross et al. who suppose an instability as the origin of biphasic behaviour.
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Figure 1.18. Spectral power in different frequency bands for the Hutt (2010) model . The
frequency bands are defined in the intervals [0.1 to 4] Hz (δ-band), [4 to 8] Hz (θ-band) and [8
to 12] Hz (α-band). (a) Spectral power in different frequency bands in the single solution case
with ΘE = ΘI = −60 mV and ce = ci = 0.06 (mV)−1. (b) Spectral power enhancement on the
top branch of the triple stationary solutions. Parameters are ΘE = −50 mV, ΘI = −60 mV,
ce = ci = 0.114 (mV)
−1 (from Figs 9 and 11 of [44]).
1.3.5 Hindriks and van Putten (2012) anaesthesia model
Hindriks and van Putten’s 2012 anaesthetic mean-field model [40] is based on the Robin-
son thalamocortical equations [80]. The HvP model predicts increases in delta and alpha
power for moderate (up to 15%) prolongation of GABAA inhibitory response, corre-
sponding to light anaesthetic sedation, as can seen in Fig. 1.19. This mean-field model
describes the dynamics of locally averaged membrane potentials of five distinct popula-
tions of neurons within a thalamo-cortical system: pyramidal and inhibitory neurons in
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Figure 1.19. Power spectrum predicted by HvP model for baseline condition (black) and in
the anaesthesia condition in red and blue. Affinities for cortical excitatory and thalamic relay
neurons set to e = s = 0.5, while affinity for cortical inhibitory neuron is left at unity, i = 1.
(a) is the illustration of the power spectrum on a log-log scale, while (b) is power spectrum
plotted on a linear scale (based on Fig. 6(a) of [40]).
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cortex, relay and reticular neurons in thalamus, and sensory neurons which provide input
to the thalamo-cortical system. There is a time delay τ/2 = 40 ms for neural activity
propagation from thalamic relay neurons to cortical populations, and vice versa. See
Fig. 1.20.
Figure 1.20. Synaptic connections of the HvP thalamo-cortical model. The diagram illustrates
the synaptic pathways that connect the different neuronal populations. The model presents four
types of neuronal populations: cortical pyramidal neurons and interneurons, thalamo-cortical
relay neurons and thalamic reticular neurons and a time delay τ/2 = 40 ms for neural activity
propagate from thalamic sensory relay neurons to cortical populations, and vice versa (from
Fig. 1 of [41]).
For modelling the action of propofol, Hindriks and van Putten considered the fact
that the binding of propofol molecules to GABAA receptors potentiates their response by
decreasing the time constant of receptor deactivation, increasing the duration of inhibitory
synaptic transmission [1,8,27]. Therefore, the action of propofol is modelled as a decrease
in the decay rate α of GABAA inhibitory synaptic response
αab = α/pa (a, b) ∈ {(i, i), (e, i), (s, r)} , (1.23)
where e, i, s, and r denote pyramidal, inhibitory, relay, and reticular neurons, respectively,
and pa is the drug effect. Unlike other models, Hindriks and van Putten assumed the
inhibitory synaptic responses of the different neuron types have differential sensitivity to
propofol and so introduced a drug affinity, ε, such that
pa = 1 + εa(pi − 1), a ∈ {i, e, s} (1.24)
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where the εa are positive dimensionless constants. Thus the HvP model has three different
inhibitory synaptic responses h¯ii, h¯ei and h¯sr for the three distinct inhibitory connections,
hab(t) =
αabβ
β − αab
(
e−αabt − e−βt
)
. (1.25)
Computing the stationary state trajectories reveals multi-valued steady-state regions.
However, Hindriks and van Putten restricted their investigations to only the lowest steady-
state voltages. Surprisingly, their results showed that increasing drug effect causes an
increase in the firing rates in all four populations. Further details regarding this model
are presented in Chapter 6.
1.3.6 Hutt (2013) anaesthesia model
In 2013, Hutt introduced a modified anaesthesia model [43] which was based on his pre-
vious work in 2010 [44]. He modelled the effect of anaesthetic drug using the clinical
results reported by Kitamura et al [56]: the decay time-constant increases with increasing
anaesthetic concentration, while the amplitude of the responses remains constant, thus
net charge transfer increases with drug concentration.
Hutt replaced the biexponential response function of his earlier [44] model with a single
exponential function to describe drug effect at the inhibitory synapse,
h(t) = H0 e
−t/τi(p) with τi(p) = p τi(1) (1.26)
where p is a scale factor representing drug concentration; here H0 is a constant parameter
and the absence of anaesthetic drug is indicated with p = 1.
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Figure 1.21. Effect of propofol on GABAergic synapses in the Hutt (2013) model. The
synaptic response function is plotted as a function of time for three different drug concentrations
Eq. (1.26). As the drug effect increases, the decay rate decreases.
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Figure 1.22. Simulated time-series of excitatory voltages and corresponding power spectra in
the Hutt (2013) model. Two different model parameters are applied; results for each set are
presented separately on the left (A) and right (B) side of the diagram. Simulations were run for
200 ms for two different drug concentrations for each set. With increasing drug concentration,
power increases and the peak of maximum power moves to larger frequencies in the β-band for
the first set and α-band for the second set of parameters (from Fig 5 of [43]).
Hutt showed that the frequency of maximum power may increase or decrease with
increasing anaesthetic concentration relative to changes in the assumed values of particular
physiological constants. However, he reported that close to oscillatory instability, the
frequency of maximum power increases with increasing p, while far from the stability
threshold the maximum power frequency may also decrease. Figure 1.22 shows the results
for two different model parametrizations in columns A (left) and B (right). The top pairs
of panels correspond to simulations for two different drug concentrations: p = 1 and
p = 1.3; the bottom panel illustrates power spectra. Analytical results predict increase of
power in the β-band for the first set, and in the α-band for the second set with increases
of anaesthesia. These results illustrate a very strong dependency on the values assumed
for the physiological parameters.
1.4 Review of anaesthesia models
The theoretical mean-field descriptions introduced in Section 1.3 follow two approaches
to modelling the EEG features observed in the anaesthetised brain: either cortical [?, 13,
71,91] or thalamo-cortical [40,43].
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The first attempt to reproduce the effect of GABAergic anaesthetic drug (such as
propofol) was by Steyn-Ross et al [91]. They incorporated the effect of general anaesthetic
drug at the cortex as a modulation of the inhibitory neurotransmitter rate-constant,
predicting three distinct states for an anaesthetized brain, enabling the brain to switch
between awake and anaesthetized states at critical values of the drug concentration.
Liley and Bojak [13] investigated the anaesthetic drug isoflurane and its effect on brain
activity. They, however, ignored the multiple-root steady state regions in their research
results. They showed that a power surge in EEG activity at low drug concentrations
(biphasic effect) without requiring a transition between two distinct states.
Molaee-Ardakani et al [71] incorporated a slow ionic modulation of the sigmoidal
voltage-to-firing rate mapping for the excitatory cortical population by introducing a
gating variable that depolarizes excitatory neurons when they were in the low firing state,
and hyperpolarized them when they were in high firing state. Their model exhibited
bistable behaviour.
Hutt and Longtin [44] derived a spatiotemporal field equation for two coupled neural
populations consisting of pyramidal cells and GABAergic neurons that inhibit terminal
neurons under the administration of propofol. They derived an analytical expression for
the EEG power spectrum, showing biphasic behaviour for the EEG power spectrum for
both single and multi-valued steady states.
Hindriks and van Putten [40] employed Robinson’s model equations [79] to inves-
tigate general anaesthesia in the thalamo-cortical system. They applied the Hutt and
Longtin method [44] to insert drug effect into the system equations. In contrast to other
studies [13, 44, 71, 91], which assumed the same affinity for drug effect in all populations,
Hindriks and van Putten defined different affinities for different neuron populations. They
compared model predictions for propofol effect on brain activity with clinical EEG record-
ings, reporting a small increase in the alpha frequency, accompanied by increases in delta
and theta frequencies, with increased propofol concentration.
In 2013, Hutt introduced a new response function by replacing the biexponential
function of his earlier [44] model with a single exponential to describe drug effect at the
inhibitory synapse. He was able to show that the frequency of maximum power may
increase or decrease with increasing anaesthetic concentration depending on the values
assumed for particular physiological constants [43].
For this thesis, we have chosen to investigate the Waikato and HvP models of anaes-
thesia. Our goal is to investigate the drug effects on brain dynamics and in particular
the effect of anaesthetic drugs. For the Waikato model, we will extend the equations to
include the effects of NMDA (excitatory) and GABAB (inhibitory) synapses.
A notable deficiency in the Waikato model is the lack of an alpha rhythm. The Robin-
son model includes a thalamo-cortical loop as the source of alpha frequency. Hindriks and
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van Putten are the only researchers to apply anaesthesia to the Robinson model. For this
reason, we elected to investigate the HvP equations in detail.

Chapter 2
Elements of mathematics
2.1 Introduction
The theory of dynamical systems that arises in many areas of technology and natural
science emphasizes the time evolution of the state of a system. The goal when dealing
with a dynamical system is to be able to analyse, describe and make predictions about
the behaviour of the individual variables and of the complete system.
In this thesis, the focus is not only on dynamical systems described by ordinary differ-
ential equations (ODEs), as discussed in Chapters 3 and 4, but also on delay differential
equations (DDEs) (Chapters 5, 6 and 7). The first reason for choosing differential equa-
tions rather than their integral formulations is that integral equations are slow to compute
numerically and typically require a large amount of storage. The second reason is that
differential equations allow us to locate steady states and this is essential for quantifying
stability properties.
In this chapter, a brief survey is provided of the major elements of mathematics that are
require for the subsequent chapters. We start by describing the various methods available
to solve and analyse ODEs and DDEs. Then, the noise function and its significance for
modelling biological systems is discussed. I conclude with a discussion of spectral methods
which can be used to analyse the dominant modes of dynamical systems.
Solving DDEs is similar to ODEs in some respects, but there are significant differences:
• In ODEs the function and its derivatives are all evaluated at the same time, while
DDEs contain additional derivatives which depend on the solution obtained at pre-
vious times.
• In ODEs, gradient discontinuities are not a common issue, while they can be present
in DDEs,
d y(a−)
dt
6= d y(a
+)
dt
if a = n τ withn = {0, 1, 2, ...} (2.1)
where τ is the time-delay. In other words, due to the existence of delays, disconti-
nuities can appear at time τ and at multiples of τ .
• Another obvious difference between ODEs and DDEs is the initialization. In DDEs,
we have to provide not only the value of the solution at the initial point, but also
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the solution at historical times prior to the initial point. In contrast, the solution for
ODEs is completely determined by its value at the initial point (see Appendix A.1).
2.2 Delay differential equations
Delay-differential equations arise when a dynamical system induces effects of delayed
actions; or in general the model involves responses with non-zero delays. From the math-
ematical view, delay-differential equations can be expressed as some derivatives of ~y at
a time t in terms of ~y at a time t and an earlier time. We restrict our discussion to
differential equations with a single fixed delay τ
~y (n) = ~F
t, y(t), y′(t), · · · y(n−1)(t)︸ ︷︷ ︸
y and its derivatives at time t
, y(t− τ), y′(t− τ), · · · , y(n−1)(t− τ)︸ ︷︷ ︸
y and its derivatives at time t−τ
 , (2.2)
where ~y (n) is an explicit system of delay differential equations of order n with dimension
m. We apply the same notation as in Section A.1, where ~y has m dimensions and each
has an n-th order differential equation, which can be rewritten as a sets of k = n × m
first-order differential equations
d~V (t)
dt
= ~F (~V (t), ~V (t− τ)) , (2.3)
where ~V depends on the value and derivatives of ~y at some time t− τ in the past, as well
as the current value of ~y(t) and its derivatives.
2.2.1 Solving DDEs
Simple DDEs can be solved analytically in a stepwise fashion. However, most “useful”
DDEs are too complicated to be solved analytically, so we have to resort to numerical
methods such as the dde23 function in Matlab. Consider a simple first-order DDE with
a single delay and fixed coefficients,
d y(t)
dt
= Ay(t) + Aτy(t− τ), t ≥ 0
y(t) = h(t), t < 0
where h(t) defines the “history”. As illustrated in Fig 2.1, for such equations the value of
the derivative at any time depends on the solution at a previous “lagged” time.
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Figure 2.1. For a DDE, the solution y(t) for the future time 0 ≤ t < τ depends on the history
h(t) defined at previous times, −τ < t < 0.
2.2.2 Method of steps
This method converts the DDE on a given interval to an ODE over that interval by using
the known history function for that interval. The resulting equation is solved, and the
same process is repeated in the next interval with the latest found solution serving as the
history function for the next interval. Although this method may have been discovered
by several researchers [10,107], it is usually attributed to Myshkis [73].
Example: Suppose
dy(t)
dt
= −y(t− τ), for t ≥ 0 (2.4)
y(t) = h(t) = 1, for t < 0 (2.5)
where we will set the constant delay to unity: τ = 1.
To solve Eq. (2.4), first we find the solution for the interval 0 ≤ t ≤ τ . We map
the current time interval to the previous time interval which belongs to the history by
subtracting τ from 0 ≤ t ≤ τ
0 ≤ t ≤ τ =⇒ −τ ≤ t− τ ≤ 0 τ=1=⇒ −1 ≤ t− 1 ≤ 0 . (2.6)
From Eq. (2.4), the history is
y(t) = 1, for t ≤ 0 (2.7)
which can be extended to the previous interval
y(t− 1) = 1, for − 1 ≤ t− 1 ≤ 0 . (2.8)
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We rewrite Eq. (2.4) in the interval 0 ≤ t ≤ τ
dy
dt
= −y(t− 1) ⇒ dy
dt
= −1 , (2.9)
which has solution
y(t) =
∫ t
0
−y(t′ − 1)dt′ + y(0) =
∫ t
0
−dt′ + y(0) = 1− t, 0 ≤ t ≤ τ . (2.10)
Now we look for the solution for the next time interval, τ ≤ t ≤ 2τ . Using the same
method as the previous step
τ ≤ t ≤ 2τ =⇒ 0 ≤ t− 1 ≤ 1 =⇒ y(t− 1) = 1− (t− 1) .
For the interval τ ≤ t ≤ 2τ the following derivative is obtained
dy
dt
= −(1− (t− 1)) , (2.11)
whose solution is gained by direct integration
y(t) =
∫ t
1
−y(t− 1)dt+ y(1) = t
2
2
− 2t+ 1.5, τ ≤ t ≤ 2τ . (2.12)
We continue the function solution for two more time intervals:
y(t) = −t
3
6
+
3 t2
2
− 4 t+ 3.33, 2τ ≤ t ≤ 3τ ,
y(t) =
t4
24
− 2 t
3
3
+
15 t2
4
− 9 t+ 7.875, 3τ ≤ t ≤ 4τ ,
and we note the increase in solution complexity with each interval iteration.
Fig. 2.2(a) shows the solution over the extended period 0 ≤ t ≤ 8τ . The different
colours indicate the different function solutions for each delay interval. It is possible to
automate this process using, say, Matlab’s symbolic integration function int inside a
for-loop iteration, but only if the initial history function h(t) is a constant value. If
the history is a function of time, after just a few delay intervals the integration rapidly
becomes unwieldy, leading eventually to failure of the symbolic engine [23,86].
Difficulties in method of steps
First, the integral arising may not be expressible in terms of known functions. In some
cases these integrals result in very long formulae making the solution expensive to com-
pute. Second, the method is inherently finite, so that the long-time behaviour of the
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Figure 2.2. Solution of Eq. (2.4) by the method of steps and solution stability by the Lambert
method. (a) The solution obtained by applying the method of steps, with each colour indicating
different time intervals with different integration functions. (b) Eigenvalues plotted on the
complex plane. The eigenvalues obtained using the principal branch, k = 0,−1, are dominant
and determine the stability of the system with λ = −0.31 + 1.33 i. Here, k represents different
branches of the Lambert function.
solution is not always evident from the first few analytical steps.
We find that this method is not applicable for our modelling purposes since we are
dealing with a high number (typically 13) of first-order delay differential equations. This
level of complexity makes it impossible to apply this analytical method to our cortical
equations.
2.2.3 The method of characteristics
The stability properties of linear DDEs with discrete delays can be deduced using the
characteristic equation. As an example, the characteristic equation for the DDE
d ~y(t)
dt
= A~y(t) + Aτ~y(t− τ) , (2.13)
is
det(−λI + A + Aτe−τλ) = 0 , (2.14)
where λ are the characteristic roots or eigenvalues of the solution set. Because of the
exponential in the characteristic equation, the DDE has, unlike the ODE case, an infinite
number of eigenvalues, making stability analysis more involved. Even though there are
an infinite number of eigenvalues, there is only one pair of eigenvalues with a dominant
real part, and these determine the stability of the system [4]. It is important to note that
the characteristic equation can only be formed when the differential equation is linear and
homogeneous, and has a constant time delay.
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Asl and Ulsoy [4] introduced an analytical method for solving systems of DDEs such
as Eq. (2.13) using the matrix Lambert W function.1 However, their method is applicable
only when the matrix coefficients A and Aτ commute. In 2006, Yi, Ulsoy and Nelson [109]
extended the matrix Lambert W approach to handle the case of non-commuting A and
Aτ matrices. Here, we summarise their method.
Rearranging Eq. (2.13),
d ~y(t)
dt
−A ~y(t)−Aτ ~y(t− τ) = 0 for t < 0 . (2.15)
We assume there is a solution for Eq. (2.13) in the form
~y(t) = ~y0e
St , (2.16)
where S is an m×m matrix. Substituting Eq. (2.16) into (2.15)
S~y0e
St −A ~y0eSt −Aτ ~y0eS(t−τ) = 0 ,
which factorizes to (
S−A−Aτ e−Sτ
)
~y0e
St = 0 .
As ~y(t) = ~y0e
St is a non-zero solution, then for every moment of time t, we must have,
S−A− Aτ e(−Sτ) = 0 (2.17)
In the special case Aτ = 0, the delay term disappears and the DDE collapses to an ODE
with
S−A = 0 ⇐⇒ S = A , (2.18)
giving the matrix exponential solution
~y(t) = ~y0e
At . (2.19)
1In mathematics, the Lambert-W function is a set of functions defining the branches of the inverse
relation of the function f(z) = zez where ez is the exponential function and z is any complex number:
z = f−1(zez) = W (zez)
By substituting z = W (z) in the above equation, we get the defining equation for the W function:
z = W (z)eW (z)
for any complex number z.
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Returning to the Eq. (2.17) for Aτ 6= 0, we multiply τeS τe−A τ on both sides of Eq. (2.17)
and rearrange to obtain
τeSτe−Aτ (S−A) = τeSτe−Aτ (Aτ e(−Sτ)) . (2.20)
In the general case, when the matrices S and A do not commute
τ(S−A)eS τe−A τ 6= τ(S− A)e(S−A)τ . (2.21)
We need to fix the inequality in Eq. (2.21). We take advantage of the following property
of the matrix Lambert W function
W (H)eW (H) = H . (2.22)
We introduce an unknown matrix Q that satisfies,
τ(S−A)e(S−A)τ = −AττQ (2.23)
then compare Eqs. (2.22) and (2.23) to obtain,
(S−A)τ = W (−AττQ) , (2.24)
which can be solved for S to give
S =
1
τ
W (−Aττ Q)−A . (2.25)
Substituting Eq. (2.25) into (2.20) yields the following condition which can be used to
solve for the unknown matrix Q
W (−Aτ τ Q) eW (−Aτ τQ)−A τ = −Aτ τ . (2.26)
Equation (2.26) always has a unique solution Q for each branch k [109]. The solution
can be obtained numerically for a variety of initial conditions, using the fsolve function
in Matlab. Having Q, we can calculate S through Eq. (2.25), and hence deduce the
stability properties of system.
Example: We apply the method of characteristics to the previous example solved via
the method of steps
d y(t)
dt
= −y(t− τ), for t ≥ 0 and τ = 1 , (2.27)
y(t) = h(t) = 1, for t < 0 ,
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has characteristic equation
−λ− e−λ = 0 . (2.28)
There are an infinite number of solutions to this equation for complex λ
λ = Wk(−1) , (2.29)
where Wk is the k
th branch of the Lambert-W function. In Fig. 2.2(b), the complex plane
is plotted for the solution of Eq. (2.29) with the imaginary and real parts of λ displayed
on the vertical and horizontal axes respectively. As shown in the graph, as k increases, the
corresponding real part decreases; this indicates that the lowest branch usually quantifies
the stability properties. Here, k = 0,−1 are dominant and determine the stability of the
system with λ = −0.31± 1.33 i and for k = 1,−2 the solution is λ = −2.06± 7.58 i.
Applying the method of characteristics for the delay dynamical system which is pre-
sented in Chapters 5, 6 and 7 leads us to find out the limitation of this method. Our
mentioned system consists of 13 first-order delay differential equations, leading to 13× 13
matrices for A and Aτ . The fsolve function in Matlab is used, with the aim of solving
Eq. (2.26) for the unknown matrix Q. Using fsolve requires an accurate initial guess for
matrix Q, a 13 × 13 matrix with a total of 169 elements. Choosing a good initial guess
for such a large matrix is almost impossible.
In the second attempt, the symbolic solve function in Maple was tried. This method
leads us to a very unwieldy expression which was not usable.
To solve our delay thalamo-cortical equations, two numerical methods, dde23 and
Euler, was applied successfully and the transfer function was used to analyse the system
stability. In the following sections, more detailed explanations are given on these methods.
2.2.4 Numerical methods for solving DDEs
In this section we discuss some aspects relevant to the numerical solution of DDEs. A
popular approach is to extend one of the explicit Runge-Kutta methods [87]. TheMatlab
function dde23, and its companion ddesd, take this approach by extending ODE solver
ode23. The step size is chosen by algorithm to be as small as necessary to get an accurate
solution. The dde23 and ddesd solvers have been designed for DDE systems with constant
delays.
The idea is similar to the method of steps described in Chap. 2.2.2. In solving for
0 ≤ t ≤ τ , the DDE reduces to an initial value problem for an ODE with y(t − τ)
equal to the given history h(t− τ) and initial value y(0) = h(t). We can solve this ODE
numerically using any of the standard methods. The analytical solution of the DDE on
the next interval τ ≤ t ≤ 2τ is handled the same way as the first interval, but subject
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to the challenge of keeping track of how the discontinuity at the initial point propagates
because of the delays [87].
The second method we applied to solve DDEs is the Euler algorithm, a numerical
procedure usually applied to solving ODEs with a given initial value. For our application
we have two sets of equations: the first set which behave as ODEs for times less than the
time delay τ , and the second set, behaving as DDEs for times bigger than the delay time.
For the first time interval tn ≤ τ , the standard formula of the Euler method is applied
y(tn+1) = y(tn) + y
′(tn) ∆t tn = n∆t , (2.30)
then for tn > τ , we use
y(tn+1) = y(tn) +
[
y′(tn + y′(tn − τ))
]
∆t τ = k∆t, 0 < m < k . (2.31)
2.3 Stochastic dynamical system
A stochastic dynamical system can be viewed as a deterministic system subjected to
the effects of noise. In fact, adding low-intensity noise is supposed to represent the
continuous random fluctuations which are natural events occurring in all living systems.
In nonlinear systems noise acts as a driving force that can drastically modify deterministic
dynamics [89]. In modelling brain activity, neuronal noise is an inseparable phenomenon
that is present continuously. Noise-driven fluctuations can lead to non-trivial effects such
as causing transitions between coexisting deterministic stable states, stabilizing unstable
equilibria, and shifting bifurcation points. At the very least, noise can excite the internal
modes of oscillation in both ODEs and DDEs [45].
2.3.1 Noise
Noise as a random variable is a quantity that fluctuates aperiodically in time. For our
modelling, we wish to analyse noise evoked fluctuations in excitatory soma voltage and
so assume the existence of a continuous wash of stochastic variability entering from non-
specific populations. We consider state variables that are perturbed by one or more sources
of white noise. The noise contribution is classified according to the way it interacts with
the dynamical variable of interest. If the noise intensity, b, is independent of the state of
the system, the noise is said to be “additive”. In other words, the noise ζ(t) is simply
added to the deterministic part of the system equations
dy
dt
= F (y) + b ζ(t) . (2.32)
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Alternatively, one can have “multiplicative” noise, for which the coefficient of the noise
depends on the value of one or more state variables. In such a case, the evolution equation
would take the form
dy
dt
= F (y) + b(y)ζ(t) , (2.33)
where the strength of the noise is dependent on the state of the system, y(t).
In the present work, we adopt the simplest case of additive white noise, that is, noise
that is uncorrelated in space and time.
2.3.2 Incorporating noise into a dynamical system
By incorporating noise into the model equations, we transform the ordinary differential
equations into stochastic form, also known as Langevin form. When adding noise to the
system, we need to ensure that the stochastic mapping is dimensionally consistent with
the evolution equations. For our modelling purposes, the noise function is defined as a
rapidly varying random fluctuation function of time about its mean
p˜(t) = b ξ(t) , (2.34)
where ξ(t) is white noise with zero mean
〈ξ(t)〉 = 0 , (2.35)
and delta-function covariance
〈ξm(t) ξn(t′)〉 = δmn δ(t− t′) . (2.36)
Taking the integral of Eq. (2.36), we obtain∫ ∞
−∞
〈ξm(t) ξn(t′)〉〉 dt = δmn
∫ ∞
−∞
δ(t− t′) dt = 1 . (2.37)
Equation (2.37) shows that the Dirac delta-function, δ(t), carries units of inverse time,
since the Kronecker delta δmn does not carry any units. Therefore, ξ(t) must have units of
inverse square-root of time [s−1/2]. The coefficient b of Eq. (2.34) must not only fulfil the
requirements of dimensional consistency, but also control the strength of the noise in the
system equations. In this thesis, we wish to incorporate white noise as the non-specific
subcortical flux input.
In our stochastic simulations, we approximate white noise by drawing samples from
Matlab’s Gaussian-distributed unit-variance random-number generator, randn, such
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that
ξ(t) =
randn√
∆t
, (2.38)
where the numbers taken from randn are taken to be dimensionless, and where ∆t is the
simulation time-step. Thus ξ(t) has variance 1/∆t, giving the correct white-noise limit
as ∆t → 0.
Here, it is important to mention that noise can only be added to a fixed time-step in-
tegrator (e.g., Euler); adding noise to a variable time-step integrator (e.g., dde23, ode45)
will give unreliable results because the step-adjustment algorithm necessarily assumes a
fully deterministic system. Integration of stochastic differential equations requires con-
siderable care.
2.4 Power spectral density
In all brain modelling, detecting the dominant frequency components is one of the key
goals as these can be referred to specific states of rhythmic brain activity. Fourier trans-
form methods are applied to quantify the frequency content of clinical recordings and
of modelling equation predictions. The relevant Fourier theory is summarised in Ap-
pendix A.2. We now give a brief overview of how to estimate the input–output transfer
function for a linear system of equations. This is relevant to our analysis of the Robinson
(Ch 5) and HvP models (Chs 6, 7).
2.4.1 Transfer function
Transfer functions are commonly used in the analysis of systems such as single-input
single-output filters, typically within the fields of signal processing, communication theory,
and control theory [36]. Transfer functions relate the output or response of a system such
as a filter circuit to the input or stimulus. We can compute the transfer function for any
dynamical system which can be described as a set of linear partial differential equations,
even of very high order. The transfer function is a convenient representation of a linear
time-invariant dynamical system. The order of the differential equations is of no concern
as we do not work directly with these equations, and this property is considered to be one
of the advantages of using transfer function instead of standard linear stability analysis.
The transfer function is defined as a relation between the output and input of the
linear system, and is usually presented in the (k, ω) frequency domain, where k = 2pi/λ
and ω = 2pif . After suitable rearrangement of the system equations, we obtain
H(k, ω) =
F (k, ω)
G(k, ω)
, (2.39)
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where F (k, ω) is the output function and G(k, ω) is the input to the system; both are
expressed as polynomial equations. To calculate the power spectral density, one computes
the mod-square,
PSD ≡ |H(k, ω)|2 . (2.40)
Here, it is important to mention that the roots of the numerator function F (k, ω)
indicate the zeros of the system, while setting G(k, ω) to zero, also known as the dispersion
curve, determines the poles of the system. In fact, poles are eigenvalues and they describe
the main dynamics of the system. If we assume λ is one of the poles in the frequency
domain, written as λ = α+ i ω, then the corresponding eigenvalue expression in the time
domain follows the relation U = −i λ. Thus the imaginary part of the eigenvalue in
frequency domain corresponds to the real part of the time-domain eigenvalue, i.e., the
damping rate. For more details see [36]. We use the transfer function in Chapters 6 and
7 to analyse the stability of a delay dynamical system.
Chapter 3
Theoretical investigation of anaesthetic
effects in the extended Waikato model
3.1 Introduction
Continuum models of the cortex aim to describe the interactions of the neural populations
that generate the electrical perturbations and rhythms which can be detected with scalp
and cortical EEG (electroencephalogram) electrodes.
In the continuum (mean-field) model, neural parameters have been averaged over the
population of neurons in a small volume of cortex. However, the basic frame for delivering
the effect of spikes in the mean-field model is the same as that for an individual neuron:
presynaptic flux activity travels along the axon to the synaptic terminals; these presynptic
inputs generate postsynaptic potentials. Activity entering the dendritic tree is integrated
at the soma, producing a fluctuation in the soma voltage. In the standard Waikato
mean-field model, the net neuron voltage is determined by axon-dendritic activity at the
chemical synapses; excitatory inputs are mediated by AMPA receptors and inhibitory
inputs by GABAA receptors.
The aim of the current work is to investigate the effect of anaesthetic drugs on the
extended Waikato model. The model is extended by incorporating additional physiological
detail: we now include four receptors (GABAA, GABAB, NMDA, AMPA) rather than
just two (GABAA, AMPA). Two classes of neural synapses are modelled: the first is the
excitatory AMPA and NMDA synapse in which the nerve impulse in a presynaptic cell
tends to increase the probability that the postsynaptic cell will fire an action potential;
the second, the inhibitory synapses GABAB and GABAA, tend to suppress postsynaptic
firing.
This chapter starts with a discussion of the mathematical formulation of the cortical
model developed by Prof Moira Steyn-Ross and colleagues at Waikato University. The
effect of increasing GABAB and NMDA gain factors on cortical activity is investigated
through linearised dispersion curve predictions and fully nonlinear dynamical grid simu-
lations.
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In 2012, Steyn-Ross et al [92] showed that in the standard Waikato model the Tur-
ing spatial mode, set by gap-junction diffusion, is protective against entering oscillatory
modes; and weakening the Turing mode by reducing gap conduction can release an uncon-
trolled Hopf oscillation and hence an increased propensity for seizure and simultaneously
an increased sensitivity to GABAAergic anaesthesia. Following the previous work, we
examine the gap-junction diffusion effect on the extended Waikato model. We investi-
gate the effect of Cx36 reduction on seizure activity while simultaneously altering the
cooperation of GABABergic and NMDAergic anaesthetic agents.
3.1.1 The extended Waikato cortical model
The cortex is modelled as a two-dimensional continuum of excitable tissue containing
interlinked populations of excitatory and inhibitory neurons. Each neuron is represented
as an RC integrator of membrane resistance Rm and capacitance C, with the resting
membrane potential acting as a battery in series with the membrane resistance, Fig. 3.1.
The total entering currents are the sum of the synaptic current Isyn due to the spike activ-
ity at the chemical synapses, plus diffusive current Igap due to gap junction connections.
This is equal to the membrane resistance current, (V rest − V )/Rm plus the membrane
displacement current, C dV/dt,
C
dV
dt
+
V (t)− V rest
Rm
= Isyn(t) + Igap(t) (3.1)
Multiplying through by membrane resistance Rm gives
R m
rest
V
CV(t)
 + I (t)
    syn
I (t)
 gap
Figure 3.1. Mapping of a membrane onto an equivalent electrical circuit. The soma membrane
behaves like a capacitor of capacitance C and the ion channels are modelled as resistors R.
Synaptic current due to the spike activity at the chemical synapses is denoted by Isyn, the
diffusive current due to gap junction connections by Igap. V rest is the resting membrane potential
for the neuron.
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Figure 3.2. Schematic representation of the connective topology within and between cortical
macrocolumns. The shape of neurons follows their appearance under microscope: pyramidal
excitatory neurons are triangles; inhibitory neurons are circles.
τ
dV
dt
= V rest − V (t) + δV syn(t) + δV gap(t) (3.2)
where τ = RmC is the cell time-constant, δV
syn is the voltage perturbation due to chemical
synaptic inputs, and δV gap is the voltage change due to gap-junction currents.
Following the work of Liley et al [62, 63], cortical neurons are aggregated into small
columnar structures called macrocolumns (see Fig. 3.2) of volume ∼1 mm3 containing
∼ 105 neurons. Each macrocolumn consists of two distinct neuron populations, with 85%
being excitatory and 15% inhibitory. Neuron interactions are divided into three different
types:
1. Short range (intracortical) interactions limited to inside the macrocolumn and be-
tween the inhibitory and excitatory cells;
2. Long range (cortico-cortical) interactions represent input to excitatory and inhibitory
populations from a distance;
3. Exogenous (subcortical) interactions represent input from the thalamus and brain-
stem.
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Figure 3.3. Schematic of the Waikato model. See Figs 3.4–3.7 for details.
The standard Waikato mean-field cortical model is a population aggregate of the single
neuron model. Incoming fluxes induce postsynaptic dendrite potentials that are integrated
at the soma, driving a time-dependent perturbation about the soma resting potential.
This is illustrated in Fig. 3.3.
3.1.2 Presynaptic flux inputs
Long range flux inputs φNek and φ
A
ek are generated by distant excitatory sources Q
N,A
e ,
mediated by NMDA (N) and AMPA (A) receptors respectively, and obey 2D damped
wave equations [80] while travelling to the destination populations, which can be either
excitatory (e) or inhibitory (i),[(
∂
∂t
+ νΛAek
)2
− (ν5)2
]
φAek(
⇀
r , t) = (νΛAek)
2QAe (
⇀
r , t), k = i, e (3.3)[(
∂
∂t
+ νΛNek
)2
− (ν5)2
]
φNek(
⇀
r , t) = (νΛNek)
2QNe (
⇀
r , t) (3.4)
Here, the square brackets donate an operator, ∇2 = ∂
2
∂x2
+
∂2
∂y2
is the Laplacian differ-
ential operator in Cartesian coordinates, ν is the axonal conduction speed, and ΛN,Aek is
the inverse-length scale for axonal connections in cm−1. Subscript ek is read left to right
indicate a connection from presynaptic neuron type e (either NMDA or AMPA) to post-
synaptic neuron type k. Equations (3.3) and (3.4) (second-order) can be reformulated as
a set of eight coupled first-order DEs for both NMDA and AMPA receptors.
Short-range inputs φa, bik (inhibitory flux reaching GABAA and GABAB receptors)
and φN,Aek (local) are produced locally (i.e., within the macrocolumn) so are assumed to
propagate instantaneously. Therefore these fluxes can be replaced by their sources: Qi
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Figure 3.4. Sigmoidal functions relating firing rate to average soma potential. (a) Sigmoid
curves of Eq. (3.7): excitatory sigmoid Qe (black curve); inhibitory sigmoid Qi (red). (b) First
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inhibitory and Qe for excitatory,
φa,bik (local) = Q
a
i = Q
b
i = Qi (3.5)
φN,Aek (local) = Q
A
e = Q
N
e = Qe (3.6)
The spike-rate is represented by a sigmoidal mapping from membrane voltage Vk to
the firing rate Qk, see Fig. 3.4,
Qk =
Qmaxk
1 + e−c(Vk−θk)/σk
(3.7)
where Qmaxk is the maximum firing rate, θk is the sigmoid threshold voltage for firing and
σk is the standard deviation with c = pi/3; see Table 3.1 for values.
Subcortical inputs φscek are added into the system equations to provide a source of
low-intensity random fluctuations. The subcortical excitation is modelled as a spatiotem-
poral Gaussian distributed white noise, b ξek(
⇀
r , t) which is superimposed on a background
level of excitation 〈φscek〉,
φscek(
⇀
r , t) = 〈φscek〉+ b ξek(
⇀
r , t) (3.8)
where b is a constant scale-factor for subcortical drive to tune the level of subcortical
excitation and also to fulfil the requirements of dimensional consistency, and ξek is the
Gaussian-distributed white-noise source generated by the Matlab command randn, see
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Chap. 2.3.
The total presynaptic input for each population is the sum of long-range, short-range
and subcortical inputs,
MNek(
⇀
r , t) = NNekφ
N
e (
⇀
r , t)︸ ︷︷ ︸
long-range
+nNekQ
N
e (
⇀
r , t)︸ ︷︷ ︸
local
+φscek(
⇀
r , t)︸ ︷︷ ︸
subcortical
(3.9)
MAek(
⇀
r , t) = NAekφ
A
e (
⇀
r , t) + nAekQ
A
e (
⇀
r , t) + φscek(
⇀
r , t) (3.10)
where capital letter Nek and small nek distinguish the number of long-range and local input
connections; see Table 3.1. Inhibitory inputs include only the short range connections,
Maik(
⇀
r , t) = naikQi(
⇀
r , t) (3.11)
M bik(
⇀
r , t) = nbikQi(
⇀
r , t) (3.12)
where nik is the short-range axonal connectivity numbers for inhibitory (GABAA, GABAB)
receptors.
3.1.3 Postsynaptic responses
Presynaptic flux Mlk releases neurotransmitters into the synaptic cleft, changing the post-
synaptic dendrite voltage via charge transfer through opened ion channels. We assume
that the resulting voltage fluctuation at the dendrite, Ulk, is given by the temporal con-
volution of the dendrite impulse response Hlk(t) with presynaptic input Mlk, scaled by
the synaptic reversal potential, ψlk and gain factor ρl,
Ulk(
⇀
r , t) = ρl ψlk Φlk(
⇀
r , t) where
l = e, i
k = a, b, A,N
(3.13)
and,
Φlk(t) = [Hlk(t)⊗Mlk(t)] ≡
∫ t
0
Hlk(t− t′)Mlk(t′) dt′
where subscript l indicate the coming fluxes can be either excitatory or inhibitory and k
defines flux destinations which can be one of receptor populations (a, b, A,N).
Experimental measurements of the postsynaptic potential (PSPs) show a rapid-rise,
slow-decay curve which is well approximated by a biexponential function H(t). However,
there is a difference between the excitatory and inhibitory response functions. Excitatory
response function is assumed not to be effected by anaesthetic drug concentration,
Hmek(t) =
αmβm
βm − αm
(
e−α
m t − e−βm t) , m = A, N (3.14)
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Table 3.1. Definitions and values for cortico-cortical and intracortical parameters
Symbols Description Value Unit
ΛA,Neb inverse-length scale for axonal connection 4 cm
−1
ν axonal conduction speed 140 cm s−1
Qmaxe, i maximum firing rate 30, 60 s
−1
θe,i sigmoid threshold voltage −58.5,−58.5 mV
σe,i standard deviation for threshold 3, 5 mV
c sigmoid constant (see Eq (3.7)) pi
√
3
NA,Nek long-range axonal connectivity 2000
nA,Nek short-range axonal connectivity 800
na, bik short-range axonal connectivity 600
〈φsceb〉 tonic flux entering from subcortex 500 s−1
V revi,e reversal potential at dendrite −70, 0 mV
V resti,e neuron resting voltage −64, −64 mV
(αb, βb) GABAB (decay, rise) rates (10, 30) s
−1
(αa, βa) GABAA (decay, rise) rates (20− 40, 200) s−1
(αA, βA) AMPA (decay, rise) rates (50, 200) s−1
(αN , βN) NMDA (decay, rise) rates (15, 120) s−1
while inhibitory response functions are dependent on drug concentration factor p,
Hmik (t) =
αm(p) βm
βm − αm(p)
(
e−α
m(p) t − e−βm t) , m = a, b (3.15)
where βm and αm are the rate of rise and decay respectively. As shown in Table 3.1 and
Fig. 3.7, the rise and decay rates for each receptor type (a, b, A,N) are quite distinct.
Before defining the postsynaptic fluxes of Eq. (3.14), we simplify the equation set by
assuming particular symmetries in the inhibitory fluxes,
Φaii(t) = Φ
a
ie(t), Φ
b
ii(t) = Φ
b
ie(t) (3.16)
and similarly for the excitatory fluxes,
ΦAei(t) = Φ
A
ee(t), Φ
N
ei(t) = Φ
N
ee(t) (3.17)
Invoking these symmetries halves the number of second-order DEs from eight to four.
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Taking derivatives (for detailed calculation see Appendix B.1) of all postsynaptic in-
puts, the excitatory fluxes ΦAek and Φ
N
ek (units: spikes/s) obey second-order differential
equations. Excitatory fluxes are received by the target neural populations k,[
d
dt
+ αA
][
d
dt
+ βA
]
ΦAek(t) = α
AβAMAek(t) (3.18)[
d
dt
+ αN
][
d
dt
+ βN
]
ΦNek(t) = α
NβNMNek(t) (3.19)
and Φaik, Φ
b
ik are inhibitory flux inputs coming from inhibitory populations,[
d
dt
+ αa
][
d
dt
+ βa
]
Φaik(t) = α
aβaMaik(t) (3.20)[
d
dt
+ αb
][
d
dt
+ βb
]
Φbik(t) = α
bβbM bik(t) (3.21)
Reversal function ψlk is a dimensionless weighting factor which captures the dendritic
response sensitivity to reversal potential for all receptors,
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ψmek(Vk) =
V rev,me − Vk
V rev,me − V restk
, m = A, N (3.22)
ψmik(Vk) =
V rev,mi − Vk
V rev,mi − V restk
, m = a, b (3.23)
where V restk and V
rev
k represent the rest and reversal potentials respectively; a, b denote
inhibitory populations GABAA, GABAB; A,N denote excitatory populations AMPA,
NMDA; see Fig. 3.5.
Soma voltage from chemical synapses is modelled as postsynaptic potentials
(PSPs) summing at the neuron somatic capacitor,
Vk(t) = (soma resting potential) + (input perturbation)
= V restk + (soma impulse response)⊗ (excitatory and inhibitory voltage inputs)
= V restk + Lk ⊗ [ek(t) + ik(t)] (3.24)
where the excitatory and inhibitory voltage inputs are given by,
ek(t) = ρ
A
e ψ
A
ekΦ
A
ek(t) + ρ
N
e ψ
N
ekΦ
N
ek(t) (3.25)
ik(t) = ρ
a
iψ
a
ikΦ
a
ik(t) + ρ
b
iψ
b
ikΦ
b
ik(t) (3.26)
The soma response Lk(t) is a single exponential decay with time-constant τk (see
Fig. 3.6),
Lk =
1
τk
e−t/τk (3.27)
where τk = RmC. By taking the derivative (see Appendix B.2) of Eq. (3.24), we obtain:
τk
dVk
dt
= V restk − Vk(t) + ek(t) + ik(t) (3.28)
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Figure 3.6. Soma impulse response of Eq. (3.27) for cell time-constant τ = 40 ms.
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which is similar to Eq. (3.1) for the membrane voltage equation for a single neuron.
Soma voltage from electrical synapses Gap-junctions form resistive linkage be-
tween adjacent cells allowing the passage of ions and small molecules (Fig. 1.2).
Table 3.2. Function definitions for the cortical model
Variable Symbols Unit Equation
Firing rate Qk s
−1 (3.4)
Soma filter impulse Lk s
−1 (3.27)
Dendrite filter impulse Hlk s
−1 (3.33)
Reversal potential at dendrite ψlk – (3.22), (3.23)
The gap-junction diffusive current is modelled as:
Igapk =
a
R
52 Vk (3.29)
The incorporation of diffusive coupling within an existing mean-field synaptic model of
electrocortical activity is based on the microanatomical measurements of Fukada et al
with a defined as the area of the Fukuda-cell and R being the gap-junction resistance;
more details are in [29, 77, 93]. Including the gap-junction diffusive current, Eq. (3.28)
becomes:
τk
Rm
∂Vk
∂t
=
V restk − Vk(t)
Rm
+ Isynk + I
gap
k (3.30)
where τk/Rm = C, the membrane capacitance of Figs 3.1 and 3.3. Multiplying both sides
by Rm yields:
C
∂Vk
∂t
= V restk − Vk(t) + Isynk Rm +Dkk 52 Vk (3.31)
The diffusive coupling strength for inhibitory neurons is defined by D2 = Dii, and D1 =
Dee for excitatory diffusive coupling strength, which is much weaker, D1 = D2/100.
Diffusive coupling D1, D2 carry units of area [cm
2], so that D1,2/τ can be regarded as a
diffusion constant [cm2/s].
3.2 Modelling the action of anaesthetic agents
Different categories of anaesthetic agent can affect cortical neurons through different mech-
anisms. Here, the main focus is modelling the effect of GABAergic and dissociative anaes-
thetic agents on cortical activity.
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3.2.1 Modelling anaesthetic action of GABAergic agent
The intravenous anaesthetic agent propofol (2.6-diisopropylphenol) is a short-acting gen-
eral anaesthetic widely used for the induction and the maintenance of anaesthesia. Propo-
fol is classified as a GABA-enhancing drug. GABAergic anaesthetics tend to inhibit brain
action by increasing the duration of each inhibitory postsynaptic potential, holding the
GABAA chloride channels open longer, thus allowing an increased number of Cl
− ions to
diffuse down their concentration gradient into the cell. As a result, the cortical neurons
Table 3.3. Symbol definitions for postsynaptic equations
Symbols Description Value Unit
τe, i neuron time constant 0.04, 0.04 s
V revA,N reversal potential at dendrite 0 mV
V reva, b reversal potential at dendrite −70 mV
V reste, i neuron resting potential −64, −64 mV
ρNe NMDA excitatory synaptic gain 1.0× 10−3 mV s
ρAe AMPA excitatory synaptic gain 1.0× 10−3 mV s
ρai GABAA inhibitory synaptic gain −1.03× 10−3 mV s
ρbi GABAB inhibitory synaptic gain −1.03× 10−3 mV s
D2 i −→ i gap-junction diffusive coupling strength 0− 1.0 cm2
D1 e −→ e gap-junction diffusive coupling strength D2/100 cm2
become hyperpolarized (more negative) and therefore less likely to fire.
Clinical works show that anaesthetic drugs such as propofol tend to enhance the
effectiveness of inhibitory synapses, particularly of the fast-action GABAA and the slow-
action GABAB receptors [8, 56, 58]. GABAB synapses are less affected by propofol [84],
so have been ignored in previous anaesthesia models.
Propofol prolongs GABAA response by a dimensionless scale factor pa representing
drug concentration, αa is the decay rate of postsynaptic potential at zero drug concentra-
tion; for non-zero drug effect, the decay rate αap is a function of anaesthetic drug:
αap =
αa
pa
, pa ≥ 1 (3.32)
Therefore the action of propofol is modelled as a decrease in the decay rate of the GABAA
or a potentiating of the inhibitory synaptic responses[
d
dt
+ αap
][
d
dt
+ β
]
Φaik(t) = α
a
pβ Qi(t), pa ≥ 1 (3.33)
54 Waikato model for anaesthesia
Figure 3.7. Dendrite impulse responses for all four populations in the extended Waikato model.
(a) GABAA response plotted as a function of time; increasing the GABAA drug concentration
pa prolongs IPSP duration. (b) Gain factor on GABAB response increases with the GABAB
anaesthetic effect pb is increased. Panel (c) shows the AMPA response function, which is not
affected by anaesthetic agent. Panel (d) indicates drug effect on the gain factor at NMDA
receptors.
which contributes to changes of inhibitory fluxes through Eq. (3.34).
For GABAB receptors, propofol effect is modelled as an increase in IPSP gain [85],
obeying ρbi(pb) = pb ρ
b
i ; this allows us to control the effectiveness of GABAB fluxes entering
the soma. We highlight the GABAA and GABAB contributions to the inhibitory inputs,
Ik(t) = ρ
a
iψ
a
ik Φ
a
ik(t)︸ ︷︷ ︸
GABAA effect
+ ρbi(pb)︸ ︷︷ ︸
GABAB effect
ψbikΦ
b
ik(t) (3.34)
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3.2.2 Modelling anaesthetic action of NMDAergic agent
Dissociative agents are a class of anaesthetics that work to antagonize, or inhibit the
action of NMDA receptor; the state of anaesthesia they induce is referred to as dissocia-
tive anaesthesia, as these agents decrement perceptions of sight and sound and produce
feelings of detachment (dissociation) from the environment and self. The most common
dissociative drugs are nitrous oxide and ketamine.
Glutamate activates NMDA receptors (slow activation), the slow activation in NMDA
is due to the requirement that two agonist molecules glycine and L-glutamate must bind
to open the receptor [18,53,110]. While L-glutamate is released from specific presynaptic
terminals, low concentrations of ambient glycine present at the synapse allow receptor
activation.
A unique and significant property of the NMDA receptor channel is its sensitivity to
block by physiological concentrations of Mg2+ in presynapses [48,75]. The Mg2+ blockage
is only cleared when the NMDA receptor channels are sufficiently depolarized, see Fig. 3.8.
The conductance of the NMDA receptor is modelled as a sigmoid function of voltage and
magnesium concentration [49,50],
g(V ) = 1/(1 + e(a (V−θ)C)) (3.35)
where V is the cell voltage (mV), C is the magnesium concentration (mM), a is a coefficient
that changes depending on the magnesium concentration, and θ is the mid-point voltage
threshold.
As shown in Fig. 3.8, decreases in extracellular magnesium shift the conductance
function to the left of the graph, which corresponds to lower voltage threshold. For all
concentrations, the magnesium blockade is cleared at voltages more positive than about
+50 mV.
In Fig. 3.9(a), the NMDA gating function g(V ) is plotted for four concentrations of
magnesium C = [1, 3, 10, 50] mM for an assumed threshold θ = 0 mV. The gating func-
tions become less steep with decreasing magnesium concentration; Fig. 3.8(b) illustrates
the gate function as a function of membrane voltage for a setting of voltage threshold
θ = [−60, −50, −40, 0] mV at fixed Mg2+ concentration C = 3.7 mM. It can be seen that
decreasing voltage threshold moves the curves to the left.
The theoretical NMDA conductance function that we will apply for our NMDA mod-
elling obeys the following equation,
g(V ) = 1/(1 + e(−0.062(V+60))) (3.36)
where aC = −0.062 mV−1 corresponds to a range of drug concentration between 1 and
10 mM; see Fig. 3.8. In Fig. 3.9(c), the gating function g is plotted as a function of
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Figure 3.8. The conductance function versus membrane voltage of NMDA receptors for four
magnesium concentrations C = [0.01, 0.1, 1, 10] mM. Current amplitudes from the cell converted
to conductance, assuming a reversal potential of 0 mV, normalized to maximum conductance,
and plotted against holding potential. The data are fitted with curves generated from the gating
function derived from Eq. (3.35), from [50]. The conductance versus voltage families shift to the
right in an orderly fashion with increasing external magnesium.
voltage.
Dissociative anaesthetics are thought to reduce the effectiveness of NMDA postsynptic
event by limiting the influx of sodium ions and consequently lowering the overall level of
excitation of the postsynaptic cell [14].
To apply this hypothesis in the Waikato model, the effectiveness of NMDA receptors
is altered through the following definition:
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Figure 3.9. The conductance g of NMDA is plotted as a function of voltage for the whole
cell (a) for a set of magnesium concentrations C = [1, 3, 10, 50] mM, and (b) for a set of
voltage thresholds θ = [−60, −50, −40, 0] mV. (c) Theoretical conductance function (3.36) for
our NMDA modelling.
3.2 Modelling the action of anaesthetic agents 57
Σ
Σ
+
+
+
+
Σ
Σ
Σ
Σ
+
+
+
+
Σ
Σ
β               α
    ΝΝ
β               α
    ΑΑ
β               α
    ΝΝ
β               α
    ΑΑ
β               α
    bb
β            α(p)
aa
β            α(p)
aa
Σ
β               α
     bb
+
Σ +
Nei
A 
φee
Nee
A Nei
N Nee
N 
nii
anii
bnie
anie
b
n
ei
A nei
Nnee
A nee
N
Q e
ψei (Vi)
Α
ψ
ei (Vi)
Ν  ρ Ν (p , g)
ρΑ
ψee (Ve)
Α
ψ
ee (Ve)
Ν  ρ Ν(p  , g)
ρΑ
sc
φei
sc
φei
sc
ψii (Vi)
a ρ a
ψii (Vi)
b ρb(p  )b
ψie (Ve)
a ρ a
ψie(Ve)
b ρb(p  )b
φee
sc
ei
Α
ei
Ν
Φei
M
M Ν
ee
ΝM
ee
Α
M
ii
a
Φ
ii
b
Φ
ie
a
Φ
ie
b
Φ
Φee
Ν
Φee
Α
e
i
ee
i i
i e
Φei
Α
Q e
Ve
Vi
Q i
Nei
A 
Nee
A Nei
N 
Nee
N 
N 
N 
θ
e
i
θ
Q i
Q e
V
 gap
V
   gap
eθ
Q e
openclosed
  i
 e
 
Figure 3.10. The cerebral cortex is pictured as a continuum of macrocolumns interconnected
via their excitatory sigmoid outputs. The inter-macrocolumn communication is governed by
wave equations to include propagation delay effects. In addition, the entire macrocolumn mass
is buffeted by φscek exogenous inputs coming up from excitatory sources in the subcortex. All
inputs (local, distant, and external) are combined at the summing points to determine the Mlk
presynaptic inputs. The resulting chemical and electrical synaptic currents are integrated at the
soma capacitor to give a soma voltage Vk (k = e, i). The green boxes indicate the extensions
to the standard Waikato model, the blue and red text highlight the cooperation of GABAergic
and NMDAergic contributions. The Σ summation symbol indicates the integration of all fluxes
entering the soma RC compartment of Fig 3.3.
Ek(t) = ρ
A
e ψ
A
ekΦ
A
ek(t) + ρ
N
e ψ
N
ekΦ
N
ek(t) (3.37)
ρNe (pN) = ρ
N
e pN g(V ), pN > 1 (3.38)
where pN is the drug effect in NMDA receptors. To increase the effect of dissociative
drug in the model, we decrease the effectiveness of NMDA receptors pN .
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Figure 3.10 summarizes the cortical connectivities for the Waikato model.
3.3 Results
In the current study, we present the anaesthetized model dynamical behaviour due to
alteration of GABAA, GABAB and NMDA receptor effectiveness. The effect of Cx36 gap
junction blockade during anaesthesia is also investigated.
Before exploring the full two-dimensional behaviour due to anaesthetic effect, it is use-
ful to calculate the homogeneous steady states of the model. To locate the steady states,
all temporal and spatial derivatives are set to zero, and the noise source φscek is removed.
Then, the steady-state membrane voltage and firing rates for both the inhibitory and
excitatory neural populations are computed numerically as a function of the anaesthetic
effect pa. Here, it is important to emphasize that the all steady-state manifolds illustrated
in the current chapter are completely independent of the D2 inhibitory and D1 excitatory
diffusion coefficients, as their Laplacian operators ∇2 have been zeroed.
We focus attention in the vicinity of a general anaesthetic phase transition where
the equilibrium trajectory displays multiple steady states: an awake “top state”, and an
anaesthetized “bottom state”, separated by an unstable intermediate “mid state”.
A linear stability analysis is performed through linearisation of voltages about the
equilibrium state at the fixed anaesthetic drug effect pa , where the awake state of the
cortex is close to a critical point (loses the stability).
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Figure 3.11. GABAA effect on distribution and stability of cortical equilibrium states expressed
as (a) excitatory firing rate Qe, and (b) excitatory membrane voltage Ve. Anaesthetic drug effect
is varied over the range 0 6 pa 6 1.1 as indicated by horizontal scale bars. Region of instability
(dashed red lines) increases as the background GABAA decay-rate α
a is stepped to lower values.
Ve and Qe are linked through the sigmoid mapping of Eq. (3.7).Steady states were found using
fzero in Matlab; stability was assessed from linear eigenvalue analysis.
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3.3.1 Numerical considerations
In the homogeneous limit, the cortical Eqs (3.3, 3.18 and 3.31) are equivalent to 12 first-
order differential equations (DEs). The stochastic DEs were integrated using a forward-
time, centred-space (FTCS) Euler-Maruyama [39] algorithm custom-written in Matlab
with time step mostly ∆t = 0.1 ms. In all 2D numerical simulations, the cortex is a
square grid of side-length 25 cm which is joined at the edges to give toroidal boundaries.
All state variables were initialized at their homogeneous steady state values. The time
step was set sufficiently small that the dominant spatial feature advanced by less than
the spacing between adjacent grid points in time, thereby ensuring numerical stability.
For example the large diffusive coupling and fine spatial resolution mandate a very small
time step in order to ensure numerical stability.
3.3.2 GABAA and the extended Waikato model
Steady state distribution
To include GABAergic anaesthetic effect on GABAA receptors, the decay rate of GABAA
response function is assumed to be the main target via Eq. (3.33). Decay-rate alterations
control GABAA-mediated postsynaptic charge transfer. To explore the effect on the cortex
stability, the distribution of equilibrium states of membrane voltages V 0e and firing rates
Q0e of the excitatory neural population are plotted as a function of anaesthetic drug pa for
three inhibitory rate constants αa = [20, 30, 40] s−1.
As shown in Fig. 3.11, reducing the αa decay rate of GABAA response increases the
region of instability in the cortex.
Linear stability analysis
To predict the dynamical behaviour of the cortex about the awake state equilibrium, the
LSA calculations are performed in the presence of weak inhibitory diffusion D2 = 0.2 cm
2,
for different decay-rates. Fig. 3.12 illustrates representative dispersion curves, plotted as
a function of scaled wave number q/2pi, corresponding to a fixed value of anaesthetic drug
effect pa = 1.0. Three settings of GABAA decay rate α
a = [20, 25, 30] s−1 are selected.
Although the homogeneous cortex has access to three steady states, only the top- and
bottom-branch dispersion curves are plotted since the mid-branch is always unstable state
and the brain can never switch to that state. As the rate of decay decreases, a temporal
(Hopf) mode develops in both branches, but no spatial (Turing) mode is predicted. In
Fig. 3.13, the linear stability prediction of low frequency temporal oscillations is tested in
the cortical model through fully nonlinear grid simulations. It is important to mention
that in this thesis, the terms Hopf and Turing instability respectively refer to the regions
in which linear stability analysis predicts a dominant eigenvalue with a positive real part
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and a non-zero imaginary part (Hopf) or a positive real part, zero imaginary part and a
non-zero wavenumber (Turing).
GABAA numerical simulations
To confirm the dispersion prediction several simulations were run. Scanning Fig. 3.13 from
top to bottom, one can observe that the pattern of cortical dynamics is very sensitive to
to the value of GABAA decay rate: for small decay rates α
a ≤ 20 s−1, the Hopf instability
drives large-scale ∼1 Hz oscillations which are highly synchronized. For an intermediate
range 20 ≤ αa ≤ 25 s−1, the oscillations become slower and less synchronized. For
αa ≥ 27 s−1, these oscillations become weaker and finally disappear.
Figure 3.14 shows bird’s-eye snapshots of the evolution of spontaneous pattern forma-
tions in excitatory firing rates at ∼2 s intervals (left to right) for step increases in the
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Figure 3.12. Eigenvalue distribution curves with respect to various αa at fixed inhibitory
diffusion D2 = 0.2 cm
2. Predicted dispersion curves for spatially homogeneous cortex for (a)
top-branch, (b) bottom-branch at pa = 1.0 for selected inhibitory GABAA decay rate values
αa = [20, 25, 30] s−1. In each panel the top traces show oscillation frequency (in Hz) and the
lower traces indicate the real part of the dominant eigenvalue, Re(eig), as a function of scaled
wave number q/2pi.
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Figure 3.13. Grid simulations of the cortical model launching from the top branch for a set of
GABAA inhibitory decay-rates α
a = [20, 23, 25, 27] s−1 with a fixed GABAB effect of pb = 25%.
In the dispersion curves (first column), solid-red and dashed-blue curves are respective real and
imaginary parts of the dominant eigenvalues in the up branch. The second column is the time-
series of five points along the centred-vertical line (y=90) of the 180×180 grid. The third column
is the 10-s space-time stripchart extracted from the centred-vertical axis of the simulated cortex
with a side length 25 cm and a 180×180 grid; time step was ∆t = 10−4 s. Grid was continuously
stimulated by low-intensity spatio-temporal white noise. The fourth column is a snapshot of the
grid activity at final time step.
αa GABAA decay rates (top to bottom), presented as a 5× 5 gallery. Model parameters
match these used for Fig. 3.13.
The seizure promoting impact of gap-junction closure due to GABAAergic anaesthetic
agent was reported by Steyn-Ross et al. [92]. In the following sections, we investigate
the effect of gap-junction closure on seizure activity while simultaneously altering the
cooperation of GABABergic and NMDAergic anaesthetic agents.
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20
23
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27
α a
Time 2 s                        4 s                          6 s                           8 s                       10 s
Figure 3.14. Evolution of firing activity for stepped values of αa GABAA decay rate (vertical
axis). Cortical sheet is initialised at the homogeneous steady state stimulate by subcortical
white noise. Colour indicates the activation of cortical tissue: red, high firing activated and blue
low firing suppression; see Fig. 3.13 for colour bar.
3.3.3 GABAB and the extended Waikato model
Cortical steady states and GABAB effect
We now investigate the effect of GABAB activation (enhancement) with GABAA decay-
rate fixed at αa = 25 s−1, and other parameters set to the default values listed in Tables
3.1 and 3.3).
Figures 3.15(a) and (b) graph the distribution of Q0e and V
0
e equilibrium values as a
function of the anaesthetic drug pa for three GABAB gain factors, pb = [15%, 25%, 35%].
In each trajectory, a multi-state region is observed for a specific range of anaesthetic drug
pa . Increasing the GABAB gain factor decreases excitation of the cortex and shifts the
steady state trajectories to the left, while increasing the region of instability in both upper
and bottom branches.
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Figure 3.15. GABAB effect on steady states distribution. As shown in panel (a) increasing the
GABAB effect enhances the unstable regions for the steady state trajectories for the excitatory
cortical populations. Panel (b) shows the corresponding voltage membrane Ve to the firing rate
presented in (a), see Fig. 3.11 for more details.
GABAB linear stability analysis
To investigate the GABAB effect on the dynamical behaviour of the cortex at the equi-
librium state, a linear stability analysis is performed and compared for two GABAB set-
tings: pb = 15% and 25%; simultaneously the gap-junction diffusion effect on the extended
Waikato model is tested.
To have a reliable comparison between dispersion curve predictions of these GABAB
settings, it is desirable to have similar instability conditions on the upper branch. At
the chosen drug effects pa = 1.08 (pb = 15%) and pa = 1.0 (pb = 25%), the homogeneous
cortex has access to three steady states, see Fig. 3.15. We present dispersion curves
for the top branch only (we did not observe significant sensitivity to GABAB on the
bottom branch). Figure 3.16(a) and (b) show dispersion curves plotted for pb = 15%
and 25% respectively. Each panel is divided into the upper and lower parts present the
imaginary (±ω) and real parts (α) of the leading eigenvalue Λdom = α ± iω respectively
(the non-dominant eigenvalues have more negative real parts, therefore make a negligible
contribution to cortical stability). In each panel four settings of gap-junction diffusion
are plotted: (D1, D2)/cm
2 = (0.003, 0.3); (0.004, 0.4); (0.005, 0.5); (0.006, 0.6).
As shown in Fig. 3.16, the dispersion curves predict a Hopf instability for all gap-
junction values: at q = 0 (infinite wavelength) the real part of the leading eigenvalues
are positive with ω ' 1 Hz. A Turing instability appears at the highest diffusion setting
D2 = 0.6 cm
2 for both GABAB values. In the case of pb = 15%, a Turing instability is
predicted at q/2pi = 0.3 cm−1 (λ = 3.33 cm); while for pb = 25%, the instability develops
at q/2pi = 0.44 cm−1, corresponding to wavelength λ = 2.27 cm. These results indicate a
stronger Turing instability with a bigger wavelength for the lower GABAB effect.
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Figure 3.16. GABAB effect and model dispersion curves. Linear stability predictions are
illustrated for the top branch of homogeneous cortical system for (a) pb = 15% and (b) pb = 25%.
In each panel the lower boxes show the real part of the dominant eigenvalue, Re(eig), as a function
of wave number q/2pi; the upper traces indicate oscillation frequency (in Hz), ω = Im(eig)/2pi.
The Turing instability near 0.35 wave/cm (for D2 = 0.6 cm
2) is considerably weakened when
GABAB effect is boosted from pb = 15% to 25%.
LSA predicts both Hopf and Turing instabilities on the upper branch for the strong
diffusion effect D2 > 0.5 cm
2. Increasing GABAB unbalance the spatial mode (Turing)
in favour of the temporal mode (Hopf) on the top branch; for pb> 25%, the Turing
instability vanishes.
GABAB numerical simulations
The linear stability predictions of Fig. 3.15 indicate that increases in GABAB enhance
instability, with the cortex becoming destabilized for a wider range of anaesthetic drug.
And Fig. 3.16 shows that increasing the GABAB effect and closing gap junction unbalances
the spatial mode (Turing) in favour of the temporal mode (Hopf), allowing a seizure
oscillation to develop.
To test these predictions, a series of grid simulations of the full nonlinear cortical
equations was ran. Firing rates and soma voltages are initialized to the steady-state
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Figure 3.17. Effect of inhibitory diffusion on “awake” cortex with GABAB effect pb = 15%
and GABAA decay rate α
a = 25 s−1. (a) Dispersion curve for equilibrium top branch (solid-red
and dashed-blue curves are real and imaginary parts of dominant eigenvalue); (b) time-series for
excitatory firing rate Qe(t) of five points along the centred-vertical line (y=90)of the 180× 180
grid; (c) Qe(t, x) space-time strip-charts of activity along the midline. For D2 = 0.5 cm
2 (top
row), a stationary Turing pattern emerges; smaller diffusion values lead to oscillating patterns
of firing activity (see Fig. 3.19 for time-evolution snapshots).
values on the top branch. All grid points are then perturbed continuously by random
subcortical white noise, and the subsequent evolution of the cortical sheet is traced for
66 Waikato model for anaesthesia
Figure 3.18. Effect of inhibitory diffusion on “awake” cortex with GABAB effect pb = 25%.
(See Fig. 3.17 caption for further details, and Fig. 3.19 for time-evolution gallery.)
a total time of 20 s with grid resolution of 2.7 mm and time step of 0.1 ms. Each full-
resolution 20 s run required almost 2 h. Here, the pattern dynamics of the cortex for two
GABAB gain factors are investigated. Figures 3.17 and 3.18 illustrate the dynamical effect
of the reduction in inhibitory diffusion on pattern formation on the “awake” state of the
cortex for pb = 15% and 25% respectively. Each figure contains five rows corresponding to
five values of gap-junction strength. There are three columns: the first column indicates
the dispersion curves for the dominant eigenvalue; the second shows a 20-s time-series of
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Figure 3.19. Evolution of Qe(x, y) firing pattern (GABAB effect pb = 15%, GABAB decay-rate
αa = 25 s−1) for Fig. 3.17. The five rows correspond to five values of inhibitory diffusion D2.
Only the top row evolves to a stationary Turing pattern. Colour indicates level of activation:
red, high firing; blue, low firing.
five grid points along the vertical midline y = 90 of the of the 180 × 180 grid; the third
column is the corresponding space-time strip-chart extracted from the centred-vertical
axis.
Scanning Figs. 3.17 and 3.18 from top to bottom shows that stability and the cortical
pattern are strongly sensitive to changes in inhibitory diffusion strength D2. Moreover,
changes in GABAB setting create different dynamical characteristics in the cortical model
for each D2. As shown in Fig. 3.17 in the presence of pb = 15%, for strong diffusion D2 =
0.5 cm2, the Turing instability dominates to form a Turing pattern which is frozen in space
with no temporal oscillation. For intermediate inhibitory diffusions 0.2 < D2/cm
2 < 0.5,
a strong competition between spatial (Turing) and temporal (Hopf) modes is observed,
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Figure 3.20. Evolution of Qe(x, y) firing patterns (pb = 25%, α
a = 25 s−1) for Fig. 3.18. (See
Fig.3.19 caption for other details.)
resulting in a chaotic spatiotemporal pattern with irregular oscillations between up and
down states; for weak diffusions D2 ≤ 0.2 cm2, the temporal instability dominate to drive
large, slow oscillations.
For the greater GABAB effect of pb = 25% in Fig. 3.18, closing gap junctions unbalances
the spatial mode earlier, allowing seizure oscillations to develop at weaker gap-junction
connectivity. For intermediate inhibitory diffusions 0.2 < D2/cm
2 < 0.5, while pb = 15%
creates chaotic dynamics, pb = 25% develops mostly temporal instabilities and for the
weak diffusion D2 ≤ 0.2, the greater GABAB gain factor develops a fully synchronized
oscillation. Therefore, one can conclude that for both GABAB settings the resulting
patterns are an interaction between Turing and Hopf. Increasing GABAB tends to desta-
bilize the stationary Turing structure in favour of large-scale oscillations. This prediction
3.3 Results 69
 NSF=0.5
NSF=0.1
(c)  noise-factor=0.001(a) 
p = 15%
 0             10            20             30            40             50           60
(b) 
p  =25%
0
5
10
15
20
 NSF=0.5
 NSF=0.001
 NSF=0.1
 NSF=0.001
0
5
10
15
20
25
0
5
10
15
20
25
bb
 p = 25%
b
 p = 15%
b
p = 15%
b
 p = 25%b
 0             10            20             30            40             50           60
Time (s)Time (s)
Q
e 
(S
pi
ke
s/
s)
25
Figure 3.21. Noise intensity impact on simulations. The effect of three different NSF=
[0.001, 0.1, 0.5] on simulation results (a) pb = 15% and (b) pb = 25%. As the noise intensity
increases, the time required to develop seizure-like chaotic oscillations decreases.
of increased instability is consistent with findings from clinical experiments [9, 11].
Figures 3.19 and 3.20 show bird’s-eye snapshots of the evolution of pattern formations
for the excitatory activity. In Fig. 3.19 (pb = 15%), one can see that by time t = 5 s, a
cloud-like pattern appears, indicating slow spatial fluctuations (second column), and by
10 s, the cortex has largely organized itself into its final spatiotemporal configuration.
With strong diffusion for t ≥ 10 s (the upper row D2 = 0.5 cm2), the Turing pattern
appears as high-amplitude island-like regions surrounded by valleys of low amplitudes
with maximum contrast between the higher and lower firing rates. As a result of closing
gap-junctions (reductions in inhibitory diffusion strength), the width of the inactive (blue)
regions increases and travelling-wave patterns appear.
Comparing with the evolution for pb = 25% in Fig. 3.19, we see that the cortex or-
ganises to the final configuration in less than 5 s; as the gap-junction strengths decrease,
the cortex moves from Turing to temporal pattern without being in a chaotic state for
a large range of diffusion strength: the full temporal pattern for pb = 25% happens at
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Figure 3.22. Evidence for chaotic behaviour of the Waikato cortical equations. (a) Blue trace
Q1 shows cortical evolution for continuous white noise with NSF = 0.5, pb = 25% (corresponding
to one of the four traces in Fig. 3.21, bottom right panel). Red trace Q2 is a repeat run with
identical noise up until time t = 25s, at which point noise is turned off (vertical dashed line).
(b) Residual for Q1 − Q2 = 0 shows that traces are identical up until t = 25s. (c) Thereafter,
residual grows exponentially with Lyapunnov exponent λ = 0.92 s−1 until saturation occurs for
t & 35s.
D2 = 0.3 cm
2; while in the case of pb = 15%, the temporal pattern formation is completed
at D2 ≤ 0.2 cm2.
To test the effect of the noise scale factor (NSF) on our results, a series of simulations
of the Waikato cortical equations for three different noise intensities for two values for
GABAB effect (pb = 15% and pb = 25%) was ran using Euler-Maruyama integration with
time step of 0.3 ms in Matlab, see Figs. 3.21 to 3.23. The system equations were
perturbed continuously by identical sequences of subcortical white noise, but the scale
factor of the noise intensity was set at one of three different values (see Fig. 3.22). The
evolution of the cortical sheet was traced for a total time of 60 s. Cortical equations were
initialized to the top-branch steady-state values. Figure 3.21 shows that increasing noise
intensity reduces the time of onset of seizure-like activity. Once large-scale oscillations
have developed, the noise has little or no effect on oscillation dynamics. In contrast,
3.3 Results 71
0
5
10
15
20
25
0                                                 50                                                100                                                150                                              200
0
5
10
15
20
25
 (b) 
 (a) p =15%
b
Q
e 
(S
pi
ke
s/
s)
Time (s)
p = 25%b
Figure 3.23. Seizure-like event (SLE) activity enhanced in a theoretical Waikato mean-field
model as GABAB effect is increased. (a) The minimal effect of GABAB for pb = 15% is considered
as a baseline and (b) the greater pb = 25% impact as a modelling drug effect.
increasing the modelled GABAB effect from pb = 15 to 25% has a marked qualitative
impact on the duration of oscillatory bursts, see Fig. 3.23. We conclude that the activity
bursts seen in Figs. 3.21 to 3.23 are not noise-driven events. In fact, these are chaotic
oscillations as demonstrated in Fig. 3.22. A pair of simulations with the identical sequences
of white noise was run; for the blue trace, the noise is continuous, while noise is turned
off at 25 s for the red trace (see Fig. 3.22(a)). The red trace shows that large-scale
oscillations persist even in the absence of noise. Figure 3.22(b) and (c) present the residual
of these two traces on a linear and semi-log scale respectively. The exponential divergence
in Fig. 3.22(c) demonstrates exquisite sensitivity to changes in initial conditions, and
provides strong evidence of the chaotic nature of these oscillations.
3.3.4 NMDA and the Waikato model
The mean-field model is characterised by excitatory neurotransmitters (AMPA), and in-
hibitory neurotransmitters (GABAA, GABAB); in the current section, the model is mod-
ified by including NMDA as another excitatory neurotransmitter. The results presented
in the following sections are due to the existence of all four receptors (AMPA, NMDA,
GABAA, GABAB).
NMDA cortical steady states
Inclusion of NMDA neurotransmitter via Eq. (3.37) alters both the distribution of soma-
voltage steady states and the extent of cortical instability. Figure 3.24 shows that the
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inclusion of the NMDA term increases the level of excitation, pushing the steady-state
manifolds to the right and increasing excitation in the upper branch. For example, for
pa = 1.8, the upper-branch firing rate increases with NMDA effect: Qe = 17 s
−1(pN =
100%), Qe = 28 s
−1(pN = 200%); Qe = 32 s−1(pN = 300%)); note that the latter two
values are beyond the displayed range of Fig. 3.24(a).
NMDA stability analysis and dispersion curves
To predict the dynamical behaviour of the cortical model, a sample of dispersion curves
for anaesthetic drug effect pa = 1.08 and pa = 2.56 are plotted as a function of wave
number for two NMDA gain factors pN =[100%, 200%]; results are presented in Fig. 3.25
for the top and bottom branches. Four settings of gap junction diffusions are chosen
D2 = [0.2, 1, 2, 3] cm
2. The real part of the leading eigenvalues are plotted, since these
determine system stability.
Comparing Fig. 3.25(a) and (c) at q = 0, the real part of the dominant eigenvalues
are very similar [Re(eig)= 0.6 (pN = 100%) and Re(eig)= 0.5 (pN = 200%)]; providing us
with reasonable initial instability conditions to allow comparison between LSA of the two
NMDA settings for the non-zero wave numbers. As shown in Fig. 3.25(a) at the NMDA
gain factor pN = 100%, the Turing instability is prominent only for very strong diffusion
coefficients D2/cm
2 & 2.0, while the temporal instabilities are predicted for all inhibitory
diffusion strengths. Boosting NMDA effect to pN = 200% in Fig. 3.25(c), dispersion curves
predict that Turing peaks either decrease (D2 = 3 cm
2) or vanish (D2 = 2 cm
2), so the
Hopf temporal modes will dominate on the upper branch. Comparing panels (a) and
(c) of Fig. 3.25 for strong gap-junction diffusion, increasing NMDA effect unbalances the
spatial mode (Turing) in favour of the temporal mode (Hopf) on the top branch.
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Figure 3.24. NMDA effect on distribution of steady states. (a) Equilibrium firing rate Qe; (b)
membrane voltage Ve for the excitatory population as a function of anaesthetic effect for the
different values of NMDA effect pN = [100%, 200%, 300%].
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NMDA numerical simulations
In order to verify the numerical correctness of the model predictions, fully nonlinear
stochastic simulations were run for the full cortical system equations in Chap. 3.1. The
pattern dynamics of the cortex for two NMDA gain factors are investigated.
Figures 3.26 and 3.27 illustrate the dynamical effect of the reduction of the gap-
junction diffusion for the awake state of the cortex for pN = 100% and 200% respectively.
Each figure contains four rows corresponding to four values of gap-junction diffusion
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Figure 3.25. NMDA effect dispersion curves. (a, b) NMDA effect pN = 100% with anaesthetic
effect pa = 2.59 and pb = 20% for (a) top branch and (b) bottom branch. (c, d) Dispersion
curves for NMDA effect pN = 200%, anaesthetic effect pa = 1.8 and pb = 20%.
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strengths. Scanning Figs 3.26 and 3.27 from up to bottom show that the cortical pat-
terns are strongly impacted by changes in inhibitory diffusion values D2 for both NMDA
settings. A comparison between Figs 3.26 and 3.27 shows for intermediate inhibitory
diffusion 0.3 < D2/cm
2 < 0.5, while pN = 100% creates a chaotic dynamical behaviour
for pN = 200% mostly temporal instabilities are developed over time and for the weak
diffusion, the greater NMDA gain factors develop a synchronized oscillation with slower
oscillations in comparison to pN = 200%, the dynamical pattern is not in full synchronized
state. Scanning Column (d) from up to down indicates a Turing pattern with maximum
contrast between the higher and lower firing rates for strong diffusion value. Reduc-
tions in inhibitory diffusion strength increases the separation between activated area and
travelling-wave temporal patterns appear.
Figure 3.26. NMDA cortical dynamics for pN = 100%, αa = 20 s
−1, pb = 20%. Gap-junction
strength D2 is stepped from 0.9 (top row) to 0.3 cm
2 (bottom). Cortex is initialised at the
pa = 1.8 awake state. (a) Time-series of excitatory firing-rate Qe(t) for 20 sec. (b) Qe(t, x)
space-time chart representing the 20-sec time-evolution of cortical activity along the y = 60
midline strip. Firing rate (y-axis) ranges from 0 to 33 s−1, colour scale from blue to orange
indicates the numerical range from low to high. (c) Bird’s eye snapshot Qe(y, x) at t = 20 sec.
(d) Mesh images Qe(y, x) of the cortex when t = 20 sec. Grid resolution is 2.4 mm and time
step is 0.1 ms. Grid size is 120× 120.
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Figure 3.27. NMDA cortical dynamics for pN = 200%, αa = 20 s
−1, pb = 20% see Fig. 3.26
caption for simulation details.
Here, it is important to mention that our simulation result is not in agreement with our
finding from dispersion curve prediction in Fig. 3.25. For a specific range of gap-junction
D2 < 1, the Hopf oscillation on the upper branch loses stability through Turing bifurcation
on the lower branch which cannot be discerned from linear stability analysis. Nevertheless,
we can conclude that increased NMDA effectiveness (and hence increased excitation) tends
to weaken the spatial mode (Turing) and enhance slow temporal oscillations (Hopf).
3.4 Conclusion
Anaesthetic agents from the inductive class (e.g., propofol) affect GABAA receptors
through potentiating GABAA-induced ionic currents; this is modelled as a prolongation
of the tail of the unitary IPSP. These agents also interact with GABAB receptors through
increasing inhibitory synaptic neurotransmission [85], this modelled as an increase of in-
hibitory synaptic gain. Dissociative drugs (e.g., ketamine, nitrous oxide) affect excitatory
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synaptic neurotransmitter through the modulation of NMDA receptor function [33, 97],
the effect of these agents is modelled as a voltage-dependent alteration of excitatory
synaptic gain.
Linear stability analysis predicts that reducing the decay rate (i.e., prolonging the
decay duration) of GABAA destabilises the temporal stability in both awake and anaes-
thetised states of the cortex. Increases in GABAB gain enhance the instability in the
upper branch, while the lower branch does not show significant sensitivity to the GABAB
changes; while NMDA effectiveness affects the stability on both awake and anaesthetised
states. Dispersion curves predict that increasing GABAB and NMDA effectiveness tends
to destabilize Turing patterns in favour of a temporal mode (Hopf) with large-scale syn-
chronized oscillations that may represent a seizure state.
In both cases of GABAB and NMDA inclusion, strong gap-junction diffusivity activates
a natural mechanism for Turing bifurcation that accelerates to the spontaneous formation
of spatial patterns of high and low neural activity over the whole cortex. Simulation
pattern and linear stability prediction are in agreement in the case of GABAB. However,
in the case of NMDA modelling, for a specific range of gap-junction D2 < 1, Hopf pattern
in upper branch loses stability through a Turing instability on the lower branch. The
Waikato model indicates that the cortex may be susceptible to seizures when Cx36 gap
junctions are blocked during anaesthesia. This may explain why some anaesthetics cause
seizures, as many of these agents also block gap junctions [105].
Previous clinical work has shown that Cx36 gap junctions are crucial in determining
cortical stability [98]. However, there is a contradiction between experimental results
about gap-junction blocking agents: some report suppression of seizure activity [30,51,54],
while others provide evidence that these drugs enhance seizure activity [47, 76, 100, 108].
Some reports suggest that the excitation and suppression effects may be dependent on
concentration [31,100]. Moreover, there is some evidence that there is interaction between
gap-junctions closure and GABA [29] and NMDA activity [14,102].
However, to date no clinical experiments on either people or animals have investigated
the propensity for gap junction blockade to cause seizure activity during anaesthesia.
In the next chapter, we will test this hypothesis by designing two experiments, the
first using in vitro cortical brain slices and the second using in vivo EEG recording. The
first experiment studies the effect of GABAB on cortical slice activity (applying baclofen);
and the second experiment (EEG recording) examines whether anaesthetising mice with
a commonly used general anaesthetic (propofol)-while simultaneously blocking Cx36 gap
junctions with mefloquine-induces signs of seizure activity in brain.
Chapter 4
Experimental investigation of GABAB
enhancement and gap-junction closure
4.1 Effect of GABAB on in vitro cortical slice activity
Anaesthetic drugs, such as propofol, enhance the effectiveness of inhibitory synapses, par-
ticularly of the fast-acting GABAA receptors. The much slower acting GABAB receptors
are little affected by propofol, so have been ignored in previous anaesthesia models.
In Chap. 3, we extended the Waikato cortical model to investigate the effect of propofol
on brain activity in the presence of both GABAA and GABAB synapses. The model
predicts that enhancement of GABAB should have a seizure-promoting effect on brain
activity. To test this prediction, a set of experiments were designed based on in vitro
cortical brain slices1 [60] using the GABAB agonist
2 baclofen. The popularity of the in
vitro brain slice method is due to high controllability of experimental conditions and its
ease of use. This method has been applied to the study of anaesthetic drug effect by
Voss [101] and many others [64,69].
Baclofen has been shown previously to enhance seizure-like activity in adult hippocam-
pal rat slices at a dose of 0.1–1.5 µM in normal aCSF [61] and in activated hippocampal tis-
sue (4-AP3, zero-Mg and electrically stimulated) at a range of doses 1–50 µM [72,95,104].
In the stimulated protocols, baclofen enhances ictal (seizure) activity, while abolishing
interictal (between seizure) activity. Baclofen given to neocortical slices strongly inhibits
no-magnesium interictal activity at a dose of 1–50 µM [55].
In this study the aim is to investigate the effect of baclofen on ictal-like activity in
the anaesthetised neocortex (in the previous clinical experiments, no anaesthetic drug
was administered). Consistent with the Waikato cortical model predictions, the hypoth-
esis is that GABAB activation with baclofen should enhance seizure-like activity in the
anaesthetised cortex.
1Tissue slices are used to quantify metabolic reactions of tissues
2Agonist is a chemical that binds to and activates a receptor to produce a biological response
34-Aminopyridine (C5H6N2) is an organic compound used to characterize subtypes of the potassium
channel
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4.1.1 Method
This section describes the methods employed in these experiments such as solutions prepa-
ration, slicing, recording and data analysis. This work was carried out under the super-
vision and guidance of physiologist Dr Logan Voss.
Solutions
Two artificial cerebrospinal fluid solutions were prepared. These solutions are similar
to cerebrospinal fluid and are designed to keep the slices in a functioning condition for
several hours. Made with double distilled water, the solutions are stored at 1–4 ℃ for no
longer than 7 days. All solutions were bubbled with carbogen (95% O2 and 5% CO2) for
at least 15 minutes before use. The two solutions used were:
• Normal aCSF: NaCl (125 mM), KCl (2.5 mM), MgCl2 (1 mM), CaCl2 (2 mM),
NaH2PO4 (1.25 mM), NaHCO3 (26 mM) and D-glucose (10 mM)
• Zero-magnesium aCSF lacking magnesium ions: NaCl (124 mM), KCl (5 mM),
CaCl2 (2 mM), NaH2PO4 (1.25 mM), NaHCO3 (26 mM) and D-glucose (10 mM)
Normal aCSF was applied for brain extraction and tissue slicing, while zero-magnesium
aCSF was used to stimulate seizure-like event (SLE) activity from slices.
Removing magnesium from the aCSF unblocks and therefore activates excitatory
NMDA channels, resulting in increased tissue excitability and generation of seizure-like ac-
tivity. This is a commonly used method for inducing “seizures” in neocortical slices [101].
Slicing
Adult male and female wild-type (129 sv4) mice aged between 4 to 14 weeks were used
to obtain neocortical brain slices. The mice were anaesthetized with carbon dioxide
(approximately 30 s exposure) before decapitation and brain dissection. The brain was
freed from adjacent tissue and placed into ice-cold normal aCSF. The delay between
brain removal and slicing was not more than 10 minutes. Immediately before slicing, the
anterior and posterior 1–2 mm of cerebral cortex was removed with a razor blade. The
tissue block was glued to a stainless steel stage for slicing in ice-cold normal aCSF. The
brain was sectioned in the coronal plane (see Figure 4.1) into 6–8 slices with a thickness
of 400 µM, and then given a minimum of one hour for recovery at room temperature,
25℃ in carbogenated zero-magnesium aCSF.
Recording
For electrical recording, slices were transferred (three slices at a time) to an immersion-
style recording bath (Tissue Recording System, Kerr Scientific Instruments, New Zealand);
4common inbred strain of laboratory mouse
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Figure 4.1. Coronal brain cuts as indicated by bold green lines (a) Mouse brain viewed from
above showing the region of slicing (bold green lines); (b) a single coronal slice taken from the
region of the black line.
see Fig. 4.2. Zero-magnesium aCSF solution with addition of carbachol (33 µM), was de-
livered via gravity feed at a flow rate of 5.0 ml/min at room temperature (24–26℃).
Swartzwelder et al (1987) [95] reported that in the hippocampus the enhancing effect of
baclofen is observed only on ictal (seizure) activity, while interictal activity is suppressed.
Based on these findings carbachol was added to the bath solution to optimise prolonged
ictal-like SLE events in zero-magnesium solution [99].
Spontaneous local field potential activity was recorded from the cerebral cortex using a
50 µm teflon-coated tungsten electrode, one in each slice. The electrode was referenced to
a silver/silver-chloride disc, which served as a common reference. The signal was amplified
by a factor of 250, with 16-bit resolution and bandpass filtered between 1.0 and 3000 Hz
and the sampling rate was 10 kHz. The data were collected using LabChart6 and saved
for later analysis using custom-written MATLAB (R2014b) codes.
To protect the recordings from contamination by electrical artifacts, all experiments
were carried out in a double-shielded room which strongly attenuates external electro-
magnetic fields; however, total elimination of noise is impossible.
(a) (b)
Figure 4.2. Experimental setup for recording local field potentials from mouse brain slice in
vitro; (a) for 400-µm coronal brain slices, and (b) the recording chamber with electrode holders.
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Figure 4.3. (a) Profile of seizure-like event (SLE) activity induced in a single cortical slice from
a wild-type (129 sv) mouse during perfusion with zero-magnesium artificial cerebrospinal fluid
(0-Mg aCSF), 33 µM carbachol plus 50 µM baclofen. Each of the high-amplitude vertical lines
indicates a single SLE. (b) Expanded view of three SLEs. In this example the peak-to-peak
amplitude was approximately 165 µV, SLE length was ∼8 s and the frequency (the number
of SLEs per minute) was 3 min−1 (c) Expanded view of one SLE. The red and black colours
indicate the base line and SLE activity respectively. Compare with human seizure recording in
Fig. 1.4.
Procedure
The study was divided into experimental and control sections. In the experimental part
the effect of baclofen on SLE length, frequency and amplitude was quantified. There were
three stages to the procedure with a total duration of approximately 105 minutes:
• Baseline: Cortical slices are perfused with zero-magnesium aCSF, and 33 µM carbachol
for 30 min.
• Drug effect: Baseline solution is replaced with zero-magnesium aCSF, 33 µM carba-
chol plus 50 µM baclofen. The collected solution is discarded for the first 10 minutes
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Figure 4.4. Seizure-like event (SLE) activity induced in a single slice during (a) baseline; (b)
baclofen effect; and (c) washout.
to allow wash-in of the drug, and thereafter recirculated. This step maintains a con-
stant drug concentration in the recirculated solution. Baclofen is perfused for 45
min.
• Washout: Slices are returned to baseline solution for 30 min. Collected solution is
discarded for first 10 min before recirculating to prevent drug contamination during
the 30-min washout. The aim is to determine whether SLEs revert to pre-drug
baseline characteristics.
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Figure 4.5. Duplicate of Fig. 3.23 (simulation of GABAB effect in Waikato model) for con-
venient comparison with slice results of Fig. 4.4. We note that the propensity for prolonged
large-scale oscillations is boosted by strengthened pb .
82 Testing predictions of the Waikato model
For ease of comparison with the numerical modelling for GABAB effect reported in
Chap. 3, Fig. 4.5 is a duplicate of Fig. 3.23. If the large oscillations in the model correspond
to seizure events in the slice, then we see that SLEs are prolonged at larger GABAB values,
consistent with the slice experiments of Fig. 4.4.
Control experiments
In the second section, a series of control experiments were designed to confirm the va-
lidity of the outcomes from the baclofen experiments. Three control experiments were
undertaken.
1. Time control This part was carried out by perfusing only zero-magnesium aCSF
and 33 µM carbachol for the full 105 min. The purpose was to determine the effect
of time on SLE characteristics.
2. Drug control: saclofen + baclofen The aim was to investigate whether the effect
of baclofen on seizure-like events is consistent with action at the GABAB receptor.
This was done by adding the GABAB antagonist
5 saclofen to the baseline solution.
The procedure was as follows:
• Baseline: Perfusion of cortical slices with zero-magnesium aCSF, 33 µM carbachol
plus 100 µM saclofen for 30 min.
• Drug effect: Zero-magnesium aCSF, 33 µM carbachol, 50 µM baclofen plus
100 µM saclofen was applied, recording for 45 min. The aim was to investigate
if saclofen eliminates the baclofen effect, since both target GABAB receptors
in the slices.
• Washout: The baseline solution was applied for 30 min.
3. Drug control: saclofen The aim was to investigate the GABAB antagonist saclofen
effect on SLE characteristics. Same procedure as for baclofen, except saclofen was
added in place of baclofen.
4.1.2 Data analysis
Data preprocessing was carried out by visual inspection and obvious artefacts were re-
moved manually. In the majority of cases, SLEs were detected and analysed by applying
a semi-automated Matlab algorithm.
SLE amplitude was defined as the peak-to-peak activity, that is the difference be-
tween the maximum positive and the maximum negative deflection.
SLE frequency was computed over a 2-min sliding window with 70-s overlap, and
reported as the number of events per minute.
To define SLE length a semi-automated method was applied through Matlab code.
First, the standard deviation of an SLE-free segment was calculated. Then for each
5A receptor antagonist is a receptor ligand or drug that blocks or dampens agonist-mediated response
4.1 Effect of GABAB on in vitro cortical slice activity 83
detected SLE, using varying window lengths (40–200 samples), the SLE was deemed to
continue until the standard deviation of the window did not exceed that of the SLE-free
segment. Window lengths were manually tuned for each recording by visual inspection.
For statistical comparisons, SLE length, frequency and amplitude were averaged over
the 30 min immediately prior to drug delivery and compared to the average value during
the 45 min of drug infusion and the average value during 30 minutes of washout (drug-free
solution).
In some cases (7 recordings out of 16 for baclofen, and 1 of 16 for saclofen), SLE char-
acteristics were analysed manually because the automated algorithm failed to accurately
quantify SLE length. This was due primarily to inconsistencies in SLE features in some
recordings, and occasionally large delays between the initial SLE field potential deflection
and subsequent oscillation. In these cases SLE length was quantified by visual inspection
of five SLEs during baseline, drug and washout periods.
Comparisons were analysed using the non-parametric repeated measures analysis of
variance (ANOVA) Friedman test6. This test was used because not all data were normally
distributed. A p-value < 0.05 was interpreted as statistically significant, in which case
the Dunn multiple comparison test7 was used.
4.1.3 Results
An example of the pattern of SLE activity obtained from one slice is illustrated in Figs. 4.3
and 4.4. The main finding was that SLE duration increased during the infusion of baclofen.
The mean (SD) SLE length increased from 7.5 (9.6) s during baseline to 14.5 (19.7) s dur-
ing baclofen infusion (p < 0.01). This effect reversed during drug washout. Thus mean
SLE duration during baclofen infusion doubled compared to baseline (Fig. 4.6).
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Figure 4.6. Effect of baclofen on the
length of seizure-like events: Compar-
ison between Baseline and Drug in-
fusion shows a very significant differ-
ence (p∗∗ < 0.01); comparison between
Washout and Drug infusion shows a sig-
nificant difference (p∗ < 0.05). There
is no significant difference between
Washout and Baseline, confirming that
SLE length reverted to Baseline after
stopping baclofen infusion. The error
bars indicate standard deviation.
6The Friedman test is a non-parametric test to compare three or more matched groups
7Dunn’s test is a non-parametric pairwise multiple comparisons procedure based on rank sums, often
used as a post hoc procedure following rejection of a Kruskal-Wallis test
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Figure 4.7. Effect of baclofen on the
frequency of seizure-like events: Com-
parison between Baseline and Drug in-
fusion shows that there is a highly sig-
nificant difference (p∗∗∗ < 0.001); com-
parison between Washout and Drug
infusion shows a significant difference
(p∗ < 0.05).
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Figure 4.8. Effect of baclofen on
the amplitude of seizure-like events.
There is no significant difference be-
tween Baseline, Infusion, and Washout
conditions.
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Reflecting the increase in SLE length, the frequency of occurrence of seizure-like events
was lower during baclofen infusion (3.2 min−1) compared to baseline (5.3 min−1) and
washout (4.5 min−1). Thus, the frequency of the SLEs during baclofen infusion reduced
by a factor of 40% compared to the mean value in baseline (Fig. 4.7).
There was no significant change in the peak-to-peak SLE amplitude after the inclusion
of baclofen into the aCSF (Fig. 4.8). Table 4.1 summarizes the mean values and respective
standard deviations (SD) for different experimental stages for SLE characteristics.
The time-control results of Table 4.2 show that SLE characteristics changed over time:
SLE length and peak-to-peak amplitude reduced with time (significant difference between
the “baseline” and “washout” values (p < 0.05)). Also, SLE frequency increased over
time (note that these was no change in aCSF composition during this 105 min control
experiment). In fact, these results indicate that time has an opposite effect to that of
baclofen.
The saclofen control experiment of Table 4.3 revealed that the GABAB antagonist
cancelled the effect of the GABAB agonist baclofen: there was no significant change
in SLE characteristics when saclofen and baclofen were combined (p > 0.5). Comparing
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Tables 4.1 and 4.3, we see that SLE length in the presence of baclofen was 14.5 s compared
to 9.8 s when there was a combination of baclofen and saclofen.
Table 4.1. Effect of baclofen infusion on the characteristics of seizure-like events (n = 16 slices)
Condition length (s) frequency (min−1) amplitude (µV)
Baseline 7.5 (6.9)∗∗ 5.3 (3.4)∗∗∗ 139 (101)
Baclofen infusion 14.5 (19.7) 3.2 (1.8) 147 (92)
Wash out 9.4 (10.3)∗ 4.5 (2.9)∗ 142 (90)
Asterisks indicate level of significance relative to baclofen infusion:
p∗ < 0.05, p∗∗ < 0.01, p∗∗∗ < 0.001
Table 4.2. Effect of time on the characteristics of seizure-like events during constant washin of
0-Mg aCSF + carbachol. Here, Baseline, “Drug infusion”, and Washout are all equivalent since
there is no drug infusion (n = 9 slices)
Condition length (s) frequency (min−1) amplitude (µV)
Baseline (30 min) 8.9 (4.5) 2.7 (0.6) 132.9 (112)
“Drug infusion” (45 min) 5.6 (2.6) 4.2 (1.5) 65.3 (40.0)
Wash out (30 min) 4.2 (2.1)∗ 5.6 (3.4)∗ 52.2 (29)∗
Table 4.3. Effect of control infusion (saclofen + baclofen) on SLE characteristics (n = 9 slices)
Condition length (s) frequency (min−1) amplitude (µV)
Baseline 6.2 (4.2) 5.0 (1.9) 116.5 (84.9)
Saclofen+baclofen 9.8 (11.2) 4.2 (1.9) 98.9 (58.8)
Wash out 6.9 (5.0) 4.8 (2.5) 101.2 (67.1)
Table 4.4. Effect of saclofen infusion on SLE characteristics (n = 6 slices)
Condition length (s) frequency (min−1) amplitude (µV)
Baseline 3.1 (0.6) 5.1 (2.1) 74.3 (56.4)
Drug infusion 3.4 (1.1) 5.0 (1.5) 67.5 (46.0)
Wash out 3.0 (0.7) 5.1 (1.33) 66.7 (45.2)
Saclofen delivered on its own did not significantly change SLE characteristics (p > 0.5).
As shown in Table 4.4, SLE length, frequency and amplitude remained stable.
4.1.4 Conclusion
The aim of this first experiment was to investigate the effect of baclofen GABAB po-
tentiation on seizure-like event activity in cortical brain slices. Our hypothesis from the
theoretical modelling is that increasing GABAB activity should increase the length of
seizure like events, without effecting the amplitude. Our experimental results support
both modelling predictions, as baclofen infusion significantly enhanced SLE length in the
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slices, but had no significant effect on SLE amplitude. That this was a GABAB-mediated
effect was confirmed by blocking the baclofen effect with the GABAB antagonist saclofen.
In both slice observations (Figs 4.3 and 4.4) and model simulations (Fig. 4.5), the
duration of the intermittent large-scale oscillations is drug dependent. For the numerical
model, there is strong evidence that the oscillations are chaotic in nature (see Fig. 3.22(c));
thus bursting events are not noise-driven (Fig. 3.21). Whether or not the SLEs seen in
slice measurements are chaotic or noise-driven is unknown, and would be very challenging
to resolve since, unlike numerical simulations, noise in a biological system cannot be
suppressed.
4.2 Gap junction blockade during anaesthesia
Blockade of connexin-36 (Cx36) gap junctions during anaesthesia may be important for
destabilising brain activity. The extended mean-field Waikato model predicts that block-
ing gap-junctions enhances seizure activity in an anaesthetised brain (Chap. 3.1). This
may explain why some anaesthetics cause seizures, as many of these agents also block gap
junctions [105]. Previous work has shown that blockade of Cx36 gap junctions can have
excitatory effects in the brain [92,100]. However, to date the propensity for gap junction
blockade to cause seizure activity during anaesthesia has not been investigated.
The present experiment was designed to investigate whether closing Cx36 junctions
(the most common type of neuronal gap junction in the brain) during general anaesthesia
induces signs of seizure activity in mice. This was done by recording the electroencephalo-
gram while mice are anaesthetised with propofol, with or without pretreatment with the
gap-junction-blocking drug mefloquine.
The hypothesis was that closing the gap junctions during general anaesthesia would
induce signs of seizure activity.
4.2.1 Method
This section describes the methods employed in these experiments: drug preparation,
procedures, data recording and data analysis.
Animals
After obtaining approval (923) from the Waikato Animal Ethics Committee, male and
female (n = 5) wild-type (c57 and 129sv) mice aged 7–8 weeks, provided by the University
of Waikato animal facility, were used for this study.
Drugs
The following drugs were used during the experimental procedures:
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• propofol 10 mg/ml (Provive MCT-LCT, Claris, Australia) administered at the dose of
100 mg/kg; in the case that the main dosage did not put the animal to sleep, a
top-up dose in the range of 50–100 mg/kg was administered.
• mefloquine 5 mg/ml (Sigma-Aldrich, NZ) was dissolved in H2O, and administrated at
the dosage of 50 mg/kg. This dose of mefloquine is sufficient to block Cx36 gap
junctions but on its own does not cause seizure activity, although higher doses can
cause seizure activity [3, 70,102].
Both drugs were administered intraperitoneally (i.e., via injection into the peritoneum).
Data recording
EEG were recorded using a PowerLab 4/30 (AP Instruments, CA, USA), connected to
an Animal Bio Amp8 with three scalp electrodes.
Once the mouse had been anaesthetised, three needle electrodes were inserted under
the skin on the scalp to detect EEG activity. The needles were 26 gauge surgical steel,
sterilised with ethanol prior to use. Two needles were inserted on the top of the head
above each cerebral hemisphere (active electrodes) and the third towards the back of the
head (ground electrode). EEG recording was an essential part of this study because it was
the only accurate way to robustly identify seizure-like activity that may not be obvious
behaviourally. The recording was done over a continuous 20-min period with a 1–100 Hz
pass-band and 400-Hz sampling rate with a notch filter set to 50 Hz to eliminate mains
artifacts. EEG data were saved to computer for later analysis.
Experimental procedure
The aim of this experiment was to study the anaesthetised brain activity before and after
the administration of the gap-junction-blocking agent. This required two sets of EEG
recordings: first, monitoring the effect of propofol alone as a control; and the second,
monitoring the effect of propofol plus mefloquine on brain activity. The experimental
sequence was as follows:
• The experiment began with the injection of H2O (i.p.) at the same volume as
mefloquine
• After waiting for 30 min, propofol was administrated at the dose of 100 mg/kg in
a volume up to 300 µL to achieve full anaesthesia (indicated by the loss of righting
reflex)
• Scalp electrodes were inserted, then EEG was recorded from the anaesthetized
mouse for 20 min
• Waited until animal returned to the normal activity and full consciousness (30–45
min)
8Animal Bio Amp is a high-performance software-controlled differential amplifier. The function of the
amplifier is to amplify and filter small bioelectrical signals associated with nerve and muscle activity.
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• Mefloquine (50 mg/kg) was injected in a volume of 100 µL
• After waiting for 30 min, propofol was injected (same quantity as previously)
• Cortical activity was recorded for 20 min, see Fig. 4.9.
At the end of the experiment, the needle electrodes were removed prior to anaesthesia
wake-up and the animals were retained for use in future (unrelated) experiments. The
EEG needle electrodes were sharpened and resterilised prior to reuse.
Video recordings were also taken to capture changes in animal behaviour. We were
interested to see if there was any signs of seizure activity during the closure of gap-
junctions, but none were observed.
4.2.2 Data analysis
The first step was a visual inspection of the raw EEG to detect any seizure activity, either
interictal or ongoing oscillatory high-amplitude sharp (ictal) waves.
The second step was to compute the power spectral density for each set of data using
Matlab function spectrogram, which is based on the short-time Fourier transform (de-
scribed in Chap. A.2). The aim was to look for mefloquine effects on anaesthetised brain
activity which could be not detected through visual inspection.
4.2.3 Results and discussion
We did not observe any behavioural signs of seizure activity during any phase of the
experimental protocol. Visual inspection of raw EEG recording also showed no sign of
seizure activities in the anaesthetised brain.
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Figure 4.9. 25 s recording of animal EEG activity (a) during propofol exposure and (b)
during propofol and mefloquine exposure. Closing gap-junctions reduced the amplitude of the
anaesthetised brain activity. Recording was done over a continuous 20-min period with 1–100
Hz pass-band and 400 Hz sampling rate with the notch frequency of 50 Hz.
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Figure 4.10. EEG spectra for five anaesthetized mice. (a) to (e) Spectra in the presence of
mefloquine + propofol (red graph) and propofol only (black graph); (f) average spectral power
for all mice; the average normalized EEG spectra on (g) linear and (h) log-log axes.
The EEG power spectral densities of EEG recording for each animal for both protocols
(propofol only vs propofol plus mefloquine), are shown in Figs. 4.10 and 4.11. Spectral
density peaked at delta (1–4 Hz) and low alpha (6–10 Hz) frequencies for the propofol
only protocol. For the propofol plus mefloquine runs, the delta peak remained dominant,
but higher frequency activity was strongly suppressed.
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Figure 4.11. The area-normalized population-average EEG spectra, for more details see
Fig. 4.10.
4.3 Conclusion
The Waikato model predicts that when the brain is at the boundary between conscious-
ness and unconsciousness, closing gap junctions can cause seizure activity. However, no
seizure activity was observed when mefloquine was preadministered to animals undergo-
ing propofol anaesthesia. This may be because the animals in the current experiments
transitioned rapidly into a deeply anaesthetized state in which seizure activity would not
be expected. In other words, the brain was already on the bottom “comatose” branch of
the steady state manifold at the time that EEG recording began.
The lower power in the mefloquine group is consistent and these animals being more
deeply anaesthetised, in keeping with studies showing that Cx36 knockout mice require
less anaesthetic [46].
In the second part of this thesis, we present a detailed analysis of the Hindriks and
van Putten thalamocortical (TC) mean-field model [40] for propofol anaesthesia, an en-
hancement of the Robinson TC brain model.
Chapter 5
The Robinson thalamocortical model
5.1 Introduction
We now proceed to the second part of this thesis: a detailed investigation of the Hindriks
and van Putten (HvP) model for propofol anaesthesia. The present chapter introduces the
Robinson thalamocortical (TC) mean-field equations on which the HvP model is based.
We will examine the properties and limitations of the HvP anaesthesia model (Chap. 6),
then seek to remedy these shortcomings (Chap. 7).
5.2 Robinson thalamocortical model
We now give an overview of the thalamocortical model of Robinson, Rennie and Rowe [79].
Like the Waikato cortical model [90], the Robinson mean-field equations describe population-
averaged neural activity, but unlike the Waikato formulation, the Robinson model incorpo-
rates two-way delayed connections between cortex and thalamus. The transmission delay
is set at a fixed value of 80 ms, and, as we shall demonstrate in Sec. 5.3, is responsible
for generating the ∼8-Hz alpha rhythm. Our demonstration proceeds via two theoretical
experiments: first, by eliminating the thalamus; then by varying the TC round-trip delay
from 0 to 100 ms.
The Robinson model [79] describes the dynamics of locally averaged membrane po-
tentials of five distinct neural populations within the TC system in a mean-field represen-
tation:
• cortical pyramidal neurons (e) with large axonal ranges; these neurons form excitatory
connections to cortical and thalamic neurons
• cortical inhibitory neurons (i) with short axon ranges; these form inhibitory synapses
onto pyramidal and inhibitory cortical neurons
• thalamic sensory relay neurons (s); these excitatory neurons link activity in the tha-
lamus to the cortex
• thalamic reticular neurons (r) which form inhibitory connections to the main body of
the thalamus and are responsible for regulating thalamic activity
• non-specific neurons (n) are the excitatory populations lying outside the TC system
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Figure 5.1. Robinson model connectivity. The model contains cortex and thalamus with two
distinct excitatory and inhibitory populations in each: cortical pyramidal (e) and inhibitory
(i) in cortex, thalamic reticular nucleus (r) and thalamic sensory nuclei (s) in thalamus. Non-
specific neurons (n) lie outside the thalamocortical system. Arrowheads represent excitatory
connections; solid circles show inhibitory connections. The round-trip loop delay of τ = 80 ms
from cortex to thalamus is assumed to be split symmetrically so that the τ/2 propagation delay
for signals to travel from cortex to thalamus matches that for the return path from thalamus to
cortex.
These neural populations and their interconnections are illustrated in Fig. 5.1. There
is a round–trip loop delay of τ = 80 ms from thalamus to cortex to thalamus, split sym-
metrically between the forward and reverse branches. Symbol νab defines the synaptic
strength linking neural population b to neural population a (note that the double sub-
scripts are read from right to left). The averaged effect of a sequence of action potentials
on a neural population type a is represented as a sigmoidal mapping from voltage to
average spike-rate,
Q(Va) =
Qmax
1 + exp(−(Va − θ)/σ) , a = e, i, r, s (5.1)
where Qmax is the maximal firing rate in spike/s, Va is the voltage (mV) at the cell body
of given population a, θ is the average activation threshold (mV) at which the function
has maximum sensitivity to small changes in the soma potential, and σ is proportional
to the standard deviation of activation thresholds over the neural population. Here, it
is important to mention that all four firing rate modulation functions Qa (corresponding
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Figure 5.2. Firing rate and dendrite response functions. (a) Sigmoid curve relating average
soma potential to average firing rate, defined by Eq. (5.1). (b) Synaptic response is modelled as a
biexponential function, corresponding to Eq. (5.3). The sigmoid and synaptic response functions
for all excitatory and inhibitory populations are identical in the Robinson model. (Note that
soma potential is measured relative to resting potential.)
to four different populations) are identical in the Robinson model; see Fig. 5.2(a). How-
ever, clinical results have shown that different neuron populations have distinct threshold
voltages [57] presenting different firing rate sigmoidal curves.
Robinson model equations
The soma voltage Va(t) is the sum of postsynaptic potentials Pab(t), generated by activity
received from afferent (sending) populations b,
Va(t) = ΣbPab(t),
where postsynaptic potential Pab(t)
Pab(t) = hab(t)⊗ νabφb(t− τab) (5.2)
≡
∫ t
0
hab(t− t′)νab φb(t− t′ − τab) dt′
is the result of convolving the input flux φab, scaled by synaptic strength νab, with the
dendritic response function, hab(t), modelled here as a biexponential of rise-rate βab and
decay-rate αab (βab > αab),
hab(t) =
αabβab
βab − αab
(
e−αabt − e−βabt
)
(5.3)
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The average membrane potentials Ve, Vi, Vr and Vs for the four distinct populations
are written as follows:
Ve(t) = hee(t)⊗ υeeφe(t) + hes(t)⊗ υesQs(t− τ/2) + hei(t)⊗ υeiQi(t) (5.4)
Vi(t) = hie(t)⊗ υieφe(t) + his(t)⊗ υisQs(t− τ/2) + hii(t)⊗ υiiQi(t) (5.5)
Vs(t) = hsn(t)⊗ υsnφn(t) + hse(t)⊗ υseφe(t− τ/2) + hsr(t)⊗ υsrQr(t) (5.6)
Vr(t) = hre(t)⊗ υreφe(t− τ/2) + hrs(t)⊗ υrsQs(t) (5.7)
where all of the hab(t) are identical. Figure 5.1 illustrates the connectivity between sep-
arate cortical and thalamic populations, with time delay τ/2 = 40 ms for long-range
excitatory neural activity to travel between cortex and thalamus. A damped wave equa-
tion describes the propagation of the pyramidal neural activity Qe(t) within the cortex:
Deφe(t) = Qe(t), (5.8)
De =
(
1
γ
∂
∂t
+ 1
)2
− `2e∇2 (5.9)
where De denotes the wave operator, `e is the mean range of cortical excitatory axons in
meters, γ = v/`e is the damping rate in s
−1, and v is the axonal propagation velocity in
m s−1. Table 5.1 lists the Robinson parameter values.
5.3 Source of alpha rhythm in Robinson model
To identify the source of alpha frequency in the Robinson model, two theoretical experi-
ments are performed: the first examines the dynamical behaviour of the reduced Robinson
model resulting from the elimination of the thalamus; the second investigates the effect
of varying the TC time-delay τ . To our knowledge, such an investigation has not been
reported previously.
5.3.1 Significance of thalamus
To confirm the importance of thalamus in the Robinson model, the cortex is isolated by
cutting all connections between thalamus and cortex. Then Eqs (5.4) and (5.5) reduce
to,
Ve(t) = hee(t)⊗ υeeφe(t) + hei(t)⊗ υeiQi(t) (5.10)
Vi(t) = hie(t)⊗ υieφe(t) + hii(t)⊗ υiiQi(t) (5.11)
To determine the stability of the isolated cortex, we assume the system has achieved a
steady state, then perform a linear stability analysis. For the isolated cortex, LSA predicts
5.3 Source of alpha rhythm in Robinson model 95
Table 5.1. Parameter values for Robinson model constants. Excitatory (inhibitory) connections
have positive (negative) synaptic strength, and are shown on Fig. 5.1 in red (blue).
Parameter Symbol Robinson and HvP Unit
Maximal firing-rate Qmax 250 s−1
Synaptic strength from e to e neurons νee 1.2 mV s
Synaptic strength from i to e neurons νei −1.8 mV s
Synaptic strength from s to e neurons νes 1.2 mV s
Synaptic strength from i to i neurons νii −1.8 mV s
Synaptic strength from e to i neurons νie 1.2 mV s
Synaptic strength from s to i neurons νis 1.2 mV s
Synaptic strength from r to s neurons νsr −0.8 mV s
Synaptic strength from e to s neurons νse 1.2 mV s
Synaptic strength from s to r neurons νrs 0.2 mV s
Synaptic strength from e to r neurons νre 0.4 mV s
Average noise level νsn〈φn〉 1 mV
Rest potential (e, i, r, s) V resta 0 mV
Thalamocortical delay τ 80 ms
Cortical damping rate γ 100 s−1
Synaptic rise rate β 200 s−1
Synaptic decay rate α 50 s−1
Sigmoid threshold voltage θ 15 mV
Standard deviation for threshold σ 3.3 mV
very strong stability in the cortex with dominant eigenvalue the Λdom = −50 s−1 with
no possibility of oscillation; therefore the cortex-only reduced model cannot generate an
alpha rhythm.
5.3.2 Effect of time-delay
Although Robinson et al [79] describe the thalamus as being the source of the alpha
rhythm, no information is given regarding to the significance of the magnitude of the
time-delay. Alteration of the time-delay does not affect the steady-state manifold, but
the value of τ has a pronounced impact on system stability. Standard linear stability
analysis is not applicable in the presence of time-delay. Instead, we need to compute
the dispersion curves by transforming the system equations to the Fourier domain; see
Appendix C for details.
Figure 5.3 presents the dispersion predictions for linear stability due to alteration of
the time-delay. This figure provides clear insights as to the source of the alpha rhythm in
the Robinson model. As time-delay is increased, the stability of the system decreases (the
real part of the dominant eigenvalue becomes less negative) and the dominant frequency
changes from delta to alpha band.
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Figure 5.3. Effect of loop-delay τ on the linear stability of the original Robinson TC model
(no propofol effect). Shown are (a) the damping rates and (b) frequencies of the TC system.
The standard Robinson model fixes τ = 80 ms, giving alpha oscillations ∼8 Hz as the dominant
mode. Delta band mode is dominant for τ < 40 ms, while alpha band is favoured for τ > 62 ms.
Thus the loop delay time between cortex and thalamus plays a critical role in producing
the alpha rhythm in this model. In fact, for τ > 62 ms the alpha rhythm is dominant,
while for τ < 40 ms, the delta rhythm is preferred.
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Figure 5.5. Effect of loop-delay τ on the fluctuation power spectral density in the Robinson
TC model. This a spectrogram plot of the noise-evoked Ve spectral power as the TC delay is
smoothly varied from 0 to 100 ms over a time interval 2000 s with Euler time-step ∆t = 10−4 s.
These results confirm the stability predictions of the Fig. 5.3. Note that the zero-frequency
component has been removed by applying a 0.5 Hz high-pass filter prior to Fourier analysis.
Spectral power is normalized by noise power, which has a variance of 10−6V2; see Table 5.1.
To check the validity of these dispersion predictions, several numerical simulations were
run for different time-delay settings. Figure 5.4(a) exhibits a very slow delta oscillation
f ≈ 1 Hz in the presence of the small value of time-delay τ = 10 ms. Meanwhile,
Fig. 5.4(b) shows that raising the TC time-delay to τ = 80 ms raises the system frequency
to f ≈ 8 Hz. These findings are consistent with the dispersion predictions of Fig. 5.5.
Figure 5.5 plots a spectrogram of the white-noise-evoked Ve spectral power as the
time delay is varied from 0 to 100 ms over a time interval 2000 s with Euler time-step
∆t = 10−4 s. These results confirm the dispersion stability predictions of Fig. 5.3: the
beta and alpha-band frequencies reduce smoothly as τ is increased.
5.4 Conclusion
It is clear that the Robinson TC model is very sensitive to the time-delay for signals
travelling between thalamus and cortex. Increases in time-delay tend to destabilize the
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TC system. Emergence of alpha activity is crucially dependent on the existence of a
sufficiently large thalamocortical loop delay. The standard Robinson model sets τ =
80 ms, giving alpha oscillations ∼8 Hz as the dominant mode.
Chapter 6
Hindriks and van Putten anaesthesia
model
6.1 Introduction
This chapter presents a detailed analysis of the Hindriks and van Putten (HvP) tha-
lamocortical mean-field model for propofol anaesthesia [40]. As reported by Hindriks
and van Putten, their model predicts increases in delta and alpha power for moderate
(up to 130%) prolongation of GABAA inhibitory response, corresponding to light anaes-
thetic sedation [40]. However, we will show that for deeper anaesthetic effect, the model
jumps from a low-firing state to an extremely high-firing stable state (∼250 spikes/s),
and remains locked there even at GABAA prolongations as high as 300% which would be
expected to induce full comatose suppression of all firing activity.
Hindriks and van Putten [40] investigated general anaesthesia in the thalamocortical
(TC) system by applying the Hutt and Longtin [44] drug mechanism to the mean-field TC
equations of Robinson et al [79]. In marked contrast to other studies [13,44,71,91], which
assumed the same affinity for drug effect in all populations, Hindriks and van Putten
enforced differing sensitivities for the different neural populations. They compared model
predictions for propofol effect on brain activity with clinical EEG recordings, reporting a
small increase in the alpha frequency, accompanied by increases in delta and theta power,
as propofol concentration was raised to sedative levels.
The chapter begins with an introduction on the HvP model; then the link between
the Robinson and HvP systems is elucidated. The HvP system behaviour across the
full physiological range of anaesthetic effect (1.0 ≤ pi ≤ 3) is compared against the
originally reported results which were restricted to light anaesthetic sedation only (1.0 ≤
pi < 1.29) [40]. This comparison highlights a shortcoming of the HvP model under
deepening anaesthesia: the sedated state loses stability, causing the TC system to jump
to an extremely high-firing stable state at pi & 1.298.
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6.2 Modelling propofol drug effect: HvP equations
For modelling the action of propofol, Hindriks and van Putten considered the fact that
the binding of propofol molecules to GABAA receptors potentiates their response by
decreasing the time constant of receptor deactivation, thereby increasing the duration of
inhibitory synaptic transmission [1, 8, 25]. Thus the action of propofol is modelled as a
decrease in the decay rate αab of the GABAA inhibitory response,
αab(pa) = αab/pa (a, b) ∈ {(i, i), (e, i), (s, r)} (6.1)
where pa is assumed to vary across the i, e, s populations based on distinct propofol
affinities εab for different GABAA receptor,
pa = 1 + εab(pi − 1) with a ∈ {i, e, s} (6.2)
and εii = 1, εei = εsr = 0.5 (see Table 6.1). Thus cortical inhibitory neurons are assumed
to be more strongly impacted by propofol than either cortical excitatory and relay neurons.
This leads to three distinct inhibitory synaptic responses h¯ii, h¯ei and h¯sr,
hab(t) =
αabβ
β − αab
(
e−αab t − e−βt
)
, (a, b) ∈ {(i, i), (e, i), (s, r)} (6.3)
where αab is a function of pa. Equation (6.3) shows that the peak-height is not constant
(it is a function of anaesthetic effect); however, based on the clinical finding reported by
Bai et al [8] and Kitamura et al [56], the peak of amplitude of synaptic responses in the
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Figure 6.1. Drug effect and the decay rate for different synapses. Panel (a) presents different
sensitivity of GABAA receptors to anaesthetic agents relative to affinity for cortical inhibitory
neurons pi. Panel (b) shows the decay rate αab for different synaptic responses due to increasing
anaesthetic effect pi.
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HvP model are set to be constant by reparameterizing Eq. (6.3),
hab(t) =
H
η (αab, β)
h¯ab(t) (6.4)
where H is introduce as the synaptic efficacy, and η(αab, β) is the maximum value of h¯ab
obeying Eq. (6.5),
η (αab, β) =
αabβ
β − αab
[
exp
(
− αab
ln β
αab
β − αab
)
− exp
(
− β ln
β
αab
β − αab
)]
(6.5)
Note that the maximum height of hab indeed equals H and hence is independent of the
rate constants.
Figure 6.2 shows the hii, hei and hsr IPSP response curves. As highlighted in Fig. 6.3,
the red graphs indicate inhibitory responses that are modulated by anaesthetic effect.
The average membrane potentials Ve, Vi, Vr and Vs are
Ve(t) = hee(t)⊗ υeeφe(t) + hes(t)⊗ υesQs(t− τ/2) + hei(t)⊗ υeiQi(t) (6.6)
Vi(t) = hie(t)⊗ υieφe(t) + his(t)⊗ υisQs(t− τ/2) + hii(t)⊗ υiiQi(t) (6.7)
Vs(t) = hsn(t)⊗ υsnφn(t) + hse(t)⊗ υseφe(t− τ/2) + hsr(t)⊗ υsrQr(t) (6.8)
Vr(t) = hre(t)⊗ υreφe(t− τ/2) + hrs(t)⊗ υrsQs(t) (6.9)
with blue symbols indicating all inhibitory connections affected by anaesthetic. Setting
drug effect pi = 1 collapses the HvP model to the standard Robinson case. Note that
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Figure 6.2. Synaptic responses in the HvP model. Panels (a) and (b) show the synaptic
response due to increasing anaesthetic effect pi on the (ii) and (ei, sr) connections respectively.
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Figure 6.3. Schematic representation of cortical and thalamic connections in the HvP model.
Excitatory neural populations appear on the left (e, s) and inhibitory populations (i, r) on the
right; black boxes illustrate excitatory responses with no drug effect and blue graphs represent
inhibitory responses due to drug effect. Input fluxes φb are scaled by synaptic strengths νab,
then convolved (⊗) with response functions hab and mapped to firing rates Qa. The one-way
transmission delay between cortex and thalamus is τ/2.
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Table 6.1. Parameter values for efficacy, affinity and synaptic rates in different neuronal
populations
Parameter Symbol HvP Unit
Synaptic efficacy H 31.5 s−1
Differential affinity of propofol (type i) ii 1 –
Differential affinity of propofol (type e) ei 0.5 –
Differential affinity of propofol (type s) sr 0.5 –
Synaptic rise rate βab 200 s
−1
Synaptic decay rate αab 50 s
−1
in the Robinson model all dendritic responses are identical with a fixed rate of decay
αab = 50 s
−1.
6.3 Detailed examination of the HvP model
6.3.1 HvP model steady-state
Clinical results show relative increases in potentiation of inhibitory postsynaptic currents
of up to 300% as propofol concentration is raised to a level sufficient to induce uncon-
sciousness; this can be mapped to drug effect ranges 1.0 ≤ pi ≤ 3.0 [1, 106]. HvP system
behaviour is investigated with respect to this extended but physiological range of anaes-
thetic effect.
The steady states are calculated by setting the spatial and temporal derivatives in the
model equations to zero (∇ = 0 & ∂
∂t
= 0 and De = 1). Since the homogeneous steady-
state firing rates (Q∗e, Q
∗
i , Q
∗
s, Q
∗
r) are not dependent on time and space, they satisfy,
y(t) = hab(t)⊗ υabQ∗b (6.10)
=
∫ ∞
0
hab(t)υabQb dt
= υabQb
∫ ∞
0
hab(t) dt
=
H
ηab
υabQ
∗
b while
∫ ∞
0
h¯ab(t) dt = 1
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Substituting Eq. (6.10) in Eqs (6.6–6.9) gives:
V ∗e =
H
η
υeeQ
∗
e +
H
η
υesQ
∗
s +
H
ηei
υeiQ
∗
i (6.11)
V ∗i =
H
η
υieQ
∗
e +
H
η
υisQ
∗
s +
H
ηii
υiiQ
∗
i (6.12)
V ∗s =
H
η
υsnφn +
H
η
υseQ
∗
e +
H
ηsr
υsrQ
∗
r (6.13)
V ∗r =
H
η
υreQ
∗
e +
H
η
υrsQ
∗
s (6.14)
Computing the stationary state trajectories as a function of anaesthetic effect pi reveals
multi-valued regions; these were not reported in the HvP results [40]. For the ranges
1.0 < pi < 1.55 and 2.7 < pi < 3.0, soma voltages (and firing rates) can take on three
different values, either stable (shown in black) or unstable (red) (Fig. 6.4).
The pyramidal and reticular neural populations exhibit very high soma membrane po-
tentials on the top branch B1 (corresponding to near maximal firing rates Q ≈ 250 Hz),
even at a deep anaesthesia corresponding to GABAA prolongation as high as 300%. How-
ever, a different behaviour is observed for the relay and cortical inhibitory neurons: al-
though the B1 top branch starts at maximum firing rates at pi = 1, the high firing rates
in relay neurons drop dramatically to almost zero at pi = 2.4, while the high firing rates
in cortical inhibitory neurons falls more smoothly to a lower range (∼ 100 s−1). It is
important to note that Hindriks and van Putten [40] reported only the low activity B3
branch; see the zoomed view on the second and fourth rows of Fig. 6.4.
6.3.2 Linear stability analysis, dispersion relation
To determine the stability of a dynamical system in the presence of a time-delay, the
dispersion method in Fourier domain is applied. This transforms a delay τ in time to
a phase shift eiωτ in frequency space, and time-domain convolutions become products in
Fourier space. Thus the temporal convolution between a time-delayed signal Qb(t − τab)
and the dentritic response hab(t) maps to Fourier space as given by
Pa(t) = hab(t)⊗Qb(t− τab)←→ P˜a(ω) = Lab(ω)Q˜b(ω) e−iωτab , (6.15)
where ω denotes complex angular frequency. The Fourier transform of the synaptic re-
sponse hab(t) given the frequency response Lab(ω),
Lab(ω) =
(
1 +
iω
αab
)−1(
1 +
iω
β
)−1
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Figure 6.4. HvP model steady-states for soma voltages Ve,i,r,s (first two rows) and firing
rates Qe,i,r,s (bottom two rows). Boxed regions in first and third rows are expanded in the
zoomed views of the second and forth rows. Black and red colours indicate stable and unstable
equilibrium points respectively. Branch labels: B1 = top branch (high activity, always stable);
B2 = mid branch (always unstable); B3 = bottom branch (low activity, becomes unstable). Note
that only the stable solutions on the low activity B3 branch are reported in the HvP paper [40].
The transfer function relates the input φ˜n(ω) to the output φ˜e(ω) of the system equa-
tions (see Chap 2.4.1). For pairs of neuron types (a, b) both located either within cortex
or within thalamus [i.e., (a, b) ∈ (e, e), (e, i), (i, e), (i, i), (r, s), (s, r)] the frequency response
from neuron type b to neuron type a is given by,
ζab(ω) =
H
η(α, β)
υabQ
′(V ∗a )
(
1 +
iω
αab
)−1(
1 +
iω
βab
)−1
(6.16)
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For pairs of neuron types separated by a time delay [i.e., (a, b) ∈ (e, s), (r, e), (i, s), (s, e)]
the frequency response from neurons of type b contains a phase shift from the propagation
delay τ/2 between cortex and thalamus,
ζab(ω) =
H
η(α, β)
υabQ
′(V ∗a )
(
1 +
iω
αab
)−1(
1 +
iω
βab
)−1
(e−iωτ/2) (6.17)
In the HvP model, φe is taken to be proportional to the EEG [79]. To derive the transfer
function, we linearise the sigmoid function about the steady state (V ∗e , V
∗
i , V
∗
s , V
∗
r ) in the
time domain for Eqs. (6.6–6.9). Then the system equations are rewritten in frequency
domain. In Appendix C, we show how to derive the transfer function from φ˜n to φ˜e giving
φ˜e
φ˜n
=
ζeisn + (1− ζii)ζesn
[(D˜ − ζee)(1− ζsrs)− ζese − ζesre](1− ζii)− ζeie(1− ζsrs)− ζeise − ζeisre
(6.18)
The dispersion relation is obtained from the poles of the transfer function. This is
equivalent to setting the denominator in Eq. (6.18) to zero, giving,
[(D˜ − ζee)(1− ζsrs)− ζese − ζesre](1− ζii)− ζeie(1− ζsrs) = ζeise + ζeisre (6.19)
In the HvP model, we restrict our attention to the spatially-homogeneous dynamic
(k = 0) as it simplifies the analysis of dispersion relation. A solution for ω of Eq. (6.19)
corresponds to a thalamocortical resonance of damping rate Im(ω), angular frequency
Re(ω). Stable resonances are characterized by Im(ω) < 0 and unstable resonances are
characterized by Im(ω) > 0.
LSA shows that B1 branch is strongly stable, while B2 is strongly unstable. Our focus
here is the low activity B3 branch, since only the B3 solutions are considered in the HvP
paper [40]. Figure 6.5(b) indicates at pi = 1.298 the B3 stable branch loses stability.
To prove the validity of LSA predictions, simulations are run at three different levels
of propofol: pi = 1, stable; pi = 1.329, marginal; pi = 1.48, strongly unstable. Run (1)
shows small fluctuations about equilibrium. Run (2) transitions to growing limit cycle,
while run (3) jumps to an extreme high firing state. Our investigation shows the HvP
system is not able to return to low activity after jumping to a high activity state, and
it remains there even after reducing the drug effect, as shown in the hysteresis results of
Fig. 6.6.
Our numerical simulations confirm the existence of the B1 pathological high firing
state, and the abrupt transition from B3 to B1 branches at drug effect pi & 1.37 (Fig. 6.6).
Simulation begins at the pi = 1.0 equilibrium point on the stable portion of the low-
activity B3 branch (see Fig. 6.4), then pi is slowly ramped to 3.0 over 2000 s in an
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Figure 6.5. Distribution of HvP model pyramidal steady states voltages under anaesthetic
effect and thalamocortical simulation results at three nominated pi values. (a) Steady states
and (b) zoom view of B2 (unstable) and B3 (mixed stability) branches. (c) Stochastic simulations
are run for 20 s at three locations on the B3 branch: (1) pi = 1.0 (stable); (2) pi = 1.329 (weakly
unstable); (3) pi = 1.48 (strongly unstable). Simulation settings: Euler integrator, ∆t = 10
−4 s,
low-intensity white noise to Ve, Vi, Vr, Vs. Note that (a) and (b) replicate the top left panels of
the first two rows of Fig. 6.4.
attempt to simulate induction of anaesthesia. Rather than suppressing cortical activity,
increasing drug effect (red curves) leads to increasing voltage and firing rate, culminating
in an abrupt transition to a pathologically high-firing state for pi ' 1.37, subsequent
to loss of B3 stability for pi ' 1.29 (see Fig. 6.4). The cortex remains stuck on the
pathological B1 branch, even when pi is reduced (dashed-black curves) from 3.0 back to
1.0. Once the hyperexcited state has been reached, there is no mechanism for recovering
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Figure 6.6. Numerical simulations showing pathological phase transition and hysteresis for
the HvP model for anaesthesia. (a) Ve soma voltage and (b) Qe firing rate of excitatory cortical
neurons for increasing (red) and decreasing (dashed black) levels of anaesthetic effect pi for
1.0 ≤ pi ≤ 3.0. Simulation begins at the pi = 1.0 equilibrium point on the stable portion of
the low-activity B3 branch (see Fig. 6.4), then p is slowly ramped to 3.0 over 2000 s (Euler
simulation, time-step ∆t = 10−4 s). Increasing drug effect (red curves) leads to increasing
voltage and firing rate, culminating in an abrupt transition to a pathologically high-firing state
for pi ' 1.37, subsequent to loss of B3 stability for pi ' 1.29.
normal firing rates.
6.4 Source of alpha rhythm in the HvP model
6.4.1 Effect of time-delay
In Chap 5.3.2, we showed that the setting of thalamocortical delay is fundamental to the
generation of the alpha rhythm in the Robinson model. The standard Robinson model
sets τ = 80 ms, giving alpha oscillations ∼8 Hz as the dominant eigenvalue mode (see
Fig. 5.3). To investigate the significance of the time-delay on the generation of the alpha
rhythm in the HvP model, we performed a new set of theoretical experiments. Fig. 6.7
presents the effect of the time-delay variation on the linear stability of the HvP model.
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Figure 6.7. Effect of thalamocortical time delay τ on linear stability of the HvP model for
the low-activity branch B3. Shown are the damping rates on the left and frequencies on the
right for three different values of the time delay τ = 0, 40, 80 ms. Reducing the time delay
increases the stability of the system (left graphs), changing the dominant mode from alpha to
delta frequencies. At τ = 0, lower branch B3 is completely stable and the system no longer has
access to the extreme high-firing branch B1. DC refers to the zero-frequency eigenvalue.
We see that as time delay decreases, system stability increases and the frequency of
dominant mode rises.
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Figure 6.8. Distribution of steady states in the cortex-only HvP model. Panels (a) and (b)
represent trajectories of the excitatory voltage and firing rates respectively; panels (c) and (d)
are the corresponding inhibitory values. Panel (e) shows the real part of the dominant eigenvalue
in the lower branch, and (f) illustrates the imaginary part (damping).
6.4.2 Significance of thalamus
To confirm the importance of thalamus in the HvP model, the cortex is isolated by cutting
all connections between thalamus and cortex. Then Eqs (6.11) and (6.12) reduce to,
Ve(t) = hee(t)⊗ υeeφe(t) + hei(t)⊗ υeiQi(t) (6.20)
Vi(t) = hie(t)⊗ υieφe(t) + hii(t)⊗ υiiQi(t) (6.21)
To determine the stability of the isolated cortex, we assume the system has achieved
a steady state; Figs 6.8(a) and (c) indicate the equilibrium membrane voltages for the
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Figure 6.9. Simulations of the cortex-only reduced HvP model. Four-second time development
of the cortical excitatory (a) and inhibitory (b) populations; all simulations are launched from
the unstable middle branch.
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excitatory and inhibitory cortical populations respectively.
A linear stability analysis for the isolated cortex predicts very strong stability in both
upper and lower branches, and strong instability in the middle branch. Figure 6.8(e) and
(f) show the imaginary and the real parts of the dominant eigenvalue for the lower branch;
we note that the cortex-only reduced HvP anaesthetised model cannot generate an alpha
rhythm.
To confirm our linear stability predictions, we ran several simulations, all starting from
unstable-middle branch at the anaesthetic effect fixed at pi = 1.2. As shown in Fig. 6.9,
the isolated cortex leaves the unstable middle branch after less than 1 s and switches
either to the upper or lower branch, both of which are strongly stable.
6.5 Conclusion
We have compared the HvP system behaviour across the full physiological range of anaes-
thetic effect (1.0 ≤ pi ≤ 3) against the originally reported results [40] which were restricted
to light anaesthetic sedation only (1.0 ≤ pi < 1.29). This comparison highlights a short-
coming of the HvP model under deepening anaesthesia: the sedated state loses stability,
causing the TC system to jump to a pathologically high-firing stable state at pi & 1.298.
The high voltage state exists for both pyramidal and reticular neurons even at GABAA
prolongation as high as 300%. In fact, setting the propofol affinity in pyramidal and
reticular dendrites at half that for cortical inhibitory cells markedly decreases inhibition
in the anaesthetised brain.
We find that the HvP model dynamics is highly sensitive to the value selected for τ ,
the TC loop delay: decreasing the time delay not only changes the resonance frequency,
but also increases system stability, (Fig. 6.7). As we showed in Fig. 5.3, the loop delay is
crucial for the production of alpha rhythm.
In the next chapter, we investigate some possible solutions to eliminate the pathological
behaviour of the HvP model for deep anaesthetic effect.

Chapter 7
Modified Hindriks and van Putten
model
7.1 Introduction
In chapter 6, we compared the HvP system behaviour across the full physiological range
of anaesthetic effect (1.0 ≤ pi ≤ 3) against the originally reported results which were
restricted to light anaesthetic sedation only (1.0 ≤ pi < 1.29) [40]. This comparison high-
lighted a shortcoming of the HvP model under deepening anaesthesia. We now suggest
some modifications to overcome the unphysiological behaviour of extreme high firing rates
observed in Fig. 6.4.
In this chapter we attempt to restore biophysical fidelity with suitable adjustments to
drug efficacy, and by including synaptic reversal potentials:
• Standard drug modelling In the HvP model, the pyramidal and relay populations
are assumed to be less sensitive to propofol (ei = sr = 0.5) compared with cortical
inhibitory neurons (ii = 1). We investigate the impact of equalizing drug sensitivity
across populations by setting all efficacies equal (ii = ei = sr = 1).
• Inclusion of reversal potential We alter HvP model by incorporating rever-
sal potentials, adjusting the excitatory sigmoid parameters, and eliminating the
population-dependent anaesthetic efficacies.
7.2 Effect of efficacies in the HvP model
To gain a better understanding of how different efficacies of GABAA receptors impact
HvP system characteristics, we examine the effect of pyramidal and relay neuron efficacy
on steady-state trajectories and stability.
As shown in Fig. 6.4, the HvP model loses stability on bottom branch B3 at drug
effect pi = 1.3 and jumps to the high-firing branch B1. Since pi = 1.3 is considered as the
critical point, we are interested to learn how efficacy alterations influence system steady
states and stability at this point.
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Fig. 7.1 shows the effect of pyramidal efficacy variation on the system equilibrium
points. The efficacy for pyramidal cells varies over the valid range 0 ≤ ei ≤ 1.0, while
the efficacy for relay neurons remains unchanged as shown in Table 7.1; the drug effect is
set to pi = 1.3. We observe a single-valued steady-state region with extremely high-firing
rate for ei < 0.32. As the pyramidal efficacy ei is increased above 0.32, multi-valued
steady-states emerge. (The parameter set corresponding to the HvP model is marked
with a dashed vertical line.)
For the low range ei < 0.32, system excitation increases, leading to extremely high
firing for all populations. Conversely, increasing ei decreases excitation (e.g., at pi = 1.3,
the pyramidal membrane voltage is Ve = 160 mV in the original HvP model, but this
drops to 53 mV when ei = 1). The dispersion curve predicts very strong stability for
the top branch with no interesting dynamics. For the bottom branch B3, an instability
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Figure 7.1. Effect of pyramidal efficacy (ei) on steady state trajectories and stability for the
HvP model. Shown are steady states for all populations, with the drug effect and the relay
efficacy remaining fixed at pi = 1.3, sr = 0.5. Increasing pyramidal efficacy from 0 to 1.0 not
only alters the number of steady states from one to three but also increases system stability.
Dashed line marks the HvP set; we note that the low-activity B3 branch becomes stable as it
crosses the ei = 0.5 Hindriks marker (the discontinuity in the unstable branch near ei = 0.86
disappears if an extremely fine root search is undertaken).
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observed for the range of pyramidal efficacies 0.32 < ei < 0.5, but as efficacy is increased
(ei > 0.5) the bottom branch becomes completely stable.
The effect of relay neuron efficacy on the system equilibria is illustrated in Fig. 7.2.
Relay neuron efficacy is varied over the range of 0 ≤ sr ≤ 1.0, while the efficacy for
pyramidal neurons fixed at er = 1 and the drug effect is set to pi = 1.3. Increasing relay
efficacy does not have any significant effect.
We can conclude that the effect of pyramidal efficacy on HvP model characteristics is
much stronger than that from relay neurons. These results are reasonable as pyramidal
neurons are long-range and are able to propagate in the TC system through the wave
equation so their contribution to soma voltages in all populations is more significant.
7.3 Modified HvP model
To correct the HvP model, we propose two modifications: first, we present the HvP
model under standard drug modelling ii = ei = sr = 1; second, we introduce reversal
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Figure 7.2. Effect of the relay efficacy (sr) on steady state stability for the HvP model. Shown
are steady states for all populations, with the drug effect and the relay efficacy remaining fixed
at pi = 1.3, ei = 1. Increasing the relay efficacy from 0 to 1.0, does not have any significant
effect on the number of steady states and system stability.
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potentials. Since the mid-branch is always unstable and the thalamocortical system can
never move to that state, it is ignored in the following sections.
7.3.1 Standard drug modelling
Setting all efficacies to the maximum value (ei = ii = sr = 1) switches the HvP drug
modelling to the standard method [13, 44, 71, 91]. We calculated the steady states under
the new conditions, then performed a linear stability analysis of the top branch B1 and
bottom branch B3; see Figs 7.3 and 7.4. For each figure, panel (a) illustrates steady-
states trajectories with one highlighted branch; panels (b) and (c) show the real part and
frequency of the dominant eigenvalues for the considered branch respectively.
1.
Figure 7.3. Effect of setting all efficacies to maximum value (ii = ei = sr = 1) on the
HvP dynamical behaviour, B1 branch. Shown are (a) the steady state voltages for pyramidal
populations, (b) the damping rates and (c) frequencies. (a) Increasing all efficacies to unity
changes the steady state trajectories and decreases the range of high voltages on B1, but still
B1 corresponds to extremely high firing rates. (b) Linear stability predicts a strongly stable
behaviour. Although increasing anaesthetic effect eventually decreases the stability of B1, it
never loses stability. As shown in (b) and (c) the dominant eigenvalue is mostly of zero frequency.
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Figure 7.3(a) shows that increasing the efficacies to unity changes the steady state
trajectories and decreases the range of high voltages on B1; however, B1 still corresponds
to extremely high firing rates. The dispersion curves predict a strong stability with mostly
zero frequency for the B1 branch, Fig. 7.3(b) and (c).
The dispersion curve for bottom branch B3 is presented in Fig. 7.4. In contrast
with what we observed in the original HvP model, steady state voltages for pyramidal
populations decrease as the drug effect increases, see Fig. 7.4(a). Increasing drug effect
makes the system more stable, since the real part of dominant eigenvalues becomes more
negative (Fig. 7.4(b)). It is important to note that alpha frequency decreases as the drug
effect increases Fig. 7.4(c).
Unifying the efficacies alters the behaviour of the HvP significantly, constraining the
anaesthetized brain into a plausible range, since the thalamocortical system now has a
access to bottom branch B3 which is always stable and so never forces a jump to the
Figure 7.4. Effect of setting all efficacies to maximum value (ii = ei = sr = 1) on HvP model
dynamical behaviour, B3 bottom branch. (a) Increasing all efficacies to unity changes the steady
state trajectories and decreases membrane voltages on B3. (b) Linear stability predicts a strongly
stable behaviour. Increasing anaesthetic effect increases the stability of B3. (c) Alpha frequency
decreases as the drug effect increases.
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B1 branch. But the firing rates on the B1 branch are implausibly high, never dropping
below ∼ 200 spikes/s (even at the B1 turning point; see sigmoid mapping in Fig. 7.6(a)).
If the B1 firing rates were lower, then the upper branch could possibly be interpreted
as the “conscious” branch, with the turning point near pi = 1.4 representing the point
of transition into coma. In an effort to tame the B1 behaviour, we now examine the
consequences of including reversal potentials in the HvP equations.
7.3.2 Inclusion of reversal potential
We believe the HvP model should be modified to satisfy the following requirements:
• First, having distinct states for awake and anaesthetized so that increasing (decreas-
ing) the drug effect switches the state of the thalamocortical system from awake
(anaesthetized) to anaesthetized (awake). Studies conducted by Destexhe et al [20]
and Steriade et al [88] to determine the mean histogram of neural cell membrane
potentials also support the idea of cortical “up” and “down” states. This multi-state
idea has been adopted in previous modelling works [44,71,91].
• Second, ensuring that brain activity decreases under deepening propofol levels rather
than increasing.
• Third, constraining the upper-branch firing rate to biologically plausible values.
Reversal potential functions ψab(Vb) are incorporated into the model equations to con-
strain the incoming fluxes. The modified model parameters are presented in Table 7.1.
While the inhibitory sigmoid parameters are similar to the original values, the excitatory
threshold has been lowered so that the excitatory populations activate at lower voltages
than the inhibitory populations, Fig. 7.6(a). This ensures an appropriate inverse-S distri-
bution of steady states over the desired drug range.
Unlike HvP, in the modified model all neurons have the same inhibitory synaptic
response due to the drug effect, Fig. 7.6(b). We note that there is no experimental evidence
supporting the HvP assumption of different efficacies in different neuronal types.
Modified HvP (mHvP) system equations
The weighting function ψab, Eq. (7.1), is dimensionless factor that scales the effectiveness
of the φb incoming flux in proportion to the difference between the cell voltage Va of the
receiving neuron and the relevant ionic reversal potential V revb ,
ψab(Va) =
V revb − Va
V revb − V resta
, (7.1)
where V resta represent the reversal potentials and V
rest
a ≡ 0 is the resting voltage in the
Robinson and HP models. See Table 7.1 and Fig. 7.5.
7.3 Modified HvP model 119
After incorporating reversal potentials in the model equations, the average membrane
potentials Ve, Vi, Vr and Vs in the modified model obey the following set of coupled equa-
tions,
Ve = h(t)⊗
[
υeeψee(Ve)φe(t)
]
+ h(t)⊗
[
υesψes(Ve)Qs(t− τ/2)
]
(7.2)
+ hei(t)⊗
[
υeiψei(Ve)Qi(t)
]
Vi = h(t)⊗
[
υieψie(Vi)φe(t)
]
+ h(t)⊗
[
υisψis(Vi)Qs(t− τ/2)
]
(7.3)
+ hii(t)⊗
[
υiiψii(Vi)Qi(t)
]
Vs = h(t)⊗ υsnφn + h(t)⊗
[
υseψse(Vs)φe(t− τ/2)
]
(7.4)
+ hsr(t)⊗
[
υsrψsr(Vs)Qr(t)
]
Vr = h(t)⊗
[
υreψre(Vr)φe(t− τ/2)
]
+ h(t)⊗
[
υrsψrs(Vr)Qs(t)
]
(7.5)
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Figure 7.5. Reversal potential weighting Eq. (7.1) functions for modified HvP. We set V resta = 0
for all populations (the same as the HvP model). Graph (a) plots the five weighting functions for
flux entering excitatory populations (e, s), while graph (b) shows the corresponding weighting
functions for flux entering inhibitory populations (i, r), see Table 7.1.
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Figure 7.6. Transfer functions and synaptic responses. (a) Sigmoid curve relating average soma
potential to firing rate. In the HvP model, the sigmoid functions for all populations are identical
(green curve). However in the modified HvP model, the sigmoid functions for excitatory (red
curve) and inhibitory (blue curve) neural populations are made distinct. (b) Curves show effect
of increasing anaesthetic drug for the inhibitory populations. Unlike HvP, here we assume that
all three inhibitory populations (ii, ei, sr) have identical efficacy.
(See Table 5.3.2 for parameter values.)
As can be seen in Eqs (7.3)–(7.5), the reversal potential acts directly in the incom-
ing flux, which is then convolved with the synaptic response. Figure 7.6(b) shows the
GABAA synaptic response function; identical synaptic responses all inhibitory connec-
tions (ii, ei, sr) are assumed in the mHvP model. Increasing the GABAAergic drug con-
centration pi prolongs the IPSP duration. Table 7.1 presents the parameter values for the
mHvP model constants for the sigmoid and response functions.
Table 7.1. Parameter values for HvP and mHvP model constants. Excitatory (inhibitory) con-
nections have positive (negative) synaptic strength. Note that reversal potentials are expressed
relative to an assumed resting potential of 0 mV.
Parameter Symbol HvP Modified HvP Unit
Rest potential (e, i, r, s) V resta 0 mV
Synaptic decay rate α 50 30 s −1
Average spike-threshold θe,i 15 7, 15 mV
Spike-threshold deviation σe,i 3.3 2, 3.8 mV
Differential affinity of propofol (type i) ii 1 1 –
Differential affinity of propofol (type e) ei 0.5 1 –
Differential affinity of propofol (type s) sr 0.5 1 –
Reversal potential for excitatory (e, s) V
rev
e,s – +50 mV
Reversal potential for inhibitory (i, r) V
rev
i,r – −20 mV
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Figure 7.7. Steady-state distribution for the modified HvP model as a function of propofol
effect. The modified model predicts that the TC system now has access to a high firing state
and a low firing state such that the brain can switch from “awake ” to “anaesthetized” at a
critical level of drug concentration. The black and red colours indicate respectively stable and
unstable equilibrium points.
7.3.3 Results
Steady-states for modified HvP
A similar methodology as used for the HvP model is applied to find the steady-state
solutions for the modified HvP. The following equations define the steady-state manifold,
V ∗e = ψee(V
∗
e )h(t)υeeQ
∗
e + ψes(V
∗
s )h(t)υesQ
∗
s + ψei(V
∗
e )hei(t)υeiQ
∗
i (7.6)
V ∗i = ψie(V
∗
i )h(t)υieQ
∗
e + ψis(V
∗
i )h(t)υisQ
∗
s + ψii(V
∗
i )hii(t)υiiQ
∗
i (7.7)
V ∗s = h(t)υsnφn + ψse(V
∗
s )h(t)υseQ
∗
e + ψsr(V
∗
s )hsr(t)υsrQ
∗
r (7.8)
V ∗r = ψre(V
∗
r )h(t)υreQ
∗
e + ψrs(V
∗
r )h(t)υrsQ
∗
s (7.9)
Figure 7.7 presents the steady-state distribution for all soma voltages as a function of
propofol effect in the mHvP model. We can now identify distinct phases of the thalam-
ocortical system: high firing represents the awake state and low firing the anaesthetized
state. The fact that the steady-state distribution exhibits multi-valued soma voltages is
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Figure 7.8. Linear stability analysis for the modified HvP model. Shown are the damping
rates (a) and frequencies (b) as a function of the percentile increase in the time constant of
GABAergic receptors on cortical inhibitory neurons pi. Emergence of anaesthesia occurs at the
critical point pi = 1.364 and induction of anaesthesia happens at pi = 2.116.
very significant as it means the transition from awake (anaesthetized) to anaesthetized
(awake) cannot proceed continuously. There must be a sudden switching of state at a
certain value of drug concentration.
Dispersion relation for modified HvP
The same method as for HvP is applied on the modified model to derive the dispersion
relation; see appendix D for more details. After arranging these equations in Fourier
domain, we obtain the transfer function,
φ˜e
φ˜n
=
cr ψ
∗
ei ψ
∗
is ζeisn + (ci − ζii) crψ∗esζesn
E
(7.10)
where
E =
[
F (D ce − ζee ψ∗ee)−
[
ζese cr ψ
∗
se + ζesre ψ
∗
sr ψ
∗
re
]
ψ∗es
]
(7.11)
× (ci − ζii)− ψ∗ei
[
F ζeie ψ
∗
ie + ψ
∗
is [ζeise crψ
∗
se + ζeisre ψ
∗
sr ψ
∗
re]
]
F = cs cr − ζsrs ψ∗rs ψ∗sr
ce = 1 + Lee υee
(
φ∗e
V reve − V sse
)
+ Lesυes
(
Q∗s
V revs − V sse
)
+ Lei υei
(
Q∗i
V revi − V sse
)
ci = 1 + Lie υie
(
φ∗e
V reve − V ssi
)
+ Lisυis
(
Q∗s
V revs − V ssi
)
+ Lii υii
(
Q∗i
V revi − V ssi
)
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cr = 1 + Lre υre
(
φ∗e
V reve − V ssr
)
+ Lrsυrs
(
Q∗s
V revs − V ssr
)
cs = 1 + Lse υse
(
φ∗e
V revr − V ssss
)
+ Lsrυsr
(
Q∗r
V revr − V sss
)
The dispersion relation is obtained by setting the denominator in Eq. (7.10) to zero, giving
[
F (D ce − ζee ψ∗ee)−
[
ζese cr ψ
∗
se + ζesre ψ
∗
sr ψ
∗
re]ψ
∗
es
]
(ci − ζii) (7.12)
− ψ∗ei
[
F ζeie ψ
∗
ie + ψ
∗
is [ζeise crψ
∗
se + ζeisre ψ
∗
sr ψ
∗
re]
]
= 0
As for the HvP model, we restrict attention to spatially homogeneous dynamics (k =
0). A solution (ω) of Eq. (7.12) corresponds to a thalamocortical resonance with damping
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Figure 7.9. Simulations for pyramidal neurons at nominated pi values in the mHvP model.
(a) At the critical point pi = 2.116 (“awake”), TC model is marginally unstable with 2.6 Hz
oscillation; for a 600-s simulation, transition from “awake” to “coma” occurs at t = 400 s. (b)
At pi = 2.170 (close to turning point) induction of anaesthesia occurs, after transition from
“awake” to “coma”. (c) At critical point pi = 1.364 (“coma”), TC model is marginally unstable
with ∼1 Hz oscillation; for a 600-s simulation, transition occurs at t = 350 s. (d) The emergence
from anaesthesia occurs at pi = 1.330. Simulation settings: Euler integrator, ∆t = 10
−4 s,
low-intensity white noise to Vs.
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rate Im(ω), angular frequency Re(ω). Stable resonances are characterized by Im(ω) < 0
and unstable by Im(ω) > 0.
As shown in Fig. 7.8, linear stability predicts that the top branch loses stability at
pi = 2.116, defining a point at which induction of anaesthesia can occur; while in the
bottom branch, emergence of anaesthesia occurs at the critical point pi = 1.364. The
modified model predicts a drug-effect hysteresis in which the measured drug concentration
is larger at induction than at emergence. The prediction of hysteresis is supported by
theoretical and clinical works by other research groups [35,59,91].
Figure 7.9 shows simulation results for pyramidal neurons at nominated pi values in
the mHvP model. We identify distinct phases of the anaesthetized thalamocortical system
with high firing = “awake”; low firing = “anaesthetized”. Simulation results are consistent
with the stability predictions of Fig. 7.8: at the critical points pi = 2.116 and pi = 1.364,
TC model is marginally unstable and for a long simulation, transition from awake (coma)
to coma (awake) occurs at t = 400 s (350 s). The dominant frequency observed in the
awake state is ∼3 Hz and ∼1 Hz in the anaesthetized state.
7.4 Conclusion and discussion
In this chapter, two solutions were proposed to improve biophysical fidelity of the HvP
model: setting all synaptic efficacies equal (ii = ei = sr = 1), and imposing reversal
potentials.
While equalising synaptic efficacies eliminates the pathological jump into seizure for
pi & 1.3, this modification also reverses the published HvP alpha-band trends of increasing
power and (weakly) increasing alpha frequency during sedation. Instead, the modified
HvP shows decreasing alpha power and weakly decreasing alpha frequency as propofol
effect increases. This mismatch between HvP and mHvP raises the question: what is
observed clinically?
Feshchenko et al [24] investigates propofol-induced alpha, and reported decreasing
of alpha power with increasing drug concentration. Ching et al [17] found broadband
beta-activity which slowed into the alpha-range at the point of induction; the alpha-band
frequency and power reduced with further increases of propofol. Gugino et al [35] showed
decreasing posterior alpha at light sedation, and increasing frontal predominance with
deeper sedation. None of these studies reported an increase in alpha frequency for light
sedation.
The second modification (equalizing efficacies, tuning sigmoid parameters and incor-
porating reversal potentials) alters the steady-state solutions to give bistable behaviour
enabling the brain to switch between awake and anaesthetized states at critical levels of
drug concentration, predicting a drug-hysteresis effect in which the measured concentra-
tion is larger at induction than at emergence. The dominant alpha frequency reported
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by Hindriks and van Putten during propofol anaesthesia disappears in favour of delta
frequency activity. The dominant frequency observed in the awake state is now ∼3 Hz
and ∼1 Hz in the anaesthetized state; the mHvP model no longer supports alpha-band
oscillations in the awake state.
Further investigations have shown that the alpha resonance can be reactivated by
weakening the inhibition of the thalamocortical loop. The revised HvP model now exhibits
a decrease in alpha frequency with deepening anaesthesia, consistent with clinical reports
[17,24]. This new work is being written up for publication.

Chapter 8
Summary and future work
8.1 Summary
In this thesis, we have investigated two mean-field descriptions for the effect of general
anaesthetic agents on brain activity: the extended Waikato cortical model (WM) and the
Hindriks and van Putten (HvP) thalamocortical model.
8.1.1 Anaesthetic effects in extended Waikato model
The Waikato cortical model represents the cortex as small columnar structures containing
∼105 neurons, with 85% being excitatory and 15% inhibitory. In the extended Waikato
model, the net neuron voltage is determined by axo-dendritic activity at the chemical
synapses (excitatory inputs mediated by AMPA and NMDA receptors; inhibitory inputs
by GABAA and GABAB receptors), plus input from electrical synapses. Inductive anaes-
thetic agents affect GABAA receptors by potentiating GABAA-induced ionic currents,
modelled as a prolongation of the IPSP tail. These agents also interact with GABAB-
receptors by increasing inhibitory synaptic gain. Dissociative drugs affect excitatory
synaptic neurotransmission through modulation of NMDA receptor function, modelled
as a voltage-dependent alteration of excitatory synaptic gain.
We investigated the effect of reduced gap junction conductance on cortical activ-
ity while simultaneously altering the effectiveness of GABAA-,GABAB- and NMDAergic
anaesthetic agents. Linear stability analysis predicts that reducing the decay rate of
GABAA response destabilises the temporal stability in both awake and anaesthetised
states of the cortex. Dispersion curves suggest that increasing GABAB and NMDA ef-
fectiveness will tend to destabilize Turing patterns in favour of a temporal mode (Hopf)
with large-scale synchronized oscillations that may represent a seizure state.
These extended Waikato model investigations indicate that the cortex may be suscep-
tible to seizures when gap junctions are blocked during anaesthesia. This may explain
why some anaesthetics cause seizures, as many of these agents also block gap junctions.
The model also predicts that enhancement of GABAB should have a seizure-promoting
effect on brain activity.
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We tested these Waikato model predictions with two biological experiments. We found
that potentiation of GABAB receptors, using the GABAB agonist baclofen in slices of
mouse cortical tissue, tended to enhance seizure-like activity. However, our in vivo in-
vestigation of the effect of closure of gap junctions, using mefloquine, did not reveal any
seizure patterns in anaesthetized mouse EEG signals.
8.1.2 Anaesthetic effects in the HvP and mHvP models
The second part of this thesis presented an introduction, examination and modification of
the Hindrks and van Putten (HvP) anaesthesia model. First, the Robinson thalamocor-
tical model which provides the foundation equations for the HvP model was introduced.
The source of alpha activity was investigated, and we confirmed that the alpha frequency
and amplitude is crucially dependent on the existence of a sufficiently long thalamocorti-
cal loop delay, τ . The standard Robinson model sets τ = 80 ms, giving alpha oscillations
∼8 Hz as the dominant mode.
Hindriks and van Putten applied anaesthetic drug to the Robinson mean-field equa-
tions by lengthening IPSPs in a drug-dependent fashion, but enforced differing sensitivities
for the different neural populations. The HvP paper limits itself to light sedation levels of
anaesthesia only (pi . 1.3), and is silent about model behaviour at deeper levels. In fact,
we found that for deeper anaesthetic effect, HvP jumps from low-firing to an extremely
high-firing stable state of∼250 spikes/s, and remains locked there even at GABAA pro-
longations as high as 300% which would be expected to induce full comatose suppression.
This occurs because the authors set the propofol affinity in pyramidal and reticular den-
drites at half that for that of cortical inhibitory cells, thus reducing inhibition in the
anaesthetised brain.
To overcome this pathological behaviour, we tested two possible modifications: first,
eliminating the population-dependent anaesthetic sensitivity (efficacy) of the HvP model
by setting (ii = ei = sr = 1); second, incorporating reversal potentials and tuning the
excitatory sigmoid defining the mapping from voltage to firing rate. Both modifications
eliminate the (pathological) lower-branch instability at pi . 1.3, and the upper branch
now displays a decreasing trend with pi, terminating at a turning point near pi . 1.4.
Although the first modification results in alpha oscillations on the bottom branch, this
alpha component is completely lost when the second set of modifications is applied to
HvP.
8.2 Future work
There are several aspects of this thesis that could be extended in future work:
1. Identification of key parameters
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Working with the Waikato and HvP anaesthesia models, we found that certain
parameters played a critical role in determining steady-state and dynamical be-
haviours. Only a subset of model sensitivities were explored in this thesis. It would
be useful to undertake a more comprehensive and systematic sensitivity analysis to
identify all key parameters. This knowledge should provide insights and might allow
oversimplifications and construction of reduced models.
2. Gap junctions and seizure
The Waikato model predicts that when the brain is at the boundary between con-
sciousness and unconsciousness, closing gap junctions can promote seizure activity.
However, no seizure activity was observed when mefloquine, a gap-junction blocker,
was preadministered to animals under propofol anaesthesia. Surgery could be per-
formed to implant skull electrodes in mice lacking the gene for connexin-36. These
mice could be anaesthetised with propofol and their cortical EEG recorded to cap-
ture any seizure activity near transition. This experiment would determine whether
our null result was due to the fact that our EEG recording could only begin after
the animals had been anaesthetized, so were already in coma.
3. Loss of alpha in modified HvP
After inclusion of reversal weighting functions in the modified HvP model the alpha
rhythm was lost, being replaced by a dominant delta-band oscillation. Perhaps the
modifications have unbalanced the thalamic and cortical contributions such that
loop dynamics have been suppressed in favour of cortical delta. This could be
investigated further in an endeavour to restore the alpha component.

Appendix A
Elements of mathematics
A.1 Ordinary differential equations
Ordinary differential equations are a set of coupled nth-order differential equations con-
taining functions of one independent variable and its derivatives. An nth-order differential
equation is usually solved by reexpressing as a set of n first-order ODEs.
Assume ~y is a vector whose elements are functions of coupled differential equations of
a system, and that ~F is a vector function of y and its derivatives; thus
~y (n) = ~F
(
t, y, y′, y′′, · · · , y(n−1)) (A.1)
where ~y (n) is an explicit system of ordinary differential equations of order n with dimension
m. In column-vector form:
y
(n)
1
y
(n)
2
...
y
(n)
m
 =

f1
(
t, y, y′, y′′, · · · , y(n−1))
f2
(
t, y, y′, y′′, · · · , y(n−1))
...
fm
(
t, y, y′, y′′, · · · , y(n−1))
 (A.2)
To solve Eq. (A.1), ordinary differential equations of order n with dimension m can be
reshaped to k sets of first-order differential equations where k = n×m. The vectorized
form of the first-order differential equations is
d~V
dt
= ~F (~V ) (A.3)
where ~V is a vector variable containing all elements of y and its derivatives, and ~F is the
set of first-order differential equations,
−→
V = [v1 v2 ... vk]
T (A.4)
−→
F = [f1 f2 ... fk]
T
where the T superscript denotes transpose.
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Taking a multivariate Taylor expansion of the right-hand side of Eq. (A.3) about the
equilibrium point ~V ∗ we obtain,
d
dt
~V = ~F (~V ∗) +
∂ ~F
∂~V
∣∣∣∣∣
~V ∗
δ~V +
1
2!
∂2 ~F
∂~V 2
∣∣∣∣∣
~V ∗
δ~V 2 + . . . (A.5)
where δ~V = ~V − ~V ∗ is the deviation of ~V from its equilibrium value V ∗. By definition, at
the equilibrium point (steady state), ~V no longer changes with time. This means that the
equilibrium point of the system can be calculated by putting to zero the time derivative
in Eq. (A.3):
d~V
dt
= 0
which means ~F (~V ∗) = 0.
For very small values of δV , only the first term in Eq. (A.5) is considered significant;
thus
d δ~V
dt
≈ ∂
~F
∂~V
∣∣∣∣∣
~V ∗
δ~V , with
d δ~V
dt
=
d~V
dt
(A.6)
which has the matrix form,
d
dt

δv1
δv2
...
δvk

=

∂f1
∂v1
∂f1
∂v2
. . .
∂f1
∂vk
∂f2
∂v1
∂f2
∂v2
. . .
∂f2
∂vk
...
...
...
∂fn
∂v1
∂fk
∂v2
. . .
∂fk
∂vk

∣∣∣∣∣∣∣∣∣∣∣∣∣∣∣
V ∗

δv1
δv2
...
δvk

(A.7)
The partial derivatives in Eq. (A.7) define the elements of the k× k Jacobian matrix A,
d δ~V
dt
= A∗δ~V (A.8)
where A∗ is the Jacobian matrix evaluated at the equilibrium point.
In order to assess system stability, the method of characteristics is applied: we assume
Eq. (A.8) has a solution of the form vi = ξie
λit. Substituting in Eq. (A.8) we obtain,
(A− λI) ~ξ = 0 (A.9)
noting that λ is the eigenvalue of the matrix A and ~ξ is the corresponding eigenvector.
Calculating the determinant of Eq. (A.9) can determine the eigenvalues, which are the
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roots of the polynomial equation,
det(A− λI) ~ξ = 0 (A.10)
Thus, the general solution for the linear homogeneous system in Eq. (A.8) can be ex-
pressed,
V (t) =
n∑
i=1
ξi e
λit (A.11)
where λi is the set of eigenvalues of the Jacobian matrix A. The eigenvalues of the
Jacobian are, in general, complex values,
λi = αi + i ωi (A.12)
where αi and ωi are the real and imaginary parts of the eigenvalue respectively. The
complex part of the eigenvalue contributes an oscillatory component to the solution. If
any real part of the eigenvalues αi > 0, then ~V
∗ is unstable; this indicates a divergent
trajectory which tends to move away from the equilibrium point with time. Provided all
the real part of all eigenvalues αi < 0, the steady-state ~V
∗ is stable, indicating a trajectory
which converges towards the equilibrium point. If one eigenvalue has a zero real part and
the other eigenvalues have negative real parts, ~V ∗ will be associated with a long-lived or
slow mode, a phenomenon known as critical slowing down.
A.2 Spectral analysis
Spectral analysis is the process of decomposing a stationary time-series into its compo-
nent harmonics, quantifying power distribution as a function of frequency. To analyse
the frequency spectrum for either clinical or model-generated time-sampled signals, the
Matlab function spectrogram, based on the short-time Fourier transform, is useful.
Mathematically, for the continuous-time case, the function to be transformed is mul-
tiplied by a window function which is nonzero for only a certain period of time. The
Fourier transform of the resulting signal is taken as the window is slid along the time-
axis, resulting in a two-dimensional representation of the signal [2]. For any normalized
window W (τ), we have ∫ ∞
−∞
W (τ) dτ = 1 , (A.13)
where Eq. (A.13) can be rewritten as∫ ∞
−∞
W (t− τ) dτ = 1 . (A.14)
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Thus, a continnuous-time signal y(t) can be approximated by its windowed sample,
y(t) ≈ y(t)
∫ ∞
−∞
W (t− τ) dτ =
∫ ∞
−∞
y(t)W (t− τ) dτ . (A.15)
The continuous Fourier transform of y(t) is
Y (ω) =
∫ ∞
−∞
y(t) e−jωt dt . (A.16)
Substituting Eq. (A.15) into Eq. (A.16), we obtain
Y (ω) =
∫ ∞
−∞
[ ∫ ∞
−∞
y(t)W (t− τ) e−jωt dt
]
dτ , (A.17)
allowing us to define
Y (τ, ω) =
∫ ∞
−∞
y(t)W (t− τ) e−jωt dt . (A.18)
Here Y (τ, ω) is the Fourier transform of y(t)W (t − τ), a complex function representing
the phase and magnitude of the signal over time and frequency.
However, when analysing time-sampled data, it is necessary to introduce the discrete-
time short Fourier transform approach, we need to map the continuous-time method to
discrete-time; therefore, we make the following identifications
W (t− τ) −→ W (m∆t− n∆t) ≡ Wm−n , (A.19)
y(t) −→ y(m∆t) ≡ ym (m,n are time indices) , (A.20)
Y (f) −→ Y (k∆f) ≡ Yk , (k is the frequency index) (A.21)
T = N∆t (A.22)
∆f =
1
T
=
1
N∆t
, (A.23)
where T is the length of the data record consisting of N samples taken at regular time
intervals ∆t = 1/fs with fs being the sampling rate. Applying these mappings to the
time-limited continuous Fourier transform of Eq. (A.17) leads to
Y (n, k∆f) =
N−1∑
m=0
ymWm−n e
[
−j 2pi(k∆f)(m∆t)
]
∆t ,
= ∆t
N−1∑
m=0
ymWm−n e−j2pimk/N , k = 0, 1, . . . , N−1 ,
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from which we can calculate the power spectral density (power per unit frequency), PSD,
of the signal
PSD ≡ |Y (n, k∆f)|2 . (A.24)
When one reduces a continuous-time signal to a discrete-time sequence and interpolates
back to a continuous form, the fidelity of the result relies on the sampling frequency of
the original signal. Nyquist’s theorem introduces the criterion for the minimum sampling
frequency required for perfect fidelity:
0 6 f 6 fs/2 , (A.25)
where fs = 1/∆t. If this condition is satisfied, then no information is lost in the sampling
process. Moreover, Eq. (A.25) tells us that provided the original signal contains frequency
components no higher than half the sampling rate, its Fourier transform will produce a
spectrum containing all frequencies from zero to fs/2.
Appendix B
Waikato Model
B.1 Differential equation for synaptic response
The total input flux Φ(t) is the temporal convolution of the synapse spike-rate M(t) with
the dendrite impulse response H(t),
Φ(t) = H(t)⊗M(t) ≡
∫ t
0
H(t− t′)M(t′) dt′
where H(t) is the biexponential response function,
H(t) =
αβ
β − α
(
e−α t − e−β t)
Differentiation under of the integral obeys the following theorem,
d
dt
(∫ b(t)
a(t)
f(t, t′) dt′
)
= f(t, b(t))
d
dt
b(t)− f(t, a(t)) d
dt
a(t) +
∫ b(t)
a(t)
∂
∂t
f(t, t′) dt′ (B.1)
Applying this theorem to (B.1),
d
dt
Φ =
∂
∂t
∫ t
0
H(t− t′)M(t′) dt′
=
αβ
β − α
(
∂
∂t
∫ t
0
(
e−α(t−t
′) − e−β(t−t′)
)
M(t′) dt′
)
=
αβ
β − α
∫ t
0
(
−α e−α(t−t′) + β e−β(t−t′)
)
M(t′) dt
Differentiating a second time,
d2
dt2
Φ =
αβ
β − α
(
∂
∂t
∫ t
0
(
−α e−α(t−t′) + β e−β(t−t′)
)
M(t′) dt
)
=
αβ
β − α
∫ t
0
(
α2 e−α(t−t
′) − β2 e−β(t−t′)
)
M(t′) dt+ αβM(t) (B.2)
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By adding and subtracting identical parts of (B.2) we obtain,
d2
dt2
Φ =
αβ
β − α
∫ t
0
α2 e−α(t−t
′) − αβ e−β(t−t′)M(t′) dt︸ ︷︷ ︸
−α d
dt
Φ
+
αβ
β − α
∫ t
0
αβ e−β(t−t
′) − αβ e−α(t−t′)M(t′) dt′︸ ︷︷ ︸
−αβΦ
+
αβ
β − α
∫ t
0
αβ e−α(t−t
′) − β2 e−β(t−t′)M(t′) dt︸ ︷︷ ︸
−β d
dt
Φ
+αβM(t)
Rearranging,
d2
dt2
Φ = −α d
dt
Φ− αβ Φ− β d
dt
Φ + αβM(t)
d2
dt2
Φ + (α + β)
d
dt
Φ + αβ Φ = αβM(t)
which can be written in factorized form,(
d
dt
+ α
)(
d
dt
+ +β
)
Φ = αβM(t) (B.3)
B.2 Differential equation for soma response
As presented in (3.24), the soma resting potential is perturbed by input fluctuations from
excitatory e and inhibitory i chemical synapses,
Vk(t) = V
rest
k︸︷︷︸
soma resting potential
+Lk(t)⊗ [Ek(t) + Ik(t)]︸ ︷︷ ︸
input perturbation
(B.4)
Ek(t) and Ik(t) are the excitatory and inhibitory voltage inputs, and Lk(t) is the decay
exponential function for soma response,
Lk(t) =
1
τk
e−t/τk (B.5)
Expressing (B.4) in integral form,
Vk(t) = V
rest
k +
∫ t
0
Lk(t− t′)[Ek(t′) + Ik(t′)]dt′
138 Waikato Model
Applying theorem (B.1),
d
dt
Vk(t) =
∂
∂t
∫ t
0
Lk(t− t′)[Ek(t′) + Ik(t′)] dt′
=
∫ t
0
1
τk
Lk(t− t′)[Ek(t′) + Ik(t′)] dt′ + Lk(0)[Ek(t) + Ik(t)]
= − 1
τk
∫ t
0
Lk(t− t′)[Ek(t′) + Ik(t′)] dt′ + 1
τk
[Ek(t) + Ik(t)]
giving the soma voltage equation of motion
τk
d
dt
Vk(t) = V
rest
k − Vk(t) + Ek(t) + Ik(t) (B.6)
Appendix C
Derivation of the fluctuation spectrum
for the HvP model
Applying the convolution theorem to the HvP equations (6.11–6.14), we transform to the
frequency domain,
V˜e = Leeυeeφ˜e + LeiυeiQ˜i + Lesυese
−iωτ/2Q˜s (C.1)
V˜i = Lieυieφ˜e + LiiυiiQ˜i + LisυisQ˜se
−iωτ/2 (C.2)
V˜r = Lreυreφ˜ee
−iωτ/2 + LrsυrsQ˜s (C.3)
V˜s = Lseυseφ˜ee
−iωτ/2 + LsrυsrQ˜r + Lsnυsnφn (C.4)
To derive the fluctuation function, the sigmoid functions in the time domain are linearised
about steady state (V ∗e , V
∗
i , V
∗
s , V
∗
r ),
Q(Va) ≈ Q(V ∗a ) +
dQ
dVa
∣∣∣∣∣
V ∗a
(Va − V ∗a ) (C.5)
Fourier transforming both sides of (C.5) gives,
Q˜(Va) ≈
√
2piδ(ω)Q(V ∗a ) +Q
′(V ∗a )(V˜a −
√
2piδ(ω)V ∗a ) (C.6)
We now drop the delta-functions at zero frequency since they have no impact on system
dynamics,
Q˜(Va) ≈ Q′(V ∗a ) V˜a or V˜a ≈
Q˜(Va)
Q′(V ∗a )
(C.7)
where Q′(V ∗a ) is the sigmoid slope at steady state.
For pairs of neuron types (a, b) located either within cortex or within thalamus, for
[i.e., (a, b) ∈ (e, e), (e, i), (i, e), (i, i), (r, s), (s, r)] the frequency response from neuron type
b to neuron type a is given by,
ζab(ω) = LabυabQ
′(V ∗a ) (C.8)
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For pairs of neuron types separated by a time delay [i.e., (a, b) ∈ (e, s), (r, e), (i, s), (s, e)]
the frequency response from neurons of type b contains a phase shift that is due to the
propagation delay τ/2 between cortex and thalamus and is given by
ζab(ω) = LabυabQ
′(V ∗a )(e
−iωτ/2) (C.9)
Substituting (C.7) in (C.1),
Q˜e = ζeeφ˜e + ζesQ˜s + ζeiQ˜i
where
ζee = LeeυeeQ
′(V ∗e ) ζes = Lesυese
−iωτ/2Q′(V ∗e ) ζei = LesυeiQ
′(V ∗e )
Applying the same method for the other neural populations, enables us to write simplified
versions of Eqs. (C.1–C.4) as functions of firing rates:
D˜φ˜e = ζeeφ˜e + ζesQ˜s + ζeiQ˜i (C.10)
Q˜i = ζieφ˜e + ζisQ˜s + ζiiQ˜i (C.11)
Q˜r = ζreφ˜e + ζrsQ˜s (C.12)
Q˜s = ζsnφ˜n + ζseφ˜e + ζsrQ˜r (C.13)
where D˜φ˜e = Q˜e and D˜e = (1 +
iω
γ
)2. Substituting (C.12) in (C.13) and rearranging
gives,
Q˜s =
ζsnφ˜n + (ζse + ζsre)φ˜e
1− ζsrs (C.14)
Substituting (C.14) in (C.11) enables us to eliminate Q˜s. Solving (C.11) for Q˜i,
Q˜i =
[ζie(1− ζsrs) + (ζise + ζisre)]
(1− ζii)(1− ζsrs) φ˜e +
ζisn
(1− ζii)(1− ζsrs) φ˜e (C.15)
Finally, substituting (C.15 ) in (C.10), we obtain
(D˜ − ζee)φ˜e = ζesnφ˜n + (ζese + ζesre)
1− ζsrs φ˜e +
ζeie(1− ζeise + ζeisre)
(1− ζii)(1− ζsrs) φ˜e +
ζeisn
(1− ζii)(1− ζsrs) φ˜n
(C.16)
which can be written as the transfer function φ˜e/φ˜n,
φ˜e
φ˜n
=
ζeisn + (1− ζii)ζesn
[(D˜ − ζee)(1− ζsrs)− ζese − ζesre](1− ζii)− ζeie(1− ζsrs)− ζeise − ζeisre
(C.17)
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The dispersion relation corresponding to (C.17) is obtained by setting its denominator to
zero,
[(D˜ − ζee)(1− ζsrs)− ζese − ζesre](1− ζii)− ζeie(1− ζsrs)− ζeise − ζeisre = 0 (C.18)
where the solution from (C.18) corresponds to thalamocortical resonance with damping
rate Im(ω) and angular frequency Re(ω).
For representing the combined frequency response of different anatomical loops, the
following definition is applied,
ζabc(ω) = ζab(ω)ζbc(ω) (C.19)
the indexes are from right to left, applying (C.19) we have,
ζeisre(ω) = ζei(ω)ζis(ω)ζsr(ω)ζre(ω)
ζeise(ω) = ζei(ω)ζis(ω)ζse(ω)
ζsrs(ω) = ζsr(ω)ζrs(ω)
ζeie(ω) = ζei(ω)ζie(ω)
ζeisn(ω) = ζei(ω)ζis(ω)ζsn(ω)
ζesn(ω) = ζes(ω)ζsn(ω)
Appendix D
Derivation of the fluctuation spectrum
for the mHvP model
Full model equations for the mHvP for all neural populations are express as,
Ve = h(t)⊗
[
υeeψee(Ve)φe(t)
]
+ h(t)⊗
[
υesψes(Vs)Qs(t− τ/2)
]
+ hei(t)⊗
[
υeiψei(Ve)Qi(t)
]
(D.1)
Vi = h(t)⊗
[
υieψie(Vi)φe(t)
]
+ h(t)⊗
[
υisψis(Vi)Qs(t− τ/2)
]
+ hii(t)⊗
[
υiiψii(Vi)Qi(t)
]
(D.2)
Vs = h(t)⊗ υsnφn + h(t)⊗
[
υseψse(Vs)φe(t− τ/2)
]
+ hsr(t)⊗
[
υsrψsr(Vs)Qr(t)
]
(D.3)
Vr = h(t)⊗
[
υreψre(Vr)φe(t− τ/2)
]
+ h(t)⊗
[
υrsψrs(Vr)Qs(t)
]
(D.4)
where the weighting function ψab is defined,
ψab(Va) =
V revb − Va
V revb − V resta
,
and V resta and V
rev
a represent the rest and reversal potential respectively. To derive dis-
persion relation, the modified model is simplified by linearising system variables,
Va(t) ≈ V ∗a + δVa(t) a = e, i, r, s
Qa(t− τ) ≈ Q∗a + δQa(t− τ)
ψab(Va) ≈ V
rev
b − V ∗a
V revb − V ssa
− δVa(t)
V revb − V ssa
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Substituting above definition in (D.1–D.4) and then applying convolution theorem, we
transform to the frequency domain
V˜e(ω) = Lee υee
(
V reve − V ∗e
V reve − V sse
)
δφ˜e(ω) + Les υes
(
V revs − V ∗e
V revs − V sse
)
δQ˜s(ω)e
−iωτ
−
(
Lee υee
(
φ∗e
V reve − V sse
)
+ Lesυes
(
Q∗s
V revs − V sse
))
+ Lei υei
(
V revi − V ∗e
V revi − V sse
)
δQ˜i(ω)− Lei υei
(
Q∗i
V revi − V sse
)
(D.5)
After applying definitions (C.8) and (C.9) in (D.5), we obtain cortical excitatory neuronal
voltage in frequency domain,
V˜e(ω) Ce = ζee
(
V reve − V ∗e
V reve − V sse
)
δφ˜e(ω) + ζes
(
V revs − V ∗e
V revs − V sse
)
δQ˜s(ω) + ζei
(
V revi − V ∗e
V revi − V sse
)
δQ˜i(ω)
where
Ce = 1 + Lee υee
(
φ∗e
V reve − V sse
)
+ Lesυes
(
Q∗s
V revs − V sse
)
+ Lei υei
(
Q∗i
V revi − V sse
)
Similarly, for cortical inhibitory neurons,
V˜i(ω) Ci = ζie
(
V reve − V ∗i
V reve − V ssi
)
δφ˜e(ω) + ζis
(
V revs − V ∗i
V revs − V ssi
)
δQ˜s(ω) + ζii
(
V revi − V ∗i
V revi − V ssi
)
δQ˜i(ω)
where
Ci = 1 + Lie υie
(
φ∗e
V reve − V ssi
)
+ Lisυis
(
Q∗s
V revs − V ssi
)
+ Lii υii
(
Q∗i
V revi − V ssi
)
reticular neurons,
V˜r(ω) Cr = ζre
(
V reve − V ∗r
V reve − V ssr
)
δφ˜e(ω) + ζrs
(
V revs − V ∗r
V revs − V ssr
)
δQ˜s(ω)
where
Cr = 1 + Lre υre
(
φ∗e
V reve − V ssr
)
+ Lrsυrs
(
Q∗s
V revs − V ssr
)
the relay neuronal voltages in frequency domain define by,
V˜s(ω) Cs = ζsn φn + ζse
(
V reve − V ∗s
V reve − V sss
)
δφ˜e(ω) + ζsr
(
V revr − V ∗s
V revr − V sss
)
δQ˜r(ω)
144 Derivation of the fluctuation spectrum for the mHvP model
where
Cs = 1 + Lse υse
(
φ∗e
V revr − V sss
)
+ Lsrυsr
(
Q∗r
V revr − V sss
)
(D.6)
Rearranging equations above according the definition of transfer function (see Appendix C
more for details calculation),
φ˜e
φ˜n
φ˜e
φ˜n
=
Cr ψ
∗
ei ψ
∗
is ζeisn + (Ci − ζii)Crψ∗esζesn
g
(D.7)
where g =
[[
f (D˜ Ce − ζee ψ∗ee)−
[
ζeseCr ψ
∗
se + ζesre ψ
∗
sr ψ
∗
re]ψ
∗
es
]
(Ci − ζii)
]
− ψ∗ei
[
F ζeie ψ
∗
ie + ψ
∗
is [ζeiseCrψ
∗
se + ζeisre ψ
∗
sr ψ
∗
re]
]
and f = CsCr − ζsrs ψ∗rs ψ∗sr
To analyses the stability of the system, the denominator of (D.7) is zeroed, which giving
the dispersion relation of the system.[[
f (D˜ Ce − ζee ψ∗ee)−
[
ζeseCr ψ
∗
se + ζesre ψ
∗
sr ψ
∗
re]ψ
∗
es
]
(Ci − ζii)
]
(D.8)
− ψ∗ei
[
F ζeie ψ
∗
ie + ψ
∗
is [ζeiseCrψ
∗
se + ζeisre ψ
∗
sr ψ
∗
re]
]
= 0 (D.9)
where the solution corresponds to thalamocortical resonance with damping rate Im(ω)
and angular frequency Re(ω) in the mHvP model.
Appendix E
Source codes
This section includes selected Matlab source codes that generate dispersion curve results
in the thesis.
for j=1:Nroots % cycle through each of the roots in turn...
ROOT = flipud([Nroots*ones(Nroots,1) range domain]);
R = ROOT(j,:);
[ Nroots, Qe, Qi, Ve, Vi, lambda_e_A, lambda_e_N, lambda_i_a,
lambda_i_b, del_VeRest, sc] = ...
deal(R(1), R(2), R(3), R(4), R(5), R(6), R(7), R(8),
R(9), R(10), R(11));
% excitatory and inhibitory synaptic strengths
rho_e_A = lambda_e_A * H.ge; % (AMPA)
rho_e_N = lambda_e_N * H.ge; % (NMDA)
rho_i_a = lambda_i_a * H.gi; % (GABA_a)
rho_i_b = lambda_i_b * H.gi; % (GABA_b)
% define coefficient for Robinson wave equations in phi_ee, phi_ei
VL = H.v * H.Lambda;
% postsynaptic gains at steadystate
M_ek_A = H.Nn_ek_A*Qsige(Ve) + sc*H.phi_ek_sc; % (AMPA)
M_ek_N = H.Nn_ek_N*Qsige(Ve) + sc*H.phi_ek_sc; % (AMPA)
M_ik_a = H.n_ik_a*Qsigi(Vi); % (GABAa)
M_ik_b = H.n_ik_b*Qsigi(Vi); % (GABAb)
% derivatives of sigmoid functions
d_Qe = d_Qsige(Ve);
d_Qi = d_Qsigi(Vi);
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if isempty(JAC)
% if first call, recompute JAC
disp(’--- Recomputing NUmeric Jacobian ---’);
psi_ee_A = Psi_ee(Ve);
psi_ee_N = Psi_ee(Ve);
psi_ie_a = Psi_ie_a(Ve);
psi_ie_b = Psi_ie_b(Ve);
term1 = rho_e_A *H.d_psi_ee_A*M_ek_A;
term2 = rho_e_N*M_ek_N*(H.d_psi_ee_N*g_N(Ve,Mg,Theta);
+psi_ee_N*dg_N(Ve,Mg,Theta));
term3 = rho_i_a * H.d_psi_ie_a * M_ik_a;
term4 = rho_i_b * H.d_psi_ie_b * M_ik_b;
J11 = (-1 + term1 + term2 + term3 + term4 - D1*qwavenum.^2)/H.tau_e;
J13 = rho_e_A*psi_ee_A/H.tau_e;
J15 = rho_e_N*psi_ee_N*(g_N(Ve,Mg,Theta))/H.tau_e;
J17 = rho_i_a* psi_ie_a/H.tau_e;
J19 = rho_i_b* psi_ie_b/H.tau_e;
psi_ei_A = Psi_ei(Vi);
psi_ei_N = Psi_ei(Vi);
psi_ii_a = Psi_ii_a(Vi);
psi_ii_b = Psi_ii_b(Vi);
term5 = rho_e_A *H.d_psi_ei_A*M_ek_A;
term6 = rho_e_N*M_ek_N*(H.d_psi_ei_N*g_N(Vi,Mg,Theta);
+psi_ei_N*dg_N(Vi,Mg,Theta));
term7 = rho_i_a * H.d_psi_ii_a * M_ik_a;
term8 = rho_i_b * H.d_psi_ii_b * M_ik_b;
J22 = (-1+term5+term6 + term7+ term8 - D2*qwavenum.^2)/H.tau_i;
J23 = rho_e_A*psi_ei_A/H.tau_i;
J25 = rho_e_N*psi_ei_N*(g_N(Vi,Mg,Theta))/H.tau_i;
J27 = rho_i_a* psi_ii_a/H.tau_i;
J29 = rho_i_b* psi_ii_b/H.tau_i;
J34 = 1;
J41 = H.alpha_ek_A * H.beta_ek_A *H.n_ek_A * d_Qe;
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J43 = -H.alpha_ek_A * H.beta_ek_A;
J44 = -(H.alpha_ek_A + H.beta_ek_A);
J4_11 = H.alpha_ek_A * H.beta_ek_A*H.N_ek_A ;
J56 = 1;
J61 = H.alpha_ek_N * H.beta_ek_N *H.n_ek_A * d_Qe;
J65 = -H.alpha_ek_N * H.beta_ek_N;
J66 = -(H.alpha_ek_N + H.beta_ek_N);
J6_11 = H.alpha_ek_N * H.beta_ek_N*H.N_ek_N ;
J78 = 1;
J82 = alpha_ik_a * H.beta_ik_a * H.n_ik_a*d_Qi;
J87 = -alpha_ik_a * H.beta_ik_a;
J88 = -(alpha_ik_a + H.beta_ik_a);
J9_10 = 1;
J10_2 = H.alpha_ik_b * H.beta_ik_b * H.n_ik_b*d_Qi;
J10_9 = -H.alpha_ik_b * H.beta_ik_b;
J10_10 = -(H.alpha_ik_b + H.beta_ik_b);
J11_12 = 1;
VL = H.v * H.Lambda;
J12_1 = VL^2 * d_Qe;
J12_11 = -VL^2-(H.v*qwavenum).^2;
J12_12 = -2*VL;
% the range of wave number
[F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12] =...
deal(NaN*ones(size(qwavenum)));
% the entry containing qwavenum will change
for i = 1: length(qwavenum);
Jac = [
J11(i) 0 J13 0 J15 0 J17 0 J19 0 0 0
0 J22(i) J23 0 J25 0 J27 0 J29 0 0 0
0 0 0 1 0 0 0 0 0 0 0 0
J41 0 J43 J44 0 0 0 0 0 0 J4_11 0
0 0 0 0 0 1 0 0 0 0 0 0
J61 0 0 0 J65 J66 0 0 0 0 J6_11 0
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0 0 0 0 0 0 1 0 0 0 , 0 0
0 J82 0 0 0 0 J87 J88 0 0 0 0
0 0 0 0 0 0 0 0 0 J9_10 0 0
0 J10_2 0 0 0 0 0 0 J10_9 J10_10 0 0
0 0 0 0 0 0 0 0 0 0 0 J11_12
J12_1 0 0 0 0 0 0 0 0 0 J12_11(i)J12_12];
F = eig(Jac);
[tmp, I] = sort(real(F)); F = flipud(F(I));
end
end
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